Results
104
Mutant screens 105
Two independent ethyl methanesulfonate (EMS)-mutagenized lines with altered cardenolide 106
content were characterized, and the causal mutations identified via bulked segregant analysis 107
A
2
3
4
5
10
1
6
7
8
9
14
13
12
11
15
16
17
18
19
20
21
O
5β-cardenolides
digitoxigenin
5α-cardenolides
uzarigenin
Δ4-cardenolides
canarigenin
Δ5-cardenolides
xysmalogenin
B
HO
OH
O O
H
H
HO
OH
O O
H
H
HO
OH
O O
H
H
H
HO
OH
O O
H
H
H
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
5
(BSA). EMS mutant line #635 accumulates low levels of the cardenolides found in wildtype E. 108
cheiranthoides (Figure 2A; Table S1) and instead accumulates peaks with cardenolide-like 109
fragmentation and a m/z two Daltons less than digitoxigenin glycosides, suggesting that they may 110
be Δ4- or Δ5-unsaturated cardenolides (Figures 1B). This phenotype mapped to a region on 111
chromosome 7 (Figure 2B) containing a G148E missense mutation in Erche07g001535 112
(Ec3βHSD), a gene encoding a 3β-hydroxy-Δ5-steroid dehydrogenase (3βHSD) (Figure 2C). 113
Enzymes of this type are thought to be required for cardenolide biosynthesis (30–32). 114
115
Figure 2. Identification of candidate genes for cardenolide biosynthesis in Erysimum 116
cheiranthoides. (A) Cardenolide abundances in wildtype (WT) E. cheiranthoides and ethyl 117
methanesulfonate (EMS) mutant lines. Cardenolides in mutant #454 have the same mass as 118
cardenolides found in WT plants but elute at different retention times. Presumed 119
dehydrocardenolides are identified by a characteristic genin at m/z=373.2379. N = 4, error bars 120
indicate ± s.d., letters are p<0.001, ANOV A with post-hoc Tukey’s HSD on log-transformed peak 121
areas. (B) Mapping results of bulked segregant analysis for mutant #635. Alternate (mutant) 122
allele frequency, smoothed over 1 Mbp segments, is plotted across the eight E. cheiranthoides 123
chromosomes. In plants with a mutant chemotype (red), mutant alleles dominate in the latter half 124
of chromosome seven. (C) Within this region is a 3β-hydroxysteroid dehydrogenase (Ec3βHSD) 125
with a G148E missense mutation in mutant #635 plants. (D) In mutant #454 plants, there are two 126
EMS-induced mutations in the coding region of EcP5βR2. For mapping results for mutant #454, 127
see Figure S1. Exons are shown as blue rectangles, introns as blue lines, and untranslated regions 128
Total cardenolide−related peak area
0
1
2
3
4
Normalized peak area
a
c b
b
a
b c
b
a
5β−cardenolides5α−cardenolides
dehydrocardenolides
WT
mutant #454
mutant #635
A
1 2 3 4 5 6 7 8
wildtype
635 mutant
Alternate allele frequency in wildtype and 635 mutant, smoothed
Alternate allele frequency (%)
0.0
0.2
0.4
0.6
0.8
1.0
B
DC
Chromosome
Steroid biosynthesis
Steroid related, uncharacterized
Confirmed role in cardenolide biosynthesis
Other metabolic enzyme
glycosyltransferase
EcCYP716A418
EcCYP87A126
Erche07g001535 (Ec3βHSD)
Erche07g017160 (Ec3KSI)
Erche07g010950 (EcDET2)
E
ATG TAG
Ec3βHSD CACCGGACCAC
mutant #635 CACCGAACCAC
Chr07: 19,548,921 bp 19,547,574 bp
TAAATG
EcP5βR2 TCAAAGACCTGG...TCATGGGAATTC
mutant #454 TCAAAAACCTGG...TCATGAGAATTC
Chr06: 16,478,737 bp 16,477472 bp
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
6
as yellow rectangles. (E) Cardenolide-related gene coexpression cluster from an analysis of 129
transcript abundances in 48 Erysimum species. EcCYP716A418 and EcCYP87A126 are 130
cytochrome P450s involved in cardenolide biosynthesis in E. cheiranthoides. Other candidates 131
for involvement in cardenolide biosynthesis include a 5α-reductase (EcDET2), Ec3βHSD, and a 132
3-ketosteroid isomerase (Ec3KSI). 133
134
EMS mutant #454 was described by Mirzaei et al. (33), with the cardenolide phenotype 135
being linked to a locus on chromosome 6 (Figure S1). However, no causal mutation was 136
identified in that study. We re-evaluated the cardenolide phenotype and found that mutant #454 137
plants accumulate compounds with the same mass as digitoxigenin glycosides, but with shifted 138
retention times (Figure S2). We hypothesized that these peaks represent uzarigenin glycosides 139
with 5α stereochemistry (Figure 1B, 2A; Table S1). This led us to the identification of 140
Erche06g007150 (EcP5βR2), which encodes a progesterone-5β-reductase (P5βR). This group of 141
enzymes catalyzes the stereospecific reduction of α,β-unsaturated ketones including 142
progesterone, methylvinylketone, and 2-cyclohexene-1-one (34). EcP5βR2 contained two amino 143
acid mutations (R184K and G201R) at the genetically linked locus on chromosome 6 (Figure 144
2D). We therefore hypothesized that in the absence of a functional P5βR, a steroid 5α-reductase 145
(5αR) acts on progesterone, resulting in the accumulation of 5α-cardenolides. 146
Gene coexpression analysis 147
Gene coexpression analysis across 48 Erysimum species revealed a cluster of 28 148
coexpressed genes related to steroid metabolism and cardenolide biosynthesis (Figure 2E). Two 149
genes, EcCYP87A126 and EcCYP716A418, are involved in cardenolide biosynthesis (35), and 150
one, Ec3βHSD, was identified in EMS mutant #635. Eight genes in the cluster encode enzymes 151
that are directly involved in core sterol or isoprenoid metabolism (Table S2). The remaining 152
genes are considered candidates for involvement in cardenolide biosynthesis. Of note is a gene 153
encoding a short-chain dehydrogenase/reductase (SDR), Erche07g017160 (Ec3KSI). The closest 154
Arabidopsis ortholog, AT2G33630, is annotated as having a 3β-hydroxysteroid-155
dehydrogenase/isomerase domain (IPR002225)(36). An additional candidate from the 156
coexpression cluster is a steroid 5αR, Erche07g010950 (EcDET2), which is involved in 157
brassinosteroid biosynthesis (37) and may also be involved in 5α-cardenolide biosynthesis. 158
Functional characterization of candidate enzymes 159
We examined the role of candidate enzymes for involvement in cardenolide biosynthesis by 160
functionally characterizing the recombinant purified proteins in vitro. Recombinant Ec3βHSD 161
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
7
had steroid-3-dehydrogenase activity on pregnenolone 2 to form isoprogesterone 3 in the 162
presence of NAD+. We also saw some production of progesterone 4, implying that the enzyme 163
may additionally have Δ5,4 isomerase activity (Figure 3A, S3; Table S3). As plant 3βHSD 164
enzymes typically do not possess Δ5,4 isomerase activity (31, 38, 39), we independently checked 165
for isomerase activity by supplying the enzyme directly with isoprogesterone 3, but we did not 166
see an increase in isomerization to progesterone 4 relative to a negative control (Figure 3B, S3; 167
Table S3). 168
169
Figure 3. Characterization of candidate cardenolide biosynthetic enzymes from Erysimum 170
cheiranthoides. Assays are in vitro with purified recombinant enzymes except where noted. (A) 171
Conversion of pregnenolone to isoprogesterone and progesterone by 3β-hydroxysteroid 172
dehydrogenase (Ec3βHSD) and 3-ketosteroid isomerase (Ec3KSI). (B) Conversion of 173
isoprogesterone to progesterone by Ec3βHSD and Ec3KSI. Under assay conditions, ~50% of the 174
peak area is attributable to progesterone even in the negative control. (C) Conversion of 175
progesterone to 5β-pregnane-3,20-dione by progesterone 5β-reductase 2 (EcP5βR2). (D) In N. 176
benthamiana, significantly more 5α-pregnane-3,20-dione is produced when progesterone is 177
pregnanolone
0
20
40
60
80
100Normalized peak area
Nb_4g2680Nb_677Nb_467g17Nb_467g15Nb_477Nb_4677
b
c
b
b b
a
progesterone
normalized peak area
HO
H
O
H
H
H
O
H
O
H
H
H
Ec3βHSD
EcCYP87A126
Ec3KSI
HO
O
H
H
H
O
O
H
H
H
O
O
H
H
H
O
O
H
H
H H
EcDET2
pregnenolone 2
isoprogesterone 3
progesterone 4
5β-pregnane-3,20-dione 55α-pregnane-3,20-dione 7
Ec3βHSD
epipregnanolone 6
EcCYP87A126
Ec3βHSD
Ec3KSI
EcP5βR2
+
+
+
+
+
-
-
+
+
-
+
+
+
-
+
+
-
-
+
+
+
+
-
+
Ec3βHSD
Ec3KSI
-
-
+
-
-
+
+
+
-
-
+
-
-
+
+
+
Ec3βHSD
Ec3KSI
- + -
- - +
C
F
HO
H
O
H
H
H
isopregnanolone 8
Ec3βHSD
NAD+
NADH
NADH
NAD+
NADH
NAD+
NADPH
NADP+
pregnenolone + +++ + +++ isoprogesterone +++
A
D
B
E
Ec3βHSD
Ec3KSI
- + -
- - +
5β-pregnane-3,20-dione +++
EcP5βR2 - +
progesterone ++
5α-pregnane-3,20-dione - - -
- +
- -
++
- -
GFP
EcDET2
progesterone
log10 normalized isoprogesterone peak area
Normalized peak area
0
10
100
1000
negative controlEc3βHSD
P<0.001
log10 normalized isoprogesterone peak area
Normalized peak area
0
10
100
1000
negative controlEc3βHSD
Ec3KSI
b
a
b
log10 normalized isoprogesterone peak area
Normalized peak area
0
10
100
1000
negative controlEcP5βR
P=0.013 Nicotiana benthamiana
isoprogesterone
normalized peak area5β-pregnane-3,20-dione
normalized peak area
progesterone:isoprogesterone
peak area ratio
Percent conversion to progesterone
0
5
10
15
Proportion converted to progesterone
negative controlEc3βHSD
Ec3KSI
b b
a
-+ -
-
- +
++
+
epi- or isopregnanolone
normalized peak area
epi- or isopregnanolone
normalized peak area
EcP5βR
NAPD+
NADPH
5α-pregnane-3,20-dione
normalized peak area
log10 normalized isoprogesterone peak area
Normalized peak area
0
50
100
negative controlEc3βHSD
Ec3KSIEc3βHSD +
Ec3KSI
b
a
b
a
log10 normalized progesterone peak area
normalized peak area
0
5000
10000
15000
negative controlEc3βHSD
Ec3KSIEc3βHSD +
Ec3KSI
c b c
a
log10 normalized 5apregnane320dione peak area
Normalized peak area
0
1000
2000
GFP + progEcDET2 + bufferEcDET2 + prog
b
c
a
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
8
coinfiltrated with 5α-reductase (EcDET2) compared to a negative control. (E) Reduction of 5β-178
pregnane-3,20-dione and 5ɑ-pregnane-3,20-dione to epipregnanolone or a stereoisomer by 179
Ec3βHSD but not Ec3KSI. (F) Production of epipregnanolone or stereoisomer when 180
EcCYP87A126, Ec3βHSD, Ec3KSI, and EcP5BR2 are coexpressed in N. benthamiana. For all 181
assays: N = 3 replicates per enzyme, except in (D) where N=5. Error bars indicate ± s.d., letters 182
are P<0.001, ANOV A with post-hoc Tukey’s HSD. P-values above bars are from Student’s t-test. 183
Statistics were performed on log-transformed peak areas. Negative controls used a purified 184
recombinant 2-oxoglutarate dioxygenase not otherwise discussed in this study. LCMS 185
chromatograms and MSMS spectra associated with all assays are provided in Figure S3. 186
187
We also tested Ec3βHSD for the ability to catalyze the reverse reaction, the reduction of 188
the 3-keto group of 5β-pregnane-3,20-dione 5 or 5α-pregnane-3,20-dione 7 to the 3β-hydroxyl in 189
epipregnanolone 6 or isopregnanolone 8. When Ec3βHSD was supplied with 5β-pregnane-3,20-190
dione 5 or 5α-pregnane-3,20-dione 7 as a substrate and NADH as a cofactor, we saw formation 191
of a product with m/z=319.2637 in both cases, which is consistent with epipregnanolone 6 and 192
isopregnanolone 8, but we were unable to separate these two products and the epipregnanolone 193
standard chromatographically (Figure 3E, S3; Table S3). Therefore, the exact stereochemical 194
configuration of these predicted products is not confirmed. 195
Recombinant Ec3KSI converts isoprogesterone 3 to progesterone 4 in vitro (Figure 3B, 196
S3). We also tested Ec3KSI for 3βHSD activity, but no activity was observed for either the 197
oxidation or reduction reaction (Figure 3A,E, S3; Table S3). Furthermore, when we combined 198
Ec3βHSD and Ec3KSI in a single reaction and supplied pregnenolone and NAD+, we observed 199
consumption of isoprogesterone and increased formation of progesterone relative to the same 200
reaction containing only Ec3βHSD (Figure 3A; Table S3). We therefore identified Ec3KSI as a 201
3-ketosteroid isomerase and showed that it works in concert with Ec3βHSD to convert 202
pregnenolone 2 to progesterone 4. When supplied with progesterone 4 and NADPH, recombinant 203
EcP5βR2 catalyzes the formation of 5β-pregnane-3,20-dione 5 (Figure 3C, S3; Table S3). 204
EcDET2 is membrane-bound, complicating purification of the recombinant protein. We 205
therefore coinfiltrated EcDET2 with progesterone in Nicotiana benthamiana leaves. Although 206
the 5α-reduction of progesterone 4 is catalyzed by endogenous enzymes in N. benthamiana 207
leaves even in the GFP control, more 5α-pregnane-3,20-dione 7 is produced when EcDET2 is 208
present, consistent with previous studies showing that DET2 orthologs can use progesterone 4 as 209
a substrate (40) (Figure 3D, S3; Table S3). 210
Production of epipregnanolone in N. benthamiana 211
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
9
To test whether the identified enzymes can work together in planta to produce intermediates in 212
cardenolide biosynthesis, we coexpressed the sterol side chain cleaving enzyme that initiates 213
cardenolide biosynthesis, EcCYP87A126 (35, 41) together with Ec3βHSD, Ec3KSI, and 214
EcP5βR2 in leaves of N. benthamiana and observed the production of a compound with the same 215
m/z and retention time as epipregnanolone 6, although we cannot rule out that it may be a 216
stereoisomer (Figure S3). A small amount of epipregnanolone 6 was detected as long as 217
EcCYP87A126 was present, but significantly more epipregnanolone 6 was produced if 218
Ec3βHSD, Ec3KSI, and EcP5βR2 were all included (Figure 3F; Table S3). 219
Knockouts of candidate genes have altered cardenolide profiles 220
To assess the role of candidate enzymes in cardenolide biosynthesis in vivo, we generated two 221
independent CRISPR/Cas9 knockout lines for all candidate genes (Figures S4-S8 for sequences 222
of mutants). With the exception of det2 knockout lines, which had the characteristic dwarf 223
phenotype of brassinosteroid biosynthetic mutants (37) (Figure 4A), none of the mutant lines 224
displayed obvious growth phenotypes. We analyzed cardenolide profiles via UPLC-MS, using 225
both methanolic extracts of intact cardenolides and cardenolide extracts subjected to mild acidic 226
conditions, which resulted in hydrolysis of the sugar moieties. This allowed us to directly 227
compare the cardenolide genins produced by each mutant line. For Δ4-cardenolides (canarigenin 228
glycosides), a water molecule is eliminated under acidic conditions to produce 3,5-229
anhydroperiplogenin (Figure 4C)(19, 20), which we used as a proxy for Δ4-cardenolide 230
abundance. While we did not have an authentic standard for uzarigenin, xysmalogenin, 231
canarigenin, 3,5-anhydroperiplogenin, cannogenol, or cannogenin, MSMS spectra together with 232
pathway logic allowed us to identify these compounds with reasonable confidence. To further 233
confirm our identification of uzarigenin, we performed acid hydrolysis on cardenolide extracts 234
from uzarigenin-containing Calotropis procera leaves (Figure S9)(42). 235
Based on a principal component analysis (PCA) of intact cardenolides in the mutant lines, 236
we confirmed a causal relationship between the genetically linked mutations in EMS mutants 237
#454 and #635 and their cardenolide phenotypes (Figure 4B; Table S1). Hydrolyzed extracts of 238
wildtype E. cheiranthoides and det2 single mutants were dominated by the 5β-cardenolide series: 239
digitoxigenin, cannogenol, cannogenin, and strophanthidin. All other mutant lines had altered 240
cardenolide profiles relative to wildtype, but cardenolide production was not eliminated in any of 241
the mutants. 3bhsd and 3ksi lines had similar cardenolide profiles, with both lines accumulating 242
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
10
lower levels of 5β-cardenolides compared to wildtype and containing Δ5-cardenolides with 243
m/z=373.2379, which are not found in wildtype E. cheiranthoides (Figure 4C, S10; Table S4). 244
Although the chemotype of 3bhsd and ksi lines was qualitatively very similar, the reduction in 245
5β-cardenolide abundance was more severe in 3bhsd plants (Figure S11; Table S5). One possible 246
explanation for this is a degree of functional overlap between these enzymes. To test whether 247
Ec3βHSD and Ec3KSI have redundant roles in cardenolide biosynthesis, we crossed 3bhsd-1 and 248
3ksi-1 lines to generate 3bhsd/3ksi double mutants. The double mutants had a cardenolide profile 249
very similar to 3bhsd plants (Figure S11; Table S5), suggesting that Ec3βHSD and Ec3KSI have 250
distinct roles. If the two enzymes were redundant, we would expect an additive effect on the 251
cardenolide phenotype in the double mutant. 252
253
Figure 4. Characterization of Erysimum cheiranthoides cardenolide biosynthesis mutants. 254
(A) Photo of E. cheiranthoides wildtype (WT), a steroid 5α-reductase (det2) knockout, and a 255
DET2/progesterone 5β-reductase (det2/p5br) double mutant, which display a dwarf phenotype 256
characteristic of brassinosteroid biosynthesis mutants. (B) Principal component analysis of intact 257
cardenolides detected by UPLC-MS in E. cheiranthoides WT and mutant lines: 3β-258
hydroxysteroid dehydrogenase (3bhsd), 3-ketosteroid isomerase (3ksi). Ethyl methane-sulfonate 259
(EMS) mutants #454 and #635 cluster with corresponding CRISPR/Cas9 mutant lines. Arrows 260
A
B
C
O
H
O
H
H
H
EcCYP87A126
HO
O
H
H
H
O
O
H
H
H
O
O
H
H
H
HO
OH
O O
H
H
H
HO
OH
O O
H
H
HO
OH
O O
H
H
HO
OH
O O
H
H
H
O
O
H
H
H H
5β-cardenolides5α-cardenolidesΔ4-cardenolidesΔ5-cardenolides
Ec3βHSD Ec3KSI
EcP5βR2
EcDET2
WT det2 det2/p5br2 −2 0 2 4 6
−4
−2
0
2
PCA of all peaks (normalized by internal standard)
PC1 (49.1%)
PC2 (34%)
wildtype
3bhsd−1
3bhsd−2
mutant #635
3ksi−1
3ksi−2
p5br2−1
p5br2−2
mutant #454
det2−1
det2−2
det2/p5br2−1
det2/p5br2−2
→
→
→
5β−cardenolides
5α−cardenolides
dehydrocardenolides
OH
O O
hydrolytic
conditions
3,5-anhydroperiplogenin
Peak area attributable to each genin
Proportion of total peak area
WT 3bhsd 3ksi p5br2
det2−1
det2/p5br2−2
1 2 1 2 1 2
0.00
0.25
0.50
0.75
1.00
HO
H
OH
O O
HO
H
H
HO
H
OH
O O
O
H
H
HO
OH
OH
O O
O
H
H
xysmalogenin canarigenin uzarigenin digitoxigenin cannogenol
cannogenin strophanthidin
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
11
indicate loadings for individual cardenolide mass features and are grouped into structural classes 261
by color. (C) Relative peak area of cardenolide genins following acid hydrolysis of E. 262
cheiranthoides mutant lines (N = 3 plants per line). For Δ5-cardenolides (grey; xysmalogenin), 263
5α-cardenolides (red; uzarigenin), and 5β-cardenolides (blue; digitoxigenin, cannogenin, 264
cannogenol, and strophanthidin), the cardenolide genins were detected directly via UPLC-MS. 265
Δ4-cardenolides undergo dehydration under acid conditions, so 3,5-anhydroperiplogenin was 266
detected as a proxy for canarigenin (yellow). 267
268
Acid hydrolysis confirmed the digitoxigenin-glycoside isomers in p5br2 plants to be 269
uzarigenin glycosides, with 5α configuration (Figure 4C). Additionally, p5br2 lines accumulated 270
the same m/z=373.2379 peaks observed in 3bhsd and 3ksi lines, which we observed to be a mix 271
of Δ4- and Δ5-cardenolides following hydrolysis (Figure 4C; Table S4). Notably, cardenolide 272
hydroxylation (resulting in the derived cardenolide genins cannogenol, cannogenin, and 273
strophanthidin) is eliminated in p5br2 plants, suggesting that the cardenolide hydroxylases 274
expressed in E. cheiranthoides act only on 5β-cardenolides (Figure 4C, S10). Although these 275
Results
clearly demonstrate the involvement of EcP5βR2 in cardenolide biosynthesis, we also 276
investigated a paralogous gene, EcP5βR1 (Erche02g027660), for potential involvement in the 277
pathway. EcP5βR1 acted on progesterone 4 to produce 5β-pregnane-3,20-dione 5 when co-278
infiltrated in N. benthamiana (Figure S12). However, in a EcP5βR1 knockout line, the 279
cardenolide profile was unchanged (Figure S13; Table S6). 280
In order to test whether 5α-cardenolide production in p5br2 mutants was mediated by 281
EcDET2, we generated CRISPR/Cas9 knockouts of EcDET2 in the p5br2-1 background. In 282
p5br2/det2 double mutants, production of cardenolides with a fully reduced steroid core was 283
nearly eliminated, and was replaced by accumulation of a mix of Δ4- and Δ5-cardenolides 284
(Figure 4C, Table S4), confirming that EcDET2 acts as a 5αR in cardenolide biosynthesis in the 285
absence of a functional EcP5βR2. 286
Natural variation in progesterone 5β-reductase activity across the genus Erysimum 287
We conducted a survey of the cardenolide genins across the genus by subjecting methanolic leaf 288
extracts from 44 species of Erysimum to acid hydrolysis. The following cardenolide genins were 289
detected: the 5β-cardenolides digitoxigenin, cannogenol, cannogenin, and strophanthidin; the 5α-290
cardenolide uzarigenin; the Δ4-cardenolide canarigenin; the Δ5-cardenolide xysmalogenin; and 291
an isomer of cannogenol that we speculate may be its 5α-isomer. With the exception of E. 292
collinum, which does not produce detectable levels of cardenolides, both uzarigenin and 293
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
12
strophanthidin were detected in hydrolyzed extracts of all species. Digitoxigenin, cannogenol, 294
and cannogenin were relatively rare, being mostly restricted to the monophyletic clade 295
containing E. cheiranthoides, E. sylvestre, and two closely related species of uncertain 296
taxonomic identity (43)(Figure 5A). 3,5-anhydroperiplogenin (canarigenin) and xysmalogenin 297
were also detected at low levels in some species (Figure 5A; Table S7). 298
299
Figure 5. Gene expression and cardenolide configuration across 44 species of Erysimum. (A) 300
Expression of cardenolide biosynthesis genes and detection of eight cardenolide genins 301
following acid hydrolysis mapped against an Erysimum species phylogeny (Züst et al 2020). 302
Grey indicates very low expression (<50 counts per million reads). Expression for each gene is 303
normalized separately. * indicates a frameshift mutation in P5BR2-1. Cardenolide genin 304
abundances are displayed as percent of total LC-MS peak area of all genins, mean of n=1-3 305
replicates per species. No data are displayed for E. collinum due to very low levels of 306
cardenolides. (B) Location and sequence of frame-shift mutations in the coding region of 307
EcP5bR2 orthologs from Erysimum sp. 1 (ER1), E. pieninicum (PIE), E. hungaricum (HUN), E. 308
hieraciifolium (HIE), and E. virgatum (VIR). Regions translated out of frame are indicated in 309
red, with in-frame stop codons bold and underlined. (C) Amino acid phylogeny of Erysimum 310
P5bR2 proteins for which a full sequence could be recovered from the transcriptomes. Activity 311
of selected enzymes were tested via transient expression and co-infiltration of progesterone in 312
Nicotiana benthamiana leaves. Numbers at nodes indicate bootstrap support from 10,000 313
<50
<50
<50
<50
<50
<50
<50
<50
<50
<50
<50
<50
<50
<50
<50
<50
<50
<50
<50
<50
<50
<50
<50
<50
<50
<50
<50
<50
<50
<50
Erche04g002680
Erche07g001535
Erche07g017160
Erche02g027660
Erche06g007150
Erche07g010950
MED
NEV
BAS
FIZ
NER
RUS
MEX
SCO
BIC
LAG
AMO
MEZ
FRA
CAP
ALI
CSS
CRA
COL
DIF
AND
RHA
WIT
ODO
PSE
VIR
HIE
ER1
HUN
PIE
ER2
PUL
CUS
MIC
CRE
KOT
ECE
SYL
ER4
ER3
NAX
CHR
WIC
INC
REP
0
200
400
600
800
1000
0.2
ASP_NO_STOP
VIR2
SYL
ECE_2g27660
PIE2_R
CRP_R_DN12743_i3
PSE_R
RHA_R
HUN_R
RHA3
PUL2_R
HIE1
CRP_R
ECE_6g7150
SUF
KOT_R
CSS
97
42
86
90
76
71
84
36
82
99
64
53
91
0.2
ASP_NO_STOP
VIR2
SYL
ECE_2g27660
PIE2_R
CRP_R_DN12743_i3
PSE_R
RHA_R
HUN_R
RHA3
PUL2_R
HIE1
CRP_R
ECE_6g7150
SUF
KOT_R
CSS
97
42
86
90
76
71
84
36
82
99
64
53
91
0.2
ASP_NO_STOP
VIR2
SYL
ECE_2g27660
PIE2_R
CRP_R_DN12743_i3
PSE_R
RHA_R
HUN_R
RHA3
PUL2_R
HIE1
CRP_R
ECE_6g7150
SUF
KOT_R
CSS
97
42
86
90
76
71
84
36
82
99
64
53
91
Erysimum sp. 1
E. kotschyanum
E. crassipes
E. rhaeticum
E. pseudorhaeticum
Erysimum sp. 2
E. pulchellum
E. hieraciifolium
E. virgatum
Erysimum sp. 1
E. pieninicum
E. hungaricum
E. cheiranthoides (EcP5βR2)
Erysimum sp. 4
E. sylvestre
Erysimum sp. 3
E. cheiranthoides (EcP5βR1)
cannogenol(5β)
cannogenolisomer (presumed 5ɑ)uzarigenin (5ɑ)
canarigenin (Δ4)
E. mediohispanicum
E. nevadense
E. bastetanum
E. fitzii
E. nervosum
E. ruscinonense
E. merxmuelleri
E. scoparium
E. bicolor
E. lagascae
E. amoenum
E. menziesii
E. franciscanum
E. capitatum
E. allionii
E. crassipes
E. crassicaule
E. collinum
E. diffusum
E. andrzejowskianum
E. rhaeticum
E. wittmannii
E. odoratum
E. pseudorhaeticum
E. virgatum
E. hieraciifolium
Erysimum sp. 1
E. hungaricum
E. pieninicum
Erysimum sp. 2
E. pulchellum
E. cuspidatum
E. microstylum
E. crepidifolium
E. kotschyanum
E. cheiranthoides
E. sylvestre
Erysimum sp. 4
Erysimum sp. 3
E. naxense
E. cheiri
E. wilczekianum
E. incanum
E. repandum
C
A
Active on progesterone in Nicotiana benthamiana
Inactive (truncated protein)
Not tested (truncated protein)
Not tested (full length protein)
ATG TAA
EcP5βR2 TGTGTTT...TAA
ER1-1 TGT--TT...TAA
EcP5βR2 GGATATCGGGA...GGGAGAGAGA-----------AA...TGA
PIE/HUN GG-------GA...GGGAGAGAGA-----------AA...TGA
HIE GGATATCGGGA...GG-AGAGAGA-----------AA...TGA
VIR GGATATCGGGA...GGGAGAGAGATGGGAGAGAGAAA...TGA
B
CYP87A1263βHSD3KSIP5βR1P5βR2DET2cardenolide genins
**
**
Erche04g002680
Erche07g001535
Erche07g017160
Erche02g027660
Erche06g007150
Erche07g010950
MED
NEV
BAS
BAE
FIZ
NER
RUS
MEX
SCO
BIC
LAG
AMO
MEZ
FRA
CAP
ALI
CSS
CRA
COL
DIF
AND
RHA
WIT
ODO
MAJ
PSE
VIR
HIE
ER1
HUN
PIE
ER2
PUL
CUS
MIC
CRE
KOT
ECE
SYL
ER4
ER3
NAX
CHR
WIC
INC
REP
0
5e−01
1
1.5
2
2.5
30 1000normalized expression
* P5βR2-1 frameshift mutation
xysmalogenin (Δ5)
*
digitoxigenin (5β)
cannogenin (5β) strophanthidin (5β)
P5βR2-2P5βR2-1
Peak area attributable to each genin
Proportion of total peak area
MED
NEV
BAS
FIZ
NER
RUS
MEX
SCO
BIC
LAG
AMO
MEZ
FRA
CAP
ALI
CSS
CRA
COL
DIF
AND
RHA
WIT
ODO
PSE
VIR
HIE
ER1
HUN
PIE
ER2
PUL
CUS
MIC
CRE
KOT
ECE
SYL
ER4
ER3
NAX
CHR
WIC
INC
REP
0.00 0.25 0.50 0.75 1.00
REP
INC
WIC
CHR
NAX
ER3
ER4
SYL
ECE
KOT
CRE
MIC
CUS
PUL
ER2
PIE
HUN
ER1
HIE
VIR
PSE
ODO
WIT
RHA
AND
DIF
COL
CRA
CSS
ALI
CAP
FRA
MEZ
AMO
LAG
BIC
SCO
MEX
RUS
NER
FIZ
BAS
NEV
MED
Inf −Infvalue
Erche04g002680Erche07g001535Erche07g017170Erche06g007150Erche07g010950digitoxigeninuzarigeninxysmalogenindianhydroperiplogenin
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
13
replicates and scale bar indicates estimated substitutions per site. Multiple sequence alignment 314
underlying P5bR2 protein phylogeny is available in Figure S14. 315
316
We next examined P5βR2 and DET2 sequences and expression levels across the 317
Erysimum genus to better understand how they interact to determine relative levels of 5α- and 318
5β-cardenolides. Of the three P5βR sequences found in the E. cheiranthoides genome, only two 319
have orthologs that are expressed in the species included in this study. EcP5βR1 orthologs are 320
uniformly expressed across the genus, but based on the E. cheiranthoides p5br1 knockouts, they 321
are unlikely to be involved in 5β-cardenolide biosynthesis. By contrast, EcP5βR2 orthologs are 322
only expressed at greater than 50 counts per million reads (CPM) in 15 of the 44 species 323
examined (Figure 5A; Table S8), and in five of these species, P5βR2 contains a frameshift 324
mutation (Figure 5B, S14). Based on protein phylogeny, Erysimum P5βR2 proteins can be 325
further classified into two clades, P5βR2-1 and P5βR2-2, with EcP5βR2 belonging to the 326
P5βR2-1 clade (Figure 5C). We cloned P5βR2 orthologs in both clades from six Erysimum 327
species, as well as EcP5βR1, and assessed activity via co-infiltration with progesterone 4 in N. 328
benthamiana. All full-length P5βR2 proteins were capable of converting progesterone 4 to 5β-329
pregnane-3,20-dione 5 in planta, while truncations resulted in a loss of activity (Figure 5C, S12). 330
Erysimum sp. 1 was the only species to express both P5βR2-1 and P5βR2-2, but the expressed 331
P5βR2-1 encodes a non-functional protein. Among species examined, the expression of a 332
functional P5βR2-1 was required for production of the 5β-cardenolides digitoxigenin and 333
cannogenin. 334
Orthologs of Ec3βHSD, EcKSI, and EcDET2 are expressed across the genus, including in 335
Erysimum collinum, where CYP87A126, the first gene in the pathway, is not expressed and very 336
low levels of cardenolides are produced (43) (Figure 5A), suggesting that they may have roles in 337
steroid metabolism outside of cardenolide biosynthesis. Close examination of the transcriptome 338
data revealed that some species express more than one distinct transcript of the genes examined 339
here, despite the E. cheiranthoides genome containing only one copy in the case of Ec3βHSD 340
and EcDET2. However, the nature of transcriptomic data makes it difficult to assess genomic 341
copy number, and it is unclear whether transcriptomic sequence variation is due to polypoidy in 342
some species, gene duplication and sequence divergence, or allelic variation of a single locus. 343
Phylogenetic analysis of E. cheiranthoides cardenolide biosynthesis genes 344
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
14
We inferred phylogenetic trees for Ec3βHSD, EcKSI, EcP5βR, and EcDET2 to better understand 345
their relationship to characterized genes from other species. All species examined had more than 346
one Ec3βHSD-like gene, with the exception of E. cheiranthoides. The three orthologs from E. 347
crepidifolium (44), two from D. lanata (30–32), and two from A. thaliana, AtSDR5 348
(AT2G47140) and AtSDR3 (AT2G47130) (10), have been shown to accept cardenolide 349
intermediates in vitro, but in planta evidence for involvement in cardenolide biosynthesis only 350
exists for Dl3βHSD1 (30) (Figures 6A, S15). Of the species included in the KSI gene tree, only 351
E. cheiranthoides contained more than one copy (Figures 6B, S16). To our knowledge, no 352
enzymes from this group have been biochemically characterized prior to this study. 353
354
Figure 6. Phylogenetic analysis of Erysimum cheiranthoides cardenolide biosynthetic genes. 355
Nucleotide phylogenies for cardenolide biosynthetic genes from E. cheiranthoides and selected 356
Active on cardenolide intermediates, or in vivo evidence for involvement
in vivo evidence suggests not involved
Not tested
Non-cardenolide producing species
Cg_12956
Cg_5349
EcDET2 (Erche07g010950)
AtDET2 (AT2G38050)
Dl2934
Mp0170s0018
0.2
Cg_12956
Dl2934
Cg_5349
Erche07g010950
AtDET2_AT2G38050
M_polymorpha_0170s0018
57
46
96
0.09
Ecre_5540
Ecre_9065
AtSDR5_AT2G47140
AT2G47150
Ecre_7213
Erche07g001535
AtSR3_AT2G471430
AtSDR4_AT3G29250
AT3G29260
Dl3BHSD2
Dl3BHSD1
AT3G51680
AT2G47120
98
79
97
97
100
49
62
90
94
98
Dl3βHSD1
Dl3βHSD2
AtSDR5 (AT2G47140)
Ec3βHSD (Erche07g001535)
EcreHSD1
AT2G47150
AT2G47120
EcreHSD2
AtSDR3 (AT2G47130)
AtSDR4 (AT3G29250)
AT3G29260
EcreHSD3
AtSDR2 (AT3G51680)
0.2
Erche06g011020
Dl_DN4564
Dl_DN477
Erche06g007150
Ecre_P5BR2
DlP5BR2
AT5G58750
AT4G24220_VEP1
Ecre_P5BR1
Erche02g027660
Mp0191s0002
Dl_DN67489
DlP5BR1
57
99
100
100
96
49
100
99
99
100
81
Dl_DN67489
AtP5βR2 (AT5G58750)
EcP5βR2 (Erche06g007150)
EcP5βR3 (Erche06g011020)
EcreP5βR2
Mp0191s0002
Dl_4564
DlP5βR2
AtP5βR1 (AT4G24220)
EcP5βR1 (Erche02g027660)
EcreP5βR1
Dl_DN477
DlP5βR1
Erche04g028310
Ec3KSI (Erche07g017160)
AT2G33630
Dl_DN10245
Cg_010433
AT1G47290
0.2
AT2G33630
AT1G47290
Erche04g028310
Erche07g017170
Dl_DN10245
Cg010433
98
53
88
A
B
C
D
active on pregnenolone
in vivo evidence
active on isoprogesterone
in vivo evidence
active on progesterone
in vivo evidence
active on progesterone
in vivo evidence
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
15
other species for which functional work has been done. (A) 3β-hydroxysteroid dehydrogenase 357
(3βHSD) and related short-chain dehydrogenases (SDR), (B) 3-ketosteroid isomerase (3KSI), 358
(C) progesterone 5β-reductase (P5βR), and (D) steroid 5α-reductase (DET2). Experimental 359
evidence for activity on cardenolide intermediates or in vivo evidence for involvement in 360
cardenolide biosynthesis, either in this or previous studies, are marked by black squares. 361
Enzymes for which in vivo evidence suggests the enzyme is not involved in cardenolide 362
biosynthesis are marked by red squares. Species included: Arabidopsis thaliana (At/AT), 363
Calotropis gigantea (Cg), Erysimum cheiranthoides (Ec/Erche), Erysimum crepidifolium (Ecre), 364
Digitalis lanata (Dl), and Marchantia polymorpha (Mp). Numbers at nodes indicate bootstrap 365
support from 10,000 replicates and scale bar indicates estimated substitutions per site. Multiple 366
sequence alignments underlying these phylogenies are provided in Figures S15-S18. 367
368
P5βR genes fall into two clades arising from an ancient duplication event (33.8% amino 369
acid identity between EcP5βR1 and EcP5βR2). Members of both clades have been shown to act 370
on progesterone in vitro (13, 34, 45, 46), but only DlP5βR1, which is a more closely related to 371
EcP5βR1, has a confirmed role in 5β-cardenolide biosynthesis (47). EcP5βR2, which we show to 372
be required for 5β-cardenolide biosynthesis in E. cheiranthoides, belongs to the other clade 373
(Figures 6C, S17). EcDET2, which is required for 5α-cardenolide biosynthesis in E. 374
cheiranthoides, is a single copy gene for most species examined, and it accepts progesterone as a 375
substrate even in species that do not make cardenolides, such as A. thaliana and S. lycopersicum 376
(40). Intriguingly, C. gigantea, which accumulates 5α-cardenolides, contains two copies of this 377
gene (Figures 6D, S18). 378
Discussion
379
Identification E. cheiranthoides cardenolide biosynthesis genes 380
In this study, we identified and biochemically characterized four cardenolide biosynthetic 381
enzymes from E. cheiranthoides. Of these, Ec3βHSD and EcP5βR2 belong to enzyme families 382
that have been speculated, or shown, to be involved in cardenolide biosynthesis in other species 383
(13, 30, 31, 45, 47). However, the mutant lines generated in this study provide critical in vivo 384
evidence for their role in cardenolide synthesis, and the lack of a cardenolide phenotype for 385
EcP5βR1 knockouts highlights the potential disparity between in vitro activity and in vivo 386
function. 387
We additionally demonstrate the capacity of some enzymes to assume multiple roles in 388
related metabolic pathways. The dwarf phenotype of the det2 mutant lines in this study confirms 389
that DET2 is required for brassinosteroid production in E. cheiranthoides. However, the lack of 390
cardenolides with a fully saturated ring system in the p5br2/det2 double mutants show that 391
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
16
EcDET2 can also contribute to 5α-cardenolide synthesis. Because wildtype E. cheiranthoides 392
primarily produces 5β-cardenolides, it is perhaps unsurprising that it does not have a dedicated 393
copy of DET2 for cardenolide biosynthesis that could be regulated independently or have altered 394
kinetics. In other Erysimum species that naturally accumulate higher levels of 5α-cardenolides, 395
DET2 may have been duplicated, although we were unable to confirm this with the available 396
transcriptomes. 397
The involvement of a dedicated ketosteroid isomerase in cardenolide biosynthesis has 398
been the subject of substantial research (38, 39), with others speculating that isomerization is 399
catalyzed by 3βHSD, as is the case in animals (8, 48). Activity-guided fractionation of Digitalis 400
protein extracts revealed that isomerization was catalyzed by an enzyme distinct from 3βHSD, 401
but the protein sequence of the putative 3-ketosteroid isomerase was not identified. We identified 402
Ec3KSI, a member of short chain dehydrogenase/reductase family 42E (SDR42E), as 403
responsible for catalyzing the isomerization of isoprogesterone 3 to progesterone 4 (Figure 3) 404
while lacking 3βHSD activity. Bacterial ketosteroid isomerases have been extensively 405
characterized (49), but less is known about eukaryotic enzymes with KSI activity that lack 406
3βHSD activity. We demonstrated with CRISPR/Cas9-generated knockout lines that Ec3KSI is 407
involved in cardenolide biosynthesis. However, even in the absence of Ec3KSI, 5β-cardenolides 408
are produced, albeit in lower quantities than occur in wildtype plants. It is possible that some 409
isomerization occurs non-enzymatically, or another enzyme, possibly Ec3βHSD, can partially 410
compensate for the loss of KSI activity in the mutant lines. 411
Still in question is the extent to which plant 3βHSDs also possess KSI activity. While 412
there has been at least one report of a tomato 3βHSD with KSI activity, our assays were 413
inconclusive, as we saw isomerization when Ec3βHSD was supplied with pregnenolone 2 and 414
NAD+, but not when Ec3βHSD is supplied with isoprogesterone 3. This implies either that the 415
isomerization by Ec3βHSD must accompany oxidase activity, the isomerization observed during 416
the 3βHSD assay occurred non-enzymatically, or isomerization catalyzed by Ec3βHSD is slow. A 417
comprehensive analysis of 3βHSD activity across plants, with careful attention to the 418
spontaneous isomerization of isoprogesterone 3, is warranted to differentiate these possibilities. 419
Natural variation in P5βR expression and sequence influences cardenolide stereochemistry in 420
Erysimum 421
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
17
We observed substantial interspecific variation in the accumulation of 5α-, 5β-, and dehydro-422
cardenolides across the Erysimum genus. Although cardenolides of each type had been reported 423
previously in at least one Erysimum species (22, 24, 50), other studies focused primarily on 5β-424
cardenolides (45, 51). We found that the 5β-cardenolides digitoxigenin and cannogenin were 425
restricted to a monophyletic clade containing E. cheiranthoides, E. sylvestre, and two closely 426
related species of uncertain taxonomic identity (43), and that their occurrence coincided with 427
expression of a functional P5βR2-1. In one monophyletic group of five Erysimum species, 428
P5βR2-1, while expressed, contains a frameshift mutation, corresponding with the apparent loss 429
of digitoxigenin and cannogenin synthesis. Several other species, including E. crassipes, E. 430
rhaeticum, and E. kotschyanum, express P5βR2-2 at high levels, but we did not detect 431
digitoxigenin or cannogenin glycosides in these species. We hypothesize that the P5βR2-1 clade 432
is specialized for involvement in 5β-cardenolide biosynthesis, whereas P5βR1 and P5βR2-2 433
assume other roles in plant metabolism. The fact that these enzymes are expressed and active on 434
cardenolide intermediates, but seem to be uninvolved in the pathway, points to the possibility of 435
substrate channeling or compartmentalization of cardenolide biosynthesis. 436
By contrast, strophanthidin, a more hydroxylated 5β-cardenolide, was ubiquitous across 437
the genus, and its occurrence did not depend on expression of P5βR2-1 in most species. The 438
occurrence of C5-hydroxylated 5β-cardenolides in the absence of P5βR2-1 implies the existence 439
of a P5βR-independent pathway for strophanthidin biosynthesis in Erysimum. For example, it is 440
possible that inversion of carbon 5 stereochemistry occurs during C5-hydroxylation, and in fact a 441
similar stereochemical inversion is thought to occur during C14-hydroxylation in cardenolide 442
biosynthesis (52). Alternatively, we cannot exclude the possibility that one of the other expressed 443
P5βR proteins forms digitoxigenin as an intermediate which is entirely converted by cardenolide 444
hydroxylases to strophanthidin. Interestingly, the E. cheiranthoides p5br2 mutant lacks 445
strophanthidin, suggesting that such a P5βR-independent strophanthidin pathway, if it exists, 446
may have been lost in this species. 447
Previous studies have reported digitoxigenin in several of the species for which we failed 448
to detect it in our assays (22, 24). This discrepancy may be explained in a number of ways. First, 449
we only sampled single accessions or seed batches per species, which may underestimate 450
potentially substantial intraspecific variation in plant chemistry. Second, many early studies used 451
paper chromatography or other low-resolution chromatographic techniques that would render 452
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
18
correct stereochemical assignment difficult or impossible, and even high-resolution methods may 453
miss differences in stereochemistry without appropriate reference material. For example, in a 454
previous study profiling intact cardenolides in the same species studied here, the E. 455
cheiranthoides clade exhibited a distinct chemotype with limited overlap in non-hydroxylated 456
cardenolides compared to the other species examined, which may have been a reflection of a 457
difference in carbon 5 stereochemistry (43). In particular, the E. cheiranthoides clade 458
accumulated a set of unique mono- and diglycosides of digitoxigenin, cannogenol, and 459
cannogenin, whereas most other Erysimum species accumulated an isomeric set of putative 5α-460
cardenolides with shifted HPLC retention times. Consistent with our results, no equivalent 461
pattern was apparent for strophanthidin glycosides, and no 5α-isomers of strophanthidin have 462
been described for any Erysimum species (22, 43). 463
Because core pathway enzymes are apparently active regardless of carbon 5 464
stereochemistry, switching between production of digitoxigenin and uzarigenin-glycosides only 465
requires alteration to the expression or sequence of a single enzyme, P5βR2-1. Control of the 466
production of unsaturated cardenolides, which do not occur at high levels in any of the species in 467
this study, appears to be somewhat more cryptic, with potential for expression level, gene 468
duplication, or protein-protein interactions to play a role. An analogous process controls steroidal 469
glycoalkaloid diversity in Solanum, where expression of GAME25, a SDR related to Ec3βHSD, 470
controls saturation of steroidal glycoalkaloids across the genus (53). Along with overall polarity, 471
stereochemical configuration is a major contributor to variation in toxicity and deterrent activity 472
of cardenolides (25–27, 54). As such, altering cardenolide stereochemical configuration may be a 473
relatively simple evolutionary mechanism through which Erysimum fine-tunes its defensive 474
profile to the most pervasive herbivores in a given ecological context. This theory is somewhat 475
borne out by the findings of Mirzaei et al. (33), who showed that an E. cheiranthoides P5βR2 476
mutant line, which produces primarily 5α-cardenolides, was more resistant to Trichoplusia ni 477
(cabbage loopers) and Myzus persicae (green peach aphids), but extracts from 5β-cardenolide-478
producing wildtype plants had a greater inhibitory effect on porcine Na+,K+-ATPase in vitro. 479
This work represents a step forward in our understanding of the biosynthesis of medically 480
important cardiac glycosides and provides insight into molecular mechanisms through which 481
cardenolide structural variation may be controlled. The apparently modular nature of the 482
cardenolide pathway, where the presence or activity of individual enzymes alters the pathway 483
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
19
end products, has broad implications for future engineering of the pathway in heterologous 484
systems for research or medical purposes. Such flexibility in pathway assembly may allow for 485
rapid production and testing of varied cardenolide structures for biomedical applications. 486
Furthermore, the mutant E. cheiranthoides lines presented here will facilitate investigation of the 487
functional and ecological implications of carbon 5 configuration in cardenolides. Insect feeding 488
assays and field experiments with these mutant plants would illuminate herbivore preferences 489
and provide further insight into the selective pressures that may have shaped the cardenolide 490
profiles observed in nature today. 491
Materials and methods
492
Plant growth, cloning, expression, and knockout of candidate genes 493
Plant growth, cloning of candidate genes, transient expression in Nicotiana benthamiana, and 494
CRISPR/Cas9 knockout in Erysimum cheiranthoides were performed as described previously 495
(35). For the genus-wide experiment, lyophilized tissue collected during a previous study and 496
stored at -20 °C (43) was used. Primers used for cloning of candidate genes and for generation 497
and screening of CRISPR/Cas9 mutants are provided in Table S9. 498
Mutagenic screens 499
Ethyl methanesulfonate (EMS) mutagenesis was modified from Mirzaei et al., 2020 (33). Ten 500
grams of E. cheiranthoides seeds were soaked at 4 oC overnight in 100 mL of 100 mM phosphate 501
buffer, pH 7.5. The buffer was decanted, and the seeds were resuspended in 100 mL of fresh 502
phosphate buffer with 0.6% EMS (Sigma-Aldrich, St. Louis, MO). The seeds were shaken at 23 503
oC for six hours, washed twenty times with deionized water, and grown in twenty 25x25 cm flats 504
to maturity. M2 seeds were pool-harvested from each flat at two timepoints. To screen for 505
mutants in cardenolide biosynthesis, 32 plants from each pool (in total, 1120 plants) were grown 506
for four weeks. Approximately 30 mg of leaf tissue was harvested from each plant for UHPLC-507
MS analysis. Plants that showed divergent cardenolide phenotypes were backcrossed to 508
wildtype, and F2 progeny were used for bulked segregant analysis (BSA) as described previously 509
(33). 510
Coexpression networking analysis 511
Raw RNA-sequencing reads from 48 Erysimum species (43) were downloaded from the NCBI 512
Short Read Archive (SRP225657) and were pseudoaligned to the transcriptome associated with 513
E. cheiranthoides genome v2.1 (NCBI: PRJNA563696)(55, 56) using kallisto (57) with default 514
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
20
parameters, yielding transcript counts, which were filtered to retain transcripts with more than 10 515
counts in at least 10 samples. Filtered counts were used for the mr2mods gene coexpression 516
analysis pipeline using default parameters (58). 517
Protein expression and purification 518
For protein purification, genes were inserted into the ChampionTM pET300-NT-DEST plasmid 519
(ThermoFisher Scientific, Waltham, MA), before being transformed into Rosetta(DE3) E. coli 520
(MilliporeSigma, St. Louis, MO). Single colonies were picked from LB agar plates (100 μg/mL 521
carbenicillin; 20 μg/mL chloramphenicol) to inoculate 10 mL liquid LB cultures with the same 522
antibiotics. Cultures were grown overnight at 37 °C and 225 rpm in a I2500 Incubator Shaker 523
incubator (Eppendorf, Hamburg Germany). After 18 hours, 6 mL of the culture was transferred 524
to 250 mL TB medium (59) containing the same antibiotics, and cells were grown under the 525
same conditions until OD600=0.6. Isopropyl β-d-1-thiogalactopyranoside (IPTG, ThermoFisher 526
Scientific) was added to a final concentration of 1 mM to induce protein expression, and cultures 527
were incubated at 25 °C and 225 RPM for 6 hours before being placed on ice and centrifuged at 528
5,000 rcf and 4 °C for 15 minutes in a Sorvall RC5C Plus centrifuge (ThermoFisher Scientific). 529
Cells were resuspended in 40 mL of lysis buffer, consisting of 40 mM Tris pH8, 20 mM 530
imidazole (Sigma-Aldrich, St. Louis, MO), 500 mM NaCl (ThermoFisher Scientific), 10% (v/v) 531
glycerol, and 1% (v/v) Tween 20 (Sigma-Aldrich). The cell suspension was lysed by freezing in 532
liquid N2 and thawing on ice twice, followed by sonication using a Branson Sonifier 250 while 533
still on ice, four times in 10-second intervals, with a 30-second rest between each interval. The 534
cell lysate was centrifuged for 45 minutes at 4 °C at 13,000 rcf. Following centrifugation, the 535
supernatant was loaded onto a column containing 1 mL of Ni-NTA resin (Invitrogen, Waltham, 536
MA) that had been previously equilibrated with 1 column volume of lysis buffer. After all 537
supernatant had passed through the column, 1 column volume of wash buffer (50 mM Tris pH 538
8.0, 20 mM imidazole, 500 mM NaCl, 10% (v/v) glycerol) was passed through the column. 539
Finally, 0.5 mL elution buffer (50 mM Tris pH 8.0, 250 mM imidazole, 500 mM NaCl, 10% v/v 540
glycerol) was loaded onto the column, and the flow-through was collected in a 2 mL 541
microcentrifuge tube (Laboratory Products Sales, Rochester, NY). Protein concentration was 542
measured using a NanoDrop One (ThermoFisher Scientific). 543
In vitro enzyme assays 544
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
21
Steroid-3β-hydroxysteroid dehydrogenase (3βHSD) and 3-ketosteroid isomerase (3KSI) assay 545
conditions were adapted from previous studies (39, 53). One hundred μl reactions contained 4 546
mM KPO4 buffered at pH 6.5 and 1 μg purified enzyme. For the 3βHSD oxidation, final 547
concentrations of 150 μM NAD+ (Sigma-Aldrich) and 10 μM pregnenolone (Sigma-Aldrich) 548
were used. To test for 3βHSD reductase activity, 150 μM NADH (Sigma-Aldrich) and 10 μM 5β-549
pregnane-3,20-dione (aablocks, San Diego, CA) or 5α-pregnane-3,20-dione (Sigma-Aldrich) 550
were used. For the KSI assay, the same conditions were used, but 10 μM isoprogesterone (TLC 551
Pharmaceutical Standards, Newmarket, ON) was used and NAD+/NADH were omitted. 552
Progesterone 5β-reductase (P5βR) assays were adapted from Herl et al. (13) and Sonawane et al. 553
(53). 100 μl reactions contained final concentrations of 4 mM KPO4 pH 7.2, 150 μM NADPH 554
(Cayman Chemical, Ann Arbor, MI, USA), 10 μM progesterone (Sigma-Aldrich), and 1 μg 555
purified enzyme. 556
Reactions were incubated for 1 hour at 28 °C for the 3βHSD and 3KSI assays, and at 37 557
°C for the P5βR assay. All assays were terminated by addition of 100 μl 100% methanol 558
(ThermoFisher Scientific) containing 15 μg/mL ouabain (Sigma-Aldrich) as an internal standard, 559
centrifuged at 17,000 rcf in an Eppendorf 5417R Centrifuge at 4 °C, and transferred to vials 560
(ThermoFisher Scientific) for UHPLC-MS analysis. 561
Metabolite extraction 562
Metabolites were extracted from fresh tissue of E. cheiranthoides and N. benthamiana as 563
described previously (35). Where indicated, metabolite extracts were subjected to acid hydrolysis 564
to isolate cardenolide genins using a protocol adapted from Schaller & Kries (19). In brief, 700 565
μL 100% methanol for two leaf 14 mm leaf disks of fresh E. cheiranthoides tissue or 750 μL 566
95% (v/v) methanol per 20 mg of lyophilized tissue in the genus-wide experiment, was used to 567
extract metabolites for 30 minutes at 25 °C. After centrifugation for three minutes at 17,000 rcf, 568
700 μL supernatant was transferred to a fresh microcentrifuge tube. Twenty μL of 6 M 569
hydrochloric acid was added to each tube, and samples were incubated for 18 hours at 28 °C. 570
Hydrolysis was terminated with 200 μL saturated sodium phosphate solution, and samples were 571
extracted twice with 200 μL chloroform. The organic (lower) phase was evaporated to dryness in 572
a Savant SpeedVacTM SC110 (Thermo Fisher Scientific). Samples were resuspended in 50 μL 573
methanol and centrifuged for 10 minutes at 17,000 rcf before being transferred to glass mass 574
spectrometry vials for UHPLC-MS analysis. 575
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
22
Liquid chromatography-mass spectrometry (LC-MS) analysis 576
All samples were analyzed on an UltiMate 3000 UHPLC system coupled to a Q-Exactive hybrid 577
quadrupole-orbitrap mass spectrometer (Thermo Fisher Scientific, Waltham, MA). The 578
instrument was fitted with a Supelco TitanTM C18 UHPLC Column (80Å, 100 x 2.1 mm, particle 579
size 1.9 μm; Sigma Aldrich). Injections of 2 μL were separated by a solvent gradient consisting 580
of mobile phase A (water + 0.1% (v/v) formic acid) and mobile phase B (acetonitrile + 0.1% 581
(v/v) formic acid). A 13-minute method was used for analysis of non-hydrolyzed samples: 0-0.55 582
minutes, hold at 2% B; 0.5-10 minutes, linear gradient from 2%-97% B; 10-11.5 minutes, hold 583
at 97% B, 11.5-13 minutes, hold at 2% B. A longer solvent gradient was used in hydrolysis 584
experiments: 0-5 minutes, hold at 2% B; 5-22 minutes, linear gradient from 2%-97% B; 22-23.5 585
minutes, hold at 97% B, 23.5-25 minutes, hold at 2% B. All solvents were Optima LC/MS grade 586
(Thermo Fisher Scientific). The solvent flow rate was 0.5 mL/minute, the column oven was set 587
to 40 °C, and the autosampler temperature was 15 °C for all methods. The mass spectrometer 588
was run in full scan positive ionization mode. Targeted MSMS spectra were collected with an 589
isolation window of 2.0 m/z and normalized collision energy of 30%. 590
LC-MS peak areas were quantified using a custom processing method in XcaliburTM 591
Software (ThermoFisher Scientific) using the following parameters: peak detection ICIS, 592
smoothing points 1, baseline window 40, area noise factor 5, peak noise factor 15, tailing factor 593
2. Mass features used for quantification are provided in Table S10 for in-tact cardenolides, Table 594
S11 for hydrolyzed cardenolides, and Table S12 for cardenolide intermediates from in vitro and 595
N. benthamiana assays. 596
Statistical and phylogenetic analysis 597
The following functions in R statistical software (60) were used for statistical tests, which were 598
performed on log-transformed LC-MS peak areas, normalized to an internal standard: aov, 599
TukeyHSD, and t.test. Plots were made using MSnbase (61, 62), multcompView (63), and 600
pheatmap (64). 601
Sequences homologous to Ec3βHSD, EcKSI, EcP5βR2, and EcDET2 were identified 602
using BLAST against publicly available transcriptomes for Arabidopsis thaliana (65), Calotropis 603
gigantea (66), Digitalis lanata (48) (NCBI PRJNA923725), Marchantia polymorpha (67), and 604
other Erysimum species (43) (NCBI PRJNA563696), and were aligned using ClustalW (68, 69). 605
Gene phylogenies were inferred using IQ-TREE web server (70–72) with default parameters, 606
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
23
except bootstrap alignments were increased to 10,000. Raw data underlying all figures are 607
available in the Supporting Information. 608
609
ACKNOWLEDGMENTS 610
We thank Tobias Krug for assistance with laboratory assays. This research was funded by United 611
States Department of Agriculture award 2020-67013-30896, US National Science Foundation 612
award 1645256, and an award from the Triad Foundation to GJ; a Chemistry Biology Interface 613
Training Program fellowship under National Institutes of Health/National Institute of General 614
Medical Sciences (T32GM138826) and a US National Science Foundation Graduate Research 615
Fellowship (DGE–2139899) to GCY; a Swiss National Science Foundation grant (PCEFP3-616
194590) to TZ; and a Summer Undergraduate Research Fellowship from the American Society 617
of Plant Biologists and a Rawlings Cornell Presidential Research Scholar award to MLA. 618
619
COMPETING INTERESTS 620
None declared. 621
622
AUTHOR CONTRIBUTIONS 623
GCY , MLA, and GJ designed the research; GCY, MLA, and TZ performed the research; TZ 624
contributed critical plant material; GCY and MLA analyzed data; GCY , TZ, and GJ wrote and 625
edited the manuscript. 626
627
DATA A V AILABILITY 628
The raw data that support the findings of this study are available in the Supporting Information. 629
Seeds from mutant lines will be made available from the Arabidopsis Biological Resource 630
Center. Due to high mortality and poor seed set, DET2 knockout lines are not available from the 631
ABRC. 632
633
CITATIONS 634
1. G. Fraenkel, The Raison d’Etre of Secondary Plant Substances. Science (80-. ). 129, 635
1466–1470 (1959). 636
2. P. R. Ehrlich, P. H. Raven, Butterflies and Plants : A Study in Coevolution. Evolution (N. 637
Y). 18, 586–608 (1964). 638
3. P. Feeny, Defensive Ecology of the Cruciferae. Ann. Missouri Bot. Gard. 64, 221–234 639
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
24
(1977). 640
4. H. V. Cornell, B. A. Hawkins, Herbivore responses to plant secondary compounds: A test 641
of phytochemical coevolution theory. Am. Nat. 161, 507–522 (2003). 642
5. M. Berenbaum, Toxicity of a furanocoumarin to armyworms: A case of biosynthetic 643
escape from insect herbivores. Science (80-. ). 201, 532–534 (1978). 644
6. D. L. Forrister, et al., Diversity and divergence: evolution of secondary metabolism in the 645
tropical tree genus Inga. New Phytol. 237, 631–642 (2023). 646
7. A. A. Agrawal, G. Petschenka, R. A. Bingham, M. G. Weber, S. Rasmann, Toxic 647
cardenolides: Chemical ecology and coevolution of specialized plant-herbivore 648
interactions. New Phytol. 194, 28–45 (2012). 649
8. W. L. Miller, R. J. Auchus, The molecular biology, biochemistry, and physiology of 650
human steroidogenesis and its disorders. Endocr. Rev. 32, 81–151 (2011). 651
9. T. J. Bach, M. Rohmer, Isoprenoid Synthesis in Plants and Microorganisms (2013). 652
10. P. Lindemann, Steroidogenesis in plants - Biosynthesis and conversions of progesterone 653
and other pregnane derivatives. Steroids 103, 145–152 (2015). 654
11. J. Munkert, et al., Progesterone 5β-reductase genes of the Brassicaceae family as function-655
associated molecular markers. Plant Biol. 17, 1113–1122 (2015). 656
12. K. Schmidt, et al., PRISEs (progesteron 5b-reductase and/or iridoid synthase-like 1,4-657
enone reductases): Catalytic and substrate promiscuity allows for realization of multiple 658
pathways in plant metabolism. Phytochemistry 156, 9–19 (2018). 659
13. V. Herl, G. Fischer, F. Mu, W. Kreis, Molecular cloning and heterologous expression of 660
progesterone 5b-reductase from Digitalis lanata Ehrh. Phytochemistry 67, 225–231 661
(2006). 662
14. W. Kreis, The Foxgloves (Digitalis) Revisited. Planta Med. 83, 962–976 (2017). 663
15. S. Wen, et al., Cardenolides from the Apocynaceae family and their anticancer activity. 664
Fitoterapia 112, 74–84 (2016). 665
16. H. El-Askary, J. Hölzl, S. Hilal, E. S. El-Kashoury, A comparative study of the 666
cardenolide content of different organs of Gomphocarpus sinaicus. Phytochemistry 38, 667
1181–1184 (1995). 668
17. T. Warashina, K. Shikata, T. Miyase, S. Fujii, T. Noro, New cardenolide and acylated 669
lignan glycosides from the aerial parts of Asclepias curassavica. Chem. Pharm. Bull. 56, 670
1159–1163 (2008). 671
18. J. Xu, K. Takeya, H. Itokawa, Pregnanes and cardenolides from Periploca sepium. 672
Phytochemistry 29, 344–346 (1990). 673
19. F. Schaller, W. Kreis, Cardenolide genin pattern in Isoplexis plants and shoot cultures. 674
Planta Med. 72, 1149–1156 (2006). 675
20. S. Spengel, E. Hauser, H. H. Linde, A. X. Vaz, K. Meyer, Die Glykoside der Blstter von 676
Isoplexis canariensis (L.) G. Don. Helv. Chim. Acta 50, 1893–1911 (1967). 677
21. V. K. Saxena, P. K. Chaturvedi, A novel cardenolide, canarigenin-3-O-α-L-678
rhamnopyranosyl-(1->5)-O-β-D-xylofuranoside, from the rhizomes of Convallaria 679
majalis. J. Nat. Prod. 55, 39–42 (1992). 680
22. I. F. Makarevich, K. V. Zhernoklev, T. V. Slyusarskaya, G. N. Yarmolenko, Cardenolide-681
containing plants of the family Cruciferae. Chem. Nat. Compd. 30, 275–289 (1994). 682
23. J. A. Moore, C. Tamm, T. Reichstein, Die Glykoside der Goldlacksamen, Cheiranthus 683
Cheiri L. Helv. Chim. Acta 37, 755–770 (1954). 684
24. I. F. Makarevich, Cheiranthus allioni--A unique cardenolide-bearing plant. Chem. Nat. 685
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
25
Compd. 28, 265–271 (1992). 686
25. J. Nielsen, Host plant selection of monophagous and oligophagous flea beetles feeding on 687
crucifers. Entomol. Exp. Appl. 24, 362–369 (1978). 688
26. G. Petschenka, et al., Relative selectivity of plant cardenolides for Na+/K+-ATPases from 689
the monarch butterfly and non-resistant insects. Front. Plant Sci. 9, 1–13 (2018). 690
27. C. Tamm, “New aspects of cardiac glycosides: The stereochemistry of the glycosides in 691
relation to biological activity” in Proceedings of the First International Pharmacological 692
Meeting, B. Uvnās, W. Wilbrandt, P. Lindgren, Eds. (The Macmillan Company, 1963), 693
pp. 11–26. 694
28. S. Chhajed, et al., Glucosinolate Biosynthesis and the Glucosinolate–Myrosinase System 695
in Plant Defense Shweta. Agronomy 10 (2020). 696
29. S. Zhou, A. Richter, G. Jander, B. Thompson, T. Road, Beyond Defense : Multiple 697
Functions of Benzoxazinoids in Maize Metabolism Special Focus Issue – Mini Review. 698
Plant Cell Physiol. 59, 1528–1537 (2018). 699
30. T. Leykauf, et al., Overexpression and RNAi-mediated Knockdown of Two 3β-hydroxy-700
Δ5-steroid dehydrogenase Genes in Digitalis lanata Shoot Cultures Reveal Their Role in 701
Cardenolide Biosynthesis. Planta Med. 89, 833–847 (2023). 702
31. V. Herl, J. Frankenstein, N. Meitinger, F. Müller-Uri, W. Kreis, Δ5-3β-hydroxysteroid 703
dehydrogenase (3βHSD) from Digitalis lanata. Heterologous expression and 704
characterisation of the recombinant enzyme. Planta Med. 73, 704–710 (2007). 705
32. S. Seidel, W. Kreis, E. Reinhard, Δ5-3β-hydroysteroid dehydrogenase/Δ5-Δ4-ketosteroid 706
isomerase (3β-HSD), a possible enzyme of cardiac glycoside biosynthesis, in cell cultures 707
and plants of Digitalis lanata EHRH. Plant Cell Rep. 8, 621–624 (1990). 708
33. M. Mirzaei, et al., Less Is More: a Mutation in the Chemical Defense Pathway of 709
Erysimum cheiranthoides (Brassicaceae) Reduces Total Cardenolide Abundance but 710
Increases Resistance to Insect Herbivores. J. Chem. Ecol. 46, 1131–1143 (2020). 711
34. J. Munkert, et al., Iridoid synthase activity is common among the plant progesterone 5β-712
reductase family. Mol. Plant 8, 136–152 (2015). 713
35. G. C. Younkin, et al., Cardiac glycosides protect wormseed wallflower (Erysimum 714
cheiranthoides) against some, but not all, glucosinolate- adapted herbivores. New Phytol. 715
(2024) https:/doi.org/10.1111/nph.19534. 716
36. T. Paysan-Lafosse, et al., InterPro in 2022. Nucleic Acids Res. 51, D418–D427 (2023). 717
37. S. Fujioka, et al., The Arabidopsis deetiolated2 mutant is blocked early in brassinosteroid 718
biosynthesis. Plant Cell 9, 1951–1962 (1997). 719
38. N. Meitinger, et al., The catalytic mechanism of the 3-ketosteroid isomerase of Digitalis 720
lanata involves an intramolecular proton transfer and the activity is not associated with 721
the 3β-hydroxysteroid dehydrogenase activity. Tetrahedron Lett. 57, 1567–1571 (2016). 722
39. N. Meitinger, D. Geiger, T. W. Augusto, R. Maia De Pádua, W. Kreis, Purification of Δ5-723
3-ketosteroid isomerase from Digitalis lanata. Phytochemistry 109, 6–13 (2015). 724
40. F. Rosati, et al., 5α-Reductase activity in Lycopersicon esculentum: Cloning and 725
functional characterization of LeDET2 and evidence of the presence of two isoenzymes. J. 726
Steroid Biochem. Mol. Biol. 96, 287–299 (2005). 727
41. M. Kunert, et al., Promiscuous CYP87A enzyme activity initiates cardenolide 728
biosynthesis in plants. Nat. Plants 9, 1607–1617 (2023). 729
42. A. Pandey, V. Swarnkar, T. Pandey, P. Srivastava, Transcriptome and Metabolite analysis 730
reveal candidate genes of the cardiac glycoside biosynthetic pathway from Calotropis 731
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
26
procera. Sci. Rep., 1–14 (2016). 732
43. T. Züst, et al., Independent evolution of ancestral and novel defenses in a genus of toxic 733
plants (Erysimum, Brassicaceae). Elife 9, 1–42 (2020). 734
44. J. Munkert, M. Ernst, F. Müller-Uri, W. Kreis, Identification and stress-induced 735
expression of three 3β- hydroxysteroid dehydrogenases from Erysimum crepidifolium 736
Rchb. and their putative role in cardenolide biosynthesis. Phytochemistry 100, 26–33 737
(2014). 738
45. J. Munkert, P. Bauer, E. Burda, F. Müller-Uri, W. Kreis, Progesterone 5β-reductase of 739
Erysimum crepidifolium: CDNA cloning, expression in Escherichia coli, and reduction of 740
enones with the recombinant protein. Phytochemistry 72, 1710–1717 (2011). 741
46. P. Bauer, et al., Highly conserved progesterone 5 b-reductase genes (P5bR) from 5b-742
cardenolide-free and 5b-cardenolide-producing angiosperms. Phytochemistry 71, 1495–743
1505 (2010). 744
47. J. Klein, et al., RNAi-mediated gene knockdown of progesterone 5β-reductases in 745
Digitalis lanata reduces 5β-cardenolide content. Plant Cell Rep. 40, 1631–1646 (2021). 746
48. E. Carroll, B. R. Gopal, I. Raghavan, M. Mukherjee, Z. Q. Wang, A cytochrome P450 747
CYP87A4 imparts sterol side-chain cleavage in digoxin biosynthesis. Nat. Commun. 14, 748
4042 (2023). 749
49. N.-C. Ha, G. Choi, K. Y. Choi, B.-H. Oh, Structure and enzymology of Δ5-3-ketosteroid 750
isomerase. Curr. Opin. Struct. Biol. 11, 674–678 (2001). 751
50. D. M. Piatak, P.-F. L. Tang, P. D. Sørensen, Constituents of Erysimum inconspicuum. 752
Two sulfur-containing lactone compounds. J. Nat. Prod. 48, 424–428 (1985). 753
51. T. Züst, M. Mirzaei, G. Jander, Erysimum cheiranthoides, an ecological research system 754
with potential as a genetic and genomic model for studying cardiac glycoside 755
biosynthesis. Phytochem. Rev. 17, 1239–1251 (2018). 756
52. M. E. Deluca, A. M. Seldes, E. G. Gros, The 14ß-HydroxyIation in the Biosynthesis of 757
Cardenolides in Digitalis purpurea. The Role of 3ß-Hydroxy-5ß-pregn-8(14)-en-20-one. 758
Zeitschrift für Naturforsch. 42c, 77–78 (1987). 759
53. P. D. Sonawane, et al., Short-chain dehydrogenase/reductase governs steroidal specialized 760
metabolites structural diversity and toxicity in the genus Solanum. Proc. Natl. Acad. Sci. 761
115, E5419–E5428 (2018). 762
54. K. Repke, New developments in cardiac glycoside structure-activity relationships. Trends 763
Pharmacol. Sci. 6, 275–278 (1982). 764
55. S. R. Strickler, A. F. Powell, L. A. Mueller, T. Zust, G. Jander, NCBI BioProject ID 765
PRJNA563696. Rapid and independent evolution of ancestral and novel chemical 766
defenses in a genus of toxic plants (Erysimum, Brassicaceae) (2019). 767
56. M. Mirzaei, et al., Aphid resistance segregates independently of cardiac glycoside and 768
glucosinolate content in an Erysimum cheiranthoides ( wormseed wallflower ) F2 769
population. bioRxiv (2024) https:/doi.org/https://doi.org/10.1101/2024.01.11.575310. 770
57. N. L. Bray, H. Pimentel, P. Melsted, L. Pachter, Near-optimal probabilistic RNA-seq 771
quantification. Nat. Biotechnol. 34, 525–527 (2016). 772
58. J. H. Wisecaver, et al., A global coexpression network approach for connecting genes to 773
specialized metabolic pathways in plants. Plant Cell 29, 944–959 (2017). 774
59. , Terrific Broth (TB) Medium (2015) https:/doi.org/10.1101/pdb.rec085894. 775
60. R Core Team, R: A Language and Environment for Statistical Computing (2020). 776
61. L. Gatto, K. Lilley, MSnbase - an R/Bioconductor package for isobaric tagged mass 777
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
27
spectrometry data visualization, processing and quantitation. Bioinformatics 28, 288–289 778
(2012). 779
62. L. Gatto, S. Gibb, J. Rainer, MSnbase, efficient and elegant R-based processing and 780
visualisation of raw mass spectrometry data. bioRxiv (2020). 781
63. S. Graves, H.-P. Piepho, L. S. with help from Sundar Dorai-Raj, multcompView: 782
Visualizations of Paired Comparisons (2023). 783
64. R. Kolde, pheatmap: Pretty Heatmaps (2019). 784
65. T. Z. Berardini, et al., The Arabidopsis information resource: Making and mining the 785
“gold standard” annotated reference plant genome. Genesis 53, 474–485 (2015). 786
66. G. M. Hoopes, et al., Genome assembly and annotation of the medicinal plant Calotropis 787
gigantea a producer of anticancer and antimalarial cardenolides. G3 Genes, Genomes, 788
Genet. 8, 385–391 (2018). 789
67. M. K. Tello-Ruiz, P. Jaiswal, D. Ware, “Gramene: A Resource for Comparative Analysis 790
of Plants Genomes and Pathways” in Plant Bioinformatics, D. Edwards, Ed. (Springer US, 791
2022), pp. 101–131. 792
68. F. Sievers, et al., Fast, scalable generation of high-quality protein multiple sequence 793
alignments using Clustal Omega. Mol. Syst. Biol. 7 (2011). 794
69. F. Madeira, et al., Search and sequence analysis tools services from EMBL-EBI in 2022. 795
Nucleic Acids Res. 50, W276–W279 (2022). 796
70. B. Q. Minh, et al., IQ-TREE 2: New Models and Efficient Methods for Phylogenetic 797
Inference in the Genomic Era. Mol. Biol. Evol. 37, 1530–1534 (2020). 798
71. J. Trifinopoulos, L. T. Nguyen, A. von Haeseler, B. Q. Minh, W-IQ-TREE: a fast online 799
phylogenetic tool for maximum likelihood analysis. Nucleic Acids Res. 44, W232–W235 800
(2016). 801
72. D. T. Hoang, O. Chernomor, A. Von Haeseler, B. Q. Minh, L. S. Vinh, UFBoot2: 802
Improving the ultrafast bootstrap approximation. Mol. Biol. Evol. 35, 518–522 (2018). 803
804
805
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
28
Supporting Information 806
807
Article title: Four enzymes control natural variation in the steroid core of Erysimum cardenolides 808
809
Authors: Gordon C. Younkin1,2, Martin L. Alani1, Tobias Züst3, Georg Jander1§ 810
811
The following Supporting Information is available for this article: 812
Figure S1 BSA results for mutant #454 813
Figure S2 EICs of mutant #454 and p5br2-1 cardenolides 814
Figure S3 MSMS spectra of cardenolide intermediates 815
Figure S4 Sequences of 3bhsd mutants 816
Figure S5 Sequences of 3ksi mutants 817
Figure S6 Sequences of p5br2 mutants 818
Figure S7 Sequences of det2 mutants 819
Figure S8 Sequences of p5br1 mutants 820
Figure S9 EICs and MSMS spectra of cardenolide genins 821
Figure S10 Genin abundances from hydrolysis Erysimum cheiranthoides mutant cardenolides 822
Figure S11 Cardenolide abundances in 3bhsd/3ksi double mutants 823
Figure S12 EICs from P5βR enzyme activity assays in Nicotiana benthamiana 824
Figure S13 Cardenolide abundances in p5br1 mutants 825
Figure S14 Multiple sequence alignment of Erysimum P5βR proteins 826
Figure S15 Multiple sequence alignment of 3βHSD coding sequences from selected species 827
Figure S16 Multiple sequence alignment of 3KSI coding sequences from selected species 828
Figure S17 Multiple sequence alignment of P5βR2 coding sequences from selected species 829
Figure S18 Multiple sequence alignment of DET2 coding sequences from selected species 830
Table S1 Cardenolide abundances in Erysimum cheiranthoides mutant lines 831
Table S2 Coexpression cluster of cardenolide biosynthesis genes 832
Table S3 Cardenolide intermediate abundances from enzyme assays 833
Table S4 Cardenolide genin abundances in Erysimum cheiranthoides mutant lines 834
Table S5 Cardenolide abundances in 3bhsd/3ksi double mutants 835
Table S6 Cardenolide abundances in p5br1 mutant 836
Table S7 Cardenolide genin abundances in Erysimum species 837
Table S8 Expression of cardenolide biosynthetic genes in Erysimum species 838
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
29
Table S9 Sequences of primers 839
Table S10 m/z and retention times used for quantifying cardenolides in LCMS data 840
Table S11 m/z and retention times used for quantifying cardenolide genins in hydrolysis 841
experiments 842
Table S12 m/z and retention times used for quantifying cardenolide intermediates in in vitro 843
assays844
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
30
845
Figure S1. Bulked segregant analysis (BSA) from Erysimum cheiranthoides mutant #454. 846
Mutant #454 was generated via ethyl methanesulfonate (EMS) mutagenesis. Alternate (mutant) 847
allele frequency, smoothed over 1 Mbp segments, is plotted across the eight E. cheiranthoides 848
chromosomes. In plants with a mutant chemotype (red), mutant alleles dominate in the latter half 849
of chromosome seven. Within this region is a progesterone reductase (EcP5βR2) with two 850
missense mutations (R184K and G201R) in mutant #454 plants. The cardenolide phenotype 851
associated with mutant #454 and the BSA results displayed here were first described in Mirzaei 852
et al. 2020. The causal mutation at the linked locus was first described in this study. 853
854
855
856
Figure S2. Extracted ion chromatograms (EIC) for cardenolides in wildtype Erysimum 857
cheiranthoides, mutant #454, and p5br2-1. EIC for m/z 375.2535, a fragment common to 858
digitoxigenin and uzarigenin glycosides, resulting from the neutral loss of all sugar moieties, 859
leaving only the genin intact. In mutant #454 and p5br2 mutant lines, we observe cardenolides 860
with the same mass as those found in wildtype plants, but they elute at different retention times, 861
suggesting that they may be structural isomers. 862
ECHEv2.0ch01 ECHEv2.0ch02 ECHEv2.0ch03 ECHEv2.0ch04 ECHEv2.0ch05 ECHEv2.0ch06 ECHEv2.0ch07 ECHEv2.0ch08
wildtye
454 mutant
Alternate allele frequency in wildtype and 454 mutant, smoothed
Alternate allele frequency (%)
0.0 0.2 0.4 0.6 0.8 1.0
4.9e+07
p5br2−1
3.8e+07
mutant #454
4.2 4.4 4.6 4.8 5.0 5.2
6.7e+06
wildtype
EIC (m/z = 375.2535)
Retention time (minutes)
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
31
863
Figure S3. Extracted ion chromatograms (EIC) and MSMS spectra from products of in 864
vitro or Nicotiana benthamiana transient expression assays compared with authentic 865
standards. EIC (A) of isoprogesterone and progesterone formed by supplying Ec3βHSD or/and 866
Ec3KSI with pregnenolone and NAD+ in vitro. (B) MSMS spectra of progesterone. High-quality 867
isoprogesterone MSMS spectrum could not be collected from in vitro assays due to low signal. 868
(C) EIC of conversion of isoprogesterone to progesterone in vitro. (D) EIC of 5β-pregnane-3,20-869
dione formed by supplying EcP5βR2 with progesterone and NADPH in vitro, and corresponding 870
MSMS spectrum (E). (F) MSMS spectrum of 5ɑ-pregnane-3,20-dione formed by EcDET2 871
following coinfiltration with progesterone in leaves of Nicotiana benthamiana. EIC (G) and 872
MSMS spectra of epipregnanolone or diastereomer formed by supplying Ec3βHSD with 5ɑ-873
pregnane-3,20-dione (H) or 5β-pregnane-3,20-dione (I) and NADH in vitro. 874
100 150 200 250 300
Mirrored MSMS spectra
m/z
Relative intensity
81.0701
85.0649
95.0855
107.0854
135.1165147.1164
159.1164
161.1322
171.1166
173.1323175.1478185.1318199.1474
281.2253
282.2293
299.2362
85.065
135.1167
147.1167159.1166161.1322
241.1945
281.226
282.2292
299.2365
317.2468
−100
−50
0
50
100 EcP5βR2
5β−pregnane−3,20−dione standard
100 150 200 250 300
Mirrored MSMS spectra
m/z
Relative intensity
135.1165 189.1634
283.2415
301.252
135.1166
283.2417
301.2525
−100
−50
0
50
100 Ec3βHSD + 5α−pregnane−3,20−dione
epipregnanolone standard
100 150 200 250 300
Mirrored MSMS spectra
m/z
Relative intensity
135.1165
283.2416
284.2448
301.2518
135.1166
147.1167161.1323 187.148
283.2417
284.2452
301.2525
−100
−50
0
50
100 Ec3βHSD + 5β−pregnane−3,20−dione
epipregnanolone standard
B
F
H
100 150 200 250 300
Mirrored MSMS spectra
m/z
Relative intensity
97.0648
109.0647
315.2318
97.0648
109.0647
315.2314
−100
−50
0
50
100 Ec3βHSD + Ec3KSI + pregnenolone
progesterone standard
[M+H]+ (m/z 315.2324)
100 150 200 250 300
Mirrored MSMS spectra
m/z
Relative intensity
85.065
281.2264
299.2362
317.2089
318.2409
81.0701
85.065
95.0856
159.1167
161.1323
175.1479 241.1948
281.226
299.2366
−100
−50
0
50
100 EcDET2 + progesterone
5α−preganane−3,20−dione standard
[M+H]+ (m/z 317.2481)
[M-H2O+H]+ (m/z 301.2531)[M-H2O+H]+ (m/z 301.2531)
1.2e+08
Ec3βHSD
1.2e+08
Ec3KSI
6.8 7.0 7.2 7.4 7.6 7.8
1.2e+08
negative control
EIC (m/z = 315.2324)
Retention time (minutes)
A
8.4e+05
EcP5βR2
8.4e+05
negative control
6e+06
5α−pregenane−3,20−dione
7.4 7.6 7.8 8.0 8.2
1.4e+07
5β−pregenane−3,20−dione
EIC (m/z = 317.2481)
Retention time (minutes)
EcP5βR2 +
progesterone
negative control +
progesterone
C
D
G
Ec3βHSD +
5β-pregnane-3,20-dione
Ec3βHSD +
5ɑ-pregnane-3,20-dione
1.8e+06
1.8e+06
1.8e+06
7.0 7.2 7.4 7.6 7.8 8.0
6.2e+06
epipregnanolone
EIC (m/z = 301.2531)
Retention time (minutes)
negative control +
5β-pregnane-3,20-dione
epipregnanolone
negative control +
isoprogesterone
2.8e+06
Ec3βHSD
2.8e+06
Ec3KSI
2.8e+06
Ec3βHSD + Ec3KSI
2.8e+06
negative control
6.8 7.0 7.2 7.4 7.6 7.8
8.6e+06
standard
EIC (m/z = 315.2324)
Retention time (minutes)
isoprogesterone
progesterone
negative control +
pregnenolone
E
I
Ec3βHSD +
isoprogesterone
Ec3KSI +
isoprogesterone
progesterone isoprogesterone
Ec3βHSD +
pregenenolone
Ec3KSI +
pregenenolone
Ec3βHSD + Ec3KSI
pregenenolone
[M+H]+ (m/z 299.2362)
+ progesterone
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
32
875
Figure S4. Aligned nucleotide coding sequences of Erysimum cheiranthoides 3βHSD from 876
WT and mutant lines. Mutant #30 was generated via chemical mutagenesis with ethyl 877
methanesulfonate (EMS), and 3bhsd-1 and 3bhsd-2 lines were generated with CRISPR/Cas9. 878
Abbreviations: Erysimum cheiranthoides (Ec), wildtype (WT), 3β-hydroxysteroid 879
dehydrogenase (3βHSD). Sequences of gRNAs used for generation of these lines are available in 880
Table S1. MultAlin (http://multalin.toulouse.inra.fr/multalin/) was used to produce the alignment. 881
882
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
33
883
Figure S5. Aligned nucleotide coding sequences of Erysimum cheiranthoides 3KSI from WT 884
and mutant lines. 3ksi-1 and 3ksi-2 lines were generated with CRISPR/Cas9. Abbreviations: 885
Erysimum cheiranthoides (Ec), wildtype (WT), 3ketosteroid isomerase (3KSI). Sequences of 886
gRNAs used for generation of these lines are available in Table S1. MultAlin 887
(http://multalin.toulouse.inra.fr/multalin/) was used to produce the alignment. 888
889
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
34
890
Figure S7. Aligned nucleotide coding sequences of Erysimum cheiranthoides DET2 from 891
WT and mutant lines. det2-1 and det2-2 lines were generated with CRISPR/Cas9 in the WT 892
background. det2/p5br2-1 and det2/p5br2-2 lines were generated with CRISPR/Cas9 in the 893
p5br2-1 background. Abbreviations: Erysimum cheiranthoides (Ec), wildtype (WT), 894
progesterone 5β-reductase (P5βR), steroid 5α-reductase (DET2). Sequences of gRNAs used for 895
generation of these lines are available in Table S1. MultAlin 896
(http://multalin.toulouse.inra.fr/multalin/) was used to produce the alignment. 897
898
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
35
899
Figure S8. Aligned nucleotide coding sequences of Erysimum cheiranthoides P5βR1 from 900
WT and mutant lines. The p5br1-1 line was generated with CRISPR/Cas9. Abbreviations: 901
Erysimum cheiranthoides (Ec), wildtype (WT), progesterone 5β-reductase (P5βR). Sequences of 902
gRNAs used for generation of these lines are available in Table S1. MultAlin 903
(http://multalin.toulouse.inra.fr/multalin/) was used to produce the alignment. 904
905
906
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
36
907
Figure S9. Extracted ion chromatograms and MSMS spectra for cardenolide genins. 908
Selected extraction ion chromatograms (EIC) and MSMS spectra for cardenolide genins from 909
hydrolyzed extracts of Erysimum cheiranthoides wildtype (WT) and mutant leaves, compared to 910
authentic standards where available. (A) EIC of digitoxigenin and uzarigenin [M+H]+, which are 911
stereoisomers and are separated by retention time. An uzarigenin standard was not available; 912
hydrolyzed Calotropis procera leaf extract, which are known to contain uzarigenin, was used 913
instead. (B) Presumed xysmalogenin [M+H]+ is abundant in p5br2/det2 double mutants 914
compared to WT leaves. 3,5-anhydroperiplogenin [M+H]+ (C) is formed when canarigenin 915
glycosides are subjected to acidic conditions in p5br2/det2 double mutants. (D-G) Corresponding 916
MSMS spectra. Authentic standards were not available for xysmalogenin (F) or 3,5-917
anhydroperiplogenin (G). Instead, they are compared to a digitoxigenin MSMS spectrum. The 918
spectra are similar, but some peaks are shifted by 2 Daltons, providing further evidence that these 919
peaks represent dehydrocardenolides. (H) Cannogenol [M+Na]+ in E. cheiranthoides, and an 920
isomer in E. pieninicum that may be the 5α conformation. (I) Strophanthidin [M+Na]+ in E. 921
cheiranthoides compared to an authentic standard. 922
923
100 150 200 250 300 350
Mirrored MSMS spectra
m/z
Relative intensity
81.07
95.0855105.0697
107.0854
109.101
121.1009
133.1008
135.1165
145.101147.1166
159.1164
161.1322 185.1323187.1479 231.1381 257.1527
293.2251 321.2203
339.231
340.2343 357.2415
81.07
95.0854
107.0854121.1009
135.1165
147.1165161.1321 187.1478 231.1374 257.1529
293.2256 321.2207
339.2311
340.2347 357.2416
−100
−50
0
50
100 WT
digitoxigenin standard
100 150 200 250 300 350
Mirrored MSMS spectra
m/z
Relative intensity
79.0543
81.07
93.069895.0855
105.0696
107.0853
121.1008
133.1008
135.1165
145.1009147.1164159.1165
161.132
185.132
187.1477
199.1477201.1631
205.1219
231.1374
279.2098
293.2256 321.2207
339.2312
340.2342
357.2413
358.2456
81.07
93.07
95.0855
105.0699
107.0854
119.0851
121.101
131.0854
133.1009
135.1165
145.1009147.1166159.1163
161.1321
185.1324
187.1479
199.1473
201.1632
205.1219 231.1376
245.153257.1532 279.2097
293.2259
321.2205
322.2237
339.2314
340.2347
357.2421
358.245
373.2375
374.2408
−100
−50
0
50
100 p5br2−1
Calotropis
50 100 150 200 250 300 350
Mirrored MSMS spectra
m/z
Relative intensity
67.0546
71.0494
81.07
93.0698
95.0854
103.0752
105.0697
107.0852
109.1011121.1009131.0853
133.101
135.1165145.1008
159.1167 261.2206
319.2055
337.2159
357.26
81.07
95.0854
107.0854121.1009
135.1165
147.1165161.1321 187.1478 231.1374 257.1529
293.2256 321.2207
339.2311
340.2347357.2416
−100
−50
0
50
100 p5br2/det2−2
digitoxigenin standard
100 150 200 250 300 350
Mirrored MSMS spectra
m/z
Relative intensity
81.07
95.0854105.0696107.0853
109.1009119.0852131.0853
133.1009
137.0957
145.1009
147.1166
157.101
159.1165
161.1322 185.1319 291.2094 319.2051
337.2155
339.2313
355.2261
81.07
95.0854
107.0854121.1009
135.1165
147.1165161.1321 187.1478 231.1374 257.1529
293.2256 321.2207
339.2311
340.2347 357.2416
−100
−50
0
50
100 p5br2/det2−2
digitoxigenin standard
digitoxigenin [M+H]+ m/z 375.2529, RT 12.81
m/z
m/z
m/z
m/z
uzarigenin [M+H]+ m/z 375.2529, RT 12.93
presumed xysmalogenin [M+H]+ m/z 373.2379, RT 12.30
presumed 3,5-anhydroperiplogenin [M+H]+ m/z 355.2273, RT 15.99
A
B
C
D
E
F
G
5.3e+06
WT
6.8e+07
p5br2−1
2e+08
digitoxigenin
12.6 12.8 13.0 13.2 13.4
2.3e+06
Calotropis
EIC (m/z = 375.2529)
Retention time (minutes)
digitoxigenin
uzarigenin
3.4e+07
p5br2/det2−2
12.0 12.4 12.8
3.4e+07
WT
EIC (m/z = 373.2379)
Retention time (minutes)
presumed xysmalogenin
4.1e+07
p5br2/det2−2
15.8 16.2 16.6
4.1e+07
WT
EIC (m/z = 355.2273)
Retention time (minutes)
presumed 3,5-anhydroperiplogenin
1.6e+06 E. cheiranthoides
9.0 10.5 12.0
5.3e+05 E. pieninicum
EIC (m/z = 413.2304)
Retention time (minutes)
2.8e+07 E. cheiranthoides
9.0 10.0
9.2e+06 strophanthidin
EIC (m/z = 427.2097)
Retention time (minutes)
H
I
presumed cannogenol
cannogenol isomer
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
37
924
Figure S10. Normalized peak areas for cardenolide genins from hydrolyzed leaf extracts of 925
Erysimum cheiranthoides mutant lines. (A) Digitoxigenin, (B) cannogenol, (C) cannogenin, 926
(D) strophanthidin, (E) total 5β-cardenolides (sum of digitoxigenin, cannogenol, cannogenin, and 927
strophanthidin), (F) 5α-cardenolides (uzarigenin), (G) Δ4-cardenolides (dianhydroperiplogenin 928
as a proxy for canirigenin), (H) Δ5-cardenolides (xysmalogenin). Abbreviations: wildtype (WT), 929
3β-hydroxysteroid dehydrogenase (3bhsd), 3-ketosteroid isomerase (3ksi), progesterone 5β-930
reductase (p5br), and steroid 5α-reductase (det2). Error bars are ± s.d. Letters indicate P<0.05, 931
one-way ANOV A with post-hoc Tukey’s HSD test. 932
933
Δ5−cardenolides
0
20
40
60
80
100
120Normalized peak area
WT 3bhsd 3ksi p5br
det2
det2/p5br
1 2 1 2 1 2
e
a
ab
bc c
de de e
d
Δ4−cardenolides
0
20
40
60
80
100
120Normalized peak area
WT 3bhsd 3ksi p5br
det2
det2/p5br
1 2 1 2 1 2
b b b b b
b b
b
a
5α−cardenolides
0
20
40
60
80
100Normalized peak area
WT 3bhsd 3ksi p5br
det2
det2/p5br
1 2 1 2 1 2
b b b b b
a a
b b
5β−cardenolides
0
20
40
60
80
100Normalized peak area
WT 3bhsd 3ksi p5br
det2
det2/p5br
1 2 1 2 1 2
a
d d
c
c
e e
b
e
A B C
D E F
G H
Digitoxigenin
0
20
40
60
80
100Normalized peak area
WT 3bhsd 3ksi p5br
det2
det2/p5br
1 2 1 2 1 2
b
c c c c
c c
a
c
cannogenol
0
20
40
60
80
100Normalized peak area
WT 3bhsd 3ksi p5br
det2
det2/p5br
1 2 1 2 1 2
a
cd cd
c c
d d
b
d
cannogenin
0
20
40
60
80
100Normalized peak area
WT 3bhsd 3ksi p5br
det2
det2/p5br
1 2 1 2 1 2
a
c c
b b
d d
b
d
strophanthidin
0
20
40
60
80
100Normalized peak area
WT 3bhsd 3ksi p5br
det2
det2/p5br
1 2 1 2 1 2
a
d d
c
c
e e
b
e
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
38
934
Figure S11. Cardenolide analysis from Ec3βHSD/Ec3KSI double mutants. (A) PCA of 935
cardenolides detected in Erysimum cheiranthoides wildtype, 3bhsd, 3ksi, and 3bhsd/3ksi mutant 936
lines. Normalized peak area of (B) total 5β-cardenolides and (C) total dehydrocardenolides. (D) 937
Ratio of dehydrocardenolide peak area to 5β-cardenolide peak area. Abbreviations: wildtype 938
(WT), 3β-hydroxysteroid dehydrogenase (3bhsd), 3-ketosteroid isomerase (3ksi). N=3 plants per 939
line. Error bars are ± s.d. Letters indicate P<0.05, one-way ANOV A with post-hoc Tukey’s HSD 940
test. 941
942
−6 −4 −2 0 2
−1.5
−1.0
−0.5
0.0
0.5
1.0
1.5
PCA of all peaks (normalized by internal standard)
PC1 (81.9%)
PC2 (7.7%)
→
→
wildtype
3bhsd−1
3ksi−2
3bhsd/3ksi
5β−cardenolides
dehydrocardenolides
A
dehydrocardenolides
0
2
4
6
8
10
12
Normalized peak area
WT 3bhsd
−1
3ksi
−2
3bhsd/3ksi
b
a
a
a
5β−cardenolides
0
1
2
3
4
5
6
Normalized peak area
WT 3bhsd
−1
3ksi
−2
3bhsd/3ksi
a
c b
c
Ratio of dehydrocardenolides
to 5 βcardenolides
0
2
4
6
8
10
12
14
Normalized peak area
WT 3bhsd
−1
3ksi
−2
3bhsd/3ksi
c
a
b
a
Ratio of dehydrocardenolide to
5β-cardenolide peak area
B
C DPeak area ratio
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
39
943
Figure S12. Coinfiltration of Erysimum progesterone 5β-reductases and progesterone in 944
Nicotiana benthamiana leaves. Erysimum progesterone 5β-reductases (P5βR) cloned into 945
pEAQ-HT-DEST1 were infiltrated into leaves of N. benthamiana (Nb), followed by infiltration 946
of progesterone after three days. Extracted ion chromatograms (EIC) at m/z=317.2481 show 947
production of 5β-pregnane-3,20-dione. When progesterone is infiltrated into N. benthamiana 948
leaves with no co-infiltrated enzyme, 5α-pregnane-3,20-dione is produced by endogenous N. 949
benthamiana enzymes. (A) P5βR2 orthologs from selected species of Erysimum. E. 950
hieraciifolium and Erysimum sp. 1 P5βR2 proteins are truncated by a premature stop codon and 951
are non-functional in this assay. (B) P5βR1 and P5βR2 from E. cheiranthoides (Ec). The 952
retention time disparity between the two experiments is due to a shorter LCMS method used in 953
panel B. 954
955
5.2e+06 Nb+ progesterone
5.2e+06 E. kotschyanum
5.2e+06 E. crassipes
5.2e+06
E. rhaeticum
5.2e+06 E. pulchellum
5.2e+06
E. hieraciifolium
5.2e+06 Erysimum sp. 1
5.2e+06
E. cheiranthoides
3.1e+07 5β−pregnane−3,20−dione
7.4 7.5 7.6 7.7 7.8 7.9 8.0
4.7e+06 5α−pregnane−3,20−dione
EIC (m/z = 317.2481)
Retention time (minutes)
2.7e+06
EcP5βR1
2.7e+06
EcP5βR2
2.6e+06
5β−pregnane−3,20−dione
5.5 5.6 5.7 5.8 5.9 6.0 6.1 6.2
5.3e+06
5α−pregnane−3,20−dione
EIC (m/z = 317.2481)
Retention time (minutes)
A B
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
40
956
Figure S13. Cardenolide analysis from EcP5βR1 mutants. (A) PCA of cardenolides detected 957
in Erysimum cheiranthoides wildtype (WT) and p5br1 (progesterone 5β-reductase 1) mutant 958
line. (B) Normalized peak area of total cardenolides. All cardenolides in this experiment are also 959
found in WT E. cheiranthoides and are presumed to be 5β-cardenolides. No dehydrocardenolides 960
were detected. No differences were detected between groups (one way ANOV A: P = 0.957). 961
N=3. Error bars are ± s.d. 962
963
A B
−4 −2 0 2 4
−1.5
−1.0
−0.5
0.0
0.5
1.0
PCA of all peaks (normalized by internal standard)
PC1 (85.7%)
PC2 (8.4%)
→
wildtype
p5br1−1
5β−cardenolides
5β−cardenolides
0
20
40
60
80
100
120Normalized peak area
WT p5br1
−1
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
41
Figure S14. Multiple sequence alignment of progesterone 5β-reductases (P5βR) from 964
Erysimum species. All orthologs of EcP5βR2 that could be recovered from transcriptome data 965
are included, and EcP5βR1 (ECE_2g27660) is included as an outgroup. Translated proteins were 966
aligned using Clustal Omega. Species included: E. crassipes (CSS), E. cheiranthoides (ECE), 967
Erysimum sp. 1 (ER1), Erysimum sp. 2 (ER2), Erysimum sp. 3 (ER3), Erysimum sp. 4 (ER4), E. 968
hieraciifolium (HIE), E. hungaricum (HUN), E. kotschyanum (KOT), E. pieninicum (PIE), E. 969
pseudorhaeticum (PSE), E. pulchellum (PUL), E. rhaeticum (RHA), E. sylvestre (SYL), E. 970
virgatum (VIR). Sequences correspond to protein phylogeny in Figure 5c. 971
972
CLUSTAL O(1.2.4) multiple sequence alignment 973
974
975
ECE_2g27660 ---------------------------------------MSWWWAGAIGAAKKKLDDDEP 976
HIE -----------------------------------------------MESESG--ILMRR 977
VIR -----------------------------------------------MESENG--ILMRR 978
PUL -----------------------------------------------MESEKG--ILMGR 979
PIE -----------------------------------------------MESESG--ILMRR 980
HUN -----------------------------------------------MESESG--ILMRR 981
ECE_6g7150 -----------------------------------------------MESESG--ILMRR 982
SYL -----------------------------------------------MESESG--ILMRR 983
ER4 -----------------------------------------------MESESG--ILMRR 984
ER3 -----------------------------------------------MESESG--ILMRR 985
ER1_1 -----------------------------------------------MESESG--ILMRR 986
ER1_2 -------------------------------------------------- MAS--SMMRR 987
KOT MNTTIITRSSITTIITSYSLHISYLFSQSTYNNRLSSFHIKYIFPLIPFSMAS --SMMRR 988
CSS -------------------------------------------------- MAS--SMMRR 989
RHA -------------------------------------------------- MAS--SMMRR 990
PSE -------------------------------------------------- MAS--SMMRR 991
ER2 -------------------------------------------------- MAS--SMMRR 992
993
994
ECE_2g27660 TQSYESVALIIGVTGIVGNSLAEILPLSDTPGGPWKVYGVARRPRPSWNADHPIDYIQCD 995
HIE NEVDENVALIFGVTGLVGRAIVKTLL---TSEPRWKIYGVARKPEINS----MCNFISCD 996
VIR NEVDENVALIFGVTGLVGRAIVKTLL---TSEPRWKIYGVARKPEINS----MYNFISCD 997
PUL NEVDENVALIFGVTGLVGREIVKTLL---TSEPRWKIYGVARNPEINS----MYDFISCD 998
PIE NEVDENVALIFGVTGLVGRAIVKTLL---TSEPRWKIYGVARKPEINS----MCNFISCD 999
HUN NEVDENVALIFGVTGLVGRAIVKTLL---TSEPRWKIYGVARKPEINS----MCNFISCD 1000
ECE_6g7150 NEVDENVALIFGVTGLVGRAIVKTLL---TSEPRWKIYGVARKPEINS----MCNFISCD 1001
SYL NEVDENVALIFGVTGLVGRAIVKTLL---TSEPRWKIYGVARKPEINS----MCNFISCD 1002
ER4 NEVDENVALIFGVTGLVGRAIVKTLL---TSEPRWKIYGVARKPEINS----MCNFISCD 1003
ASP NEVDENVALIFGVTGLVGRAIVKTLL---TSEPRWKIYGVARKPEINS----MCNFISCD 1004
ER1_1 NEVDENVALIFGVTGLVGRAIVKTLL---TSEPRWKIYGVARKPEINS----MCNFISCD 1005
ER1_2 SEVDENVALIFGVTGLVGRAIVKTLL---TSEPRWKIYGVARKPEINS-MAEMYNFISCD 1006
KOT SEVDENVALIFGVTGLVGREIVKTLL---TSEPRWKIYGVARNPEINS----MYNFISCD 1007
CSS SEVDENVALIFGATGLVGREIVKTLL---TSEPRWKIYGVARKPETNS-MAEMYNFISCD 1008
RHA SEVEENVALIFGVTGLIGREIVKTLL---TSEPRWKIYGVARKPEISS-MAEMYSFISCD 1009
PSE SEVDENVALIFGVTGLIGREIVKTLL---TSEPRWKIYGVARKPEISS-MAEMYSFISCD 1010
ER2 SEVEENVALIFGVTGLIGREIVKTLL---TSEPRWKIYGVARKPEISS-MAEMYSFISCD 1011
.: *.****:*.**::*. :.: * * **:*****.*. . .:*.** 1012
1013
ECE_2g27660 VSNAEDARSKLSPLTDV-THVFYVTWTNRESE-S-ENCEANGSMIR--------NVLQAI 1014
HIE LLNASETKQKLTPLQDIVSHVFWVTWSGEYPLDSDECCVQNKTMLSNALD --------AI 1015
VIR LLNASETKQKLSPLQDIVSHVFWVTWSGEYPLDSDECCVQNKTMLTNALD --------AI 1016
PUL LLNASETKQKLSPLQDIVSHVFWVTWSGESPLDTDECCVQNKTMLTNALD --------AI 1017
PIE LLNASETKQKLTPLQDIVSHVFWVTWSGEYPLDSDECCVQNKTMLSNALD --------AI 1018
HUN LLNASETKQKLTPLQDIVSHVFWVTWSGEYPLDSDECCVQNKTMLSNALD --------AI 1019
ECE_6g7150 LLNASETKQKLTPLQDIVSHVFWVTWSGEYPLDSDECCVQNKTMLSNALD --------AI 1020
SYL LLNASETKQKLTPLQDIVSHVFWVTWSGEYPLDSDECCVQNKTMLSNALD --------AI 1021
ER4 LLNASETKQKLTPLQDIVSHVFWVTWSGEYPLDSDECCVQNKTMLSNALD --------AI 1022
ASP LLNASETKQKLTPLQDIVSHVFWVTWSGEYPLDSDECCVQNKTMLSNALD --------AI 1023
ER1_1 LLNASETKQKLSPLQDIVSHVFWVTWSGEYPLDSDECCVQNKTMLSNALD --------AI 1024
ER1_2 LLNASETKQKLSPLQDIVSHVFWVTWCGESPLDSDECSVQNKTMLTNALD --------AI 1025
KOT LLNASETKQKLSPLQDIVSHVFWVTWCGESPLDSDECSVQNKTMLTNALDAILPNALDAI 1026
CSS LLNASETKQKLSPLQDIVSHVFWVTWCGESPLDSDECSVQNKTMLTNALD --------AI 1027
RHA LLNASETKQKLSPLQDIVSHVFWVTWCGESPLDTDECSVQNKTMLTNALD --------AI 1028
PSE LLNASETKQKLSPLQDIVSHVFWVTWCGESPLDTDECSVQNKTMLTNALD --------AI 1029
ER2 LLNASETKQKLSPLQDIVSHVFWVTWCGESPLDTDECSVQNKTMLTNALD --------AI 1030
: **.:::.**:** *: :***:*** .. : * . * :*: ** 1031
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
42
1032
ECE_2g27660 VPHAPNLRHICLQTGTKHYVGPFSNLGGGPRHDPPFTEDMPRLQ -IQNFYYTQEDILFEE 1033
HIE LPNAKRLQHFSLQTGMHHYS----ESHGEGSSLCYYSEECPRKSSGKNFYYVLEDLLEE- 1034
VIR LPNAKRLKHFSLQTGMHHYS----ESHGEGSSLCYYSEECPRKSSGKNFYYVLEDLLEE- 1035
PUL LPNSKRLKHFSLQTGMHHYG----EAHGEGSSLCYYSEECPRKSSGKNFYYVLEDLLEE- 1036
PIE LPNAKRLKHFSLQTGMHHYS----ESHGEGSSLCYYSEECPRKSSGKNFYYVLEDLLEE- 1037
HUN LPNAKRLKHFSLQTGMHHYS----ESHGEGSSLCYYSEECPRKSSGKNFYYVLEDLLEE- 1038
ECE_6g7150 LPNAKRLKHFSLQTGMHHYS----ESHGEGSSLCYYSEECPRKSSGKNFYYVLEDLLEE- 1039
SYL LPNAKRLKHFSLQTGMHHYS----ESHGEGSSLCYYSEECPRKSSGKNFYYVLEDLLEE- 1040
ER4 LPNAKRLKHFSLQTGMHHYS----ESHGEGSSLCYYSEECPRKSSGKNFYYVLEDLLEE- 1041
ASP LPNAKRLKHFSLQTGMHHYS----ESHGEGSSLCYYSEECPRKSSGKNFYYVLEDLLEE- 1042
ER1_1 LPNAKRLKHFSLQTGMHHYS----ESHGEGSSLCYYSEECPRKSSGKNFYYVLEDLLEE- 1043
ER1_2 LPNAKRLKHFSLQTGMKHYLPLVP-SHREGSSLCYYSEESPRQSSRKNFYYVLEDLLEE- 1044
KOT LPNARRLKHFSLQTGMKYYVPLVPPSHREGSSLCYYTEESPRQTSRKNFYYVLEDLLEE - 1045
CSS LPNAKRLKHFSLQTGMKYYVPLVP-SHREGSSLCYYSEESPRQSSRNNFYYVLEDLLEE- 1046
RHA LPNAKRLKHFSLQTGMRYYVPLVP-SHREGSSLCYYTEESPRQSSRKNFYYVLEDLMEE- 1047
PSE LPNAKRLKHFSLQTGMRYYVPLNP-SHREGSSLCYYTEESPRQISRKNFYYVLEDLMEE- 1048
ER2 LPNAKRLKHFSLQTGMRYYVPLNP-SHREGSSLCYYTEESPRQISRKNFYYVLEDLMEE- 1049
:*:: .*:*:.**** ::* ::*: ** :****. **:: * 1050
1051
ECE_2g27660 IKKKESVTWSIHRPNTIFGFSPYSLMNIVGTLCVYAAICKHEGSPLLFPGSKKAWEG -FT 1052
HIE KISGNSVVWSVQRPGLLLGSSTRTLKNFMGILCVYGAMCKYLNLPFVFGGTRECWEESYI 1053
VIR KISGTSVVWSVQRPGLLLGSSTRTLKNFMGILCVYGAMCKYLNLPFVFGGTRECWEESYI 1054
PUL KISGNSVVWSVQRPGLLLGSSTRTLNNFMGILCVYGAMCKYLNLPFVFGGTRECWEESYI 1055
PIE KISGNSVVWSVQRPGLLLGSSTRTLKNFMGILCVYGAMCKYLNLPFVFGGTRECWEESYI 1056
HUN KISGNSVVWSVQRPGLLLGSSTRTLKNFMGILCVYGAMCKYLNLPFVFGGTRECWEESYI 1057
ECE_6g7150 KISGNSVVWSVQRPGLLLGSSTRTLKNFMGILCVYGAMCKYLNLPFVFGGTRECWEESYI 1058
SYL KISGNSVVWSVQRPGLLLGSSTRTLKNFMGILCVYGAMCKYLNLPFVFGGTRECWEESYI 1059
ER4 KISGNSVVWSVQRPGLLLGSSTRTLKNFMGILCVYGAMCKYLNLPFVFGGTRECWEESYI 1060
ASP KISGNSVVWSVQRPGLLLGSSTRTLKNFMGILCVYGAMCKYLNLPFVFGGTRECWEESYI 1061
ER1_1 KISGTSVVWSVQRPGLLLGSSTRTLKNFMGILCLWSNV---------------------- 1062
ER1_2 KISGTSVVWSVQRPGLLLGSSTRTLKNFMGILCLWSNV---------------------- 1063
KOT KLSGNSVVWSVQRPCLLMGSSSRTLYNFMGSLCVYGAMCKYLNLPFVFGGTRECWEESYI 1064
CSS KISGNSVVWSVQRPCLLMGSSSRTLYNFMGSLCVYGAMCKYLNLPFVFGGTRECWEESYI 1065
RHA KISGNSVVWSVQRPCLLMGSSSRTLYNFMGSLCVYGAMCKYLNLPFVFGGTRECWEESYI 1066
PSE KISGNSVVWSVQRPCLLMGSSSRTLYNFMGSLCVYGAMCKYLNLPFVFGGTRECWEESYI 1067
ER2 KISGNSVVWSVQRPCLLMGSSSRTLYNFMGSLCVYGAMCKYLNLPFVFGGTRECWEESYI 1068
. **.**::** ::* * :* *::* **::. : 1069
1070
ECE_2g27660 TASDADLIAEQQIWAAVDPY--AKNEAFNCNNADIFKWKHLWKILAEQFGIEQYGF---- 1071
HIE DGSDANLVAEQHIFAATSGKVRNRGEAFNSINGLGFTWKEIWPDIGRKLGVQVNETTMFD 1072
VIR DGSDANLVAEQHIFAATSGKVRNRGEAFNSINGVEFTWKEIWPDIGRKLGVQVNETTMFD 1073
PUL DGSDANLVAEQHIFAATSGKVRNRGEAFNAINGVGFTWKEIWPELGRKLGVQVNETTMFD 1074
PIE DGSDANLVAEQHIFAATSGKVRNRGEAFNSINGVGFTWKEIWPGGNLVCKLMKRRCLMKI 1075
HUN DGSDANLVAEQHIFAATSGKVRNRGEAFNSINGVGFTWKEIWPGGNLVCKLMKRRCLMKI 1076
ECE_6g7150 DGSDANLVAEQHIFAATSGKVRNRGEAFNSINGVGFTWKEIWPDIGRKLGVQVNETTMFD 1077
SYL DGSDANLVAEQHIFAATSGKVRNRGEAFNSINGVGFTWKEIWPDIGRKLGVQVNETTMFD 1078
ER4 DGSDANLVAEQHIFAATSGKVRNRGEAFNSINGVGFTWKEIWPDIGRKLGVQVNETTMFD 1079
ASP DGSDANLVAEQHIFAATSGKVRNRGEAFNSINGVGFTWKEIWPDIGRKLGVQVNETTMFD 1080
ER1_1 ------------------------------------------------------------ 1081
ER1_2 ------------------------------------------------------------ 1082
KOT HGSDANLVAEQHIFAATSGKVRNRGEAFNAINGDGFTWKEIWPEIGRKFGVQVNETTMFD 1083
CSS HGSDANLVAEQHIFAATSGKVRNRGEAFNAINGDGFTWKEIWPELGRKFGVQVNETTMFD 1084
RHA DGSDANLVAEQHIFAATSGKVRNRGEAFNAINGDAFTWKEIWPELGKKLGVQVNETTMFD 1085
PSE DGSDANLVAEQHIFAATSGKVRNRGEAFNAINGDAFTWKEIWPELGRKLGVQVNETTMFD 1086
ER2 DGSDANLVAEQHIFAATSGKVRNRGEAFNAINGDAFTWKEIWPELGRKLGVQVNETTMFD 1087
1088
1089
ECE_2g27660 ------EEGKNLG--LVEMMKGKERVWEEMVKENQLQEKKLDE--VGVWWFADVILGVEG 1090
HIE ---ENFWYGREM----ERENMCGTRLW--------------------------------- 1091
VIR ---ENFWYGREMGERWERENMCGTRLW--------------------------------- 1092
PUL ---ENFWYGREM--------GERKHVWDEIVVKERLVRTEIEDLA--NWVFLDGLFRCPY 1093
PIE SGMGERWEREN---------MCGTRLW--------------------------------- 1094
HUN SGMGERWEREN---------MCGTRLW--------------------------------- 1095
ECE_6g7150 ---ENFWYGREM--------GERKHVWDEIVVKEGLVRTEIEDLA--NWVFLDGLFRCPF 1096
SYL ---ENFWYGREM--------GERKHVWDEIVVKEGLVRTEIEDLA--NWVFLDGLFRCPF 1097
ER4 ---ENFWYGREM--------GERKHVWDEIVVKEGLVRTEIEDLA--NWVFLDGLFRCPF 1098
ASP ---ENFWYGREM--------GERKHVWDEIVVKEGLVRTEIEDLA--NWVFLDGLFRCPF 1099
ER1_1 ------------------------------------------------------------ 1100
ER1_2 ------------------------------------------------------------ 1101
KOT ---ENFWYGREM--------GERKHVWDEIVVKERLVRTEIEDLAKGNWVFLDGLFRMRH 1102
CSS ---ENFWYGREM--------GERKHVWDEIVVKERLVRTEIEDLAKGNWVFLDGLFRMRH 1103
RHA ---ENFWYGREM--------GERKHVWDEIVVKEGLVRTEIEDMAKGNWVFLDGLFRMRH 1104
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
43
PSE ---ENFWYGREM--------GERKHVWDEIVVKEGLVRTEIEDMAKGNWVFLDGLFRMRH 1105
ER2 ---ENFWYGREM--------GERKHVWDEIVVKEGLVRTEIEDLAKGNWVFLDGLFRMRH 1106
1107
1108
ECE_2g27660 -MIDSMNKSKEHGFLGFRNSNNSFISWIDKYKAFKIVP- 1109
HIE --------------------------------------- 1110
VIR --------------------------------------- 1111
PUL KLLGKRDKVDRFGFKRKCRTLDSILYWIDVMRDEKLIPL 1112
PIE --------------------------------------- 1113
HUN --------------------------------------- 1114
ECE_6g7150 KLLGKRDKVDRFGFKRKCRTLDSILYWIDVMRDEKLIPL 1115
SYL KLLGKRDKVDRFGFKRKCRTLDSILYWIDVMRDEKLIPL 1116
ER4 KLLGKRDKVDRFGFKRKCRTLDSILYWIDVMRDEKLIPL 1117
ASP KLLGKRDKVDRFGFKRKCRTLDSILYWIDVMR------- 1118
ER1_1 --------------------------------------- 1119
ER1_2 --------------------------------------- 1120
KOT KLLGKRDKVDRFGFTRKCRTLDSILYWIDVMRDEKLIPL 1121
CSS KLLGKRDKVDRFGFKRKCRTLDSILYWIDVMRDEKLIPL 1122
RHA KLLGKRDKVDRFGFKRKCRTLDSILYWIDVMRDEKLIPL 1123
PSE KLLGKRDKVDRFGFKRKCRTLDSILYWIDVMRDEKLIPL 1124
ER2 KLLGKRDKVDRFGFKRKCRTLDSILYWIDVMRDEKLIPF 1125
1126
1127
1128
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
44
Figure S15. Multiple sequence alignment of 3β-hydroxysteroid dehydrogenases (3βHSD). 1129
Coding sequences were aligned using Clustal Omega. Species included: Arabidopsis thaliana 1130
(AT/At), Erysimum cheiranthoides (Ec/Erche), Erysimum crepidifolium (Ecre), and Digitalis 1131
lanata (Dl). Sequences correspond to gene phylogeny in Figure 6a. 1132
1133
CLUSTAL O(1.2.4) multiple sequence alignment 1134
1135
1136
AT3G51680 ATGCCTGCCC-----------------------------AAGTGATCGCTGAGCAGACCA 31 1137
Dl3BHSD1 ------------------------------------------------------------ 0 1138
Dl3BHSD2 ------------------------------------------------------------ 0 1139
AtSDR5_AT2G47140 ------------------------------------------------------------ 0 1140
Erche07g001535 ------------------------------------------------------------ 0 1141
Ecre_5540 ------------------------------------------------------------ 0 1142
AT2G47150 ------------------------------------------------------------ 0 1143
AT2G47120 ------------------------------------------------------------ 0 1144
Ecre_7213 ------------------------------------------------------------ 0 1145
AtSR3_AT2G471430 ------------------------------------------------------------ 0 1146
AtSDR4_AT3G29250 ATGCCAAAACTCTTGGTTATATTTAACATTATATATCCTTTGCAATCCCTCAAGAAGGAT 60 1147
Ecre_9065 ------------------------------------------------------------ 0 1148
AT3G29260 ------------------------------------------------------------ 0 1149
1150
1151
AT3G51680 CCTTTCACTCCGTCCACG-------ACACCATTATGGAGGAGACGAATACAACTTTATAT 84 1152
Dl3BHSD1 --------------------------------------------------- ATGTCGTCA 9 1153
Dl3BHSD2 ------------------------------------------------------ ATGTCA 6 1154
AtSDR5_AT2G47140 ------------------------------------------------------ ATGTCT 6 1155
Erche07g001535 ------------------------------------------------------ ATGCTT 6 1156
Ecre_5540 ------------------------------------------------------ atgcct 6 1157
AT2G47150 ------------------------------------------------------------ 0 1158
AT2G47120 --------------------------------------------------- ATGTCGGGA 9 1159
Ecre_7213 ------------------------------------------------------ atgtcg 6 1160
AtSR3_AT2G471430 ------------------------------------------------------ ATGTCG 6 1161
AtSDR4_AT3G29250 ACATTCAATTTTTGGTGGTCTTTTCAAAAGTGGAAATACAACAAAACAATGTCGGGACTT 120 1162
Ecre_9065 --------------------------------------------------- atgtccgga 9 1163
AT3G29260 ------------------------------------------------------ ATGTCG 6 1164
1165
1166
AT3G51680 CCTAAGAGGTTGGAAGGAAAAGTAGCCATCATAACCGGAGGCGCACATGGAATAGGCAAA 144 1167
Dl3BHSD1 AAGCCAAGGTTGGAGGGTAAAGTGGCAATCATCACCGGAGCCGCTAGCGGCATCGGCGAG 69 1168
Dl3BHSD2 AAGCAAAGGTTGGAAGGCAAAGTCGCAATCGTCACCGGCGCTGCTAGCGGTATCGGCGAG 66 1169
AtSDR5_AT2G47140 GGAAAAAGATTGGATGGCAAAATCGTAATTATTACTGGCGGAGCAAGCGGGATTGGGGCT 66 1170
Erche07g001535 GGAAACACATTGGATGGCAAAATCGTAATTATCACCGGTGGAGCAAGCGGGATTGGTGCT 66 1171
Ecre_5540 ggaaacatgttggatggcaaaatcgttattatcaccggtggagcaagcgggattggtgct 66 1172
AT2G47150 ---------ATGGATGGCAAAATCGTGATTATAACAGGGGGAGCCAGTGGGACAGGAGCC 51 1173
AT2G47120 CTCAGTAGATTGGAAGGCAAGATCGTAATTATAACAGGCGGAGCCAGCGGGATTGGAGCC 69 1174
Ecre_7213 ggactcagattggatggcaaaatcgtaattataacaggcggagccagcgggattggagcc 66 1175
AtSR3_AT2G471430 GGACTCAGATTGGATGGCAAAATCGCAATAATAACAGGCGGAGCTAGCGGGATTGGAGCC 66 1176
AtSDR4_AT3G29250 AGGCAAGTATTGGATGGCAAGATCGCAATTATAACAGGCGGAGCTAGTGGGATTGGAGCT 180 1177
Ecre_9065 ctcggaagattagatggcaagatcgcaattataacaggtggagctagcgggattggagcg 69 1178
AT3G29260 GGACAAAGATTGGATGGCAAGATCGTAATTATAACAGGCGGGGCTAGTGGGATCGGAGCT 66 1179
* ** ** ** * * ** * ** ** * ** ** * ** 1180
1181
AT3G51680 GCAACCGTCATGTTATTCGCTAGACACGGTGCCACAGTGGTGATTGCTGACGTGGACAAC 204 1182
Dl3BHSD1 GAGACGGCAAGATTGTTCGTGGAGCATGGCGCCTCAGTGGTGGTGGCGGACGTCCAGGAC 129 1183
Dl3BHSD2 GCGGCAGCCAGACTATTTATCGAGCATGGCGCCAGAGTGGTGGTGGCTGACATACAAGAC 126 1184
AtSDR5_AT2G47140 GAGTCCGTTCGATTATTTACCGAACACGGCGCTCGAGTCGTGATCGTTGATGTACAGGAT 126 1185
Erche07g001535 GAGTCCGTCAGGCTATTTACCGACCATGGCGCTCGAGTCGTGATAGTTGACATACAAGAC 126 1186
Ecre_5540 gagtccgtcaggctatttaccgaccatggcgctcgagtcgtcatagttgacatacaagac 126 1187
AT2G47150 GAATCCGCTAGGTTGTTCACTGACCACGGAGCTCAAGTGGTTGTAGTTGACTTACAAGAA 111 1188
AT2G47120 GACGCCGCTAGGCTGTTCACGGACCACGGAGCTAAGGTGGTTATAGTTGACGTACAAGAA 129 1189
Ecre_7213 gaagcggctaggctgttcacggaccacggagctaaggtgatcatcgttgacttacaagaa 126 1190
AtSR3_AT2G471430 GAAGCGGTTAGGCTGTTCACGGACCACGGAGCTAAGGTGGTCATCGTTGACTTTCAAGAA 126 1191
AtSDR4_AT3G29250 GAAGCGGTTAGGTTGTTCACGGACCATGGAGCTAAAGTGGTCATCGTGGACATACAAGAA 240 1192
Ecre_9065 gaagcggctaggttgttcacggatcatggagctaaagtggttatcgttgacgtacaagaa 129 1193
AT3G29260 GAAGCAGCGAGGTTGTTCACGGACCATGGAGCTAAAGTTGTCATCGTTGACTTACAAGAG 126 1194
* * * * ** ** ** ** ** * * * ** * * * 1195
1196
AT3G51680 GTAGCTGGCTCTTCCCTGGCTAAGTCACTCTCATCCCACAAAACCTCCCCGATGGTGGCA 264 1197
Dl3BHSD1 GAATTGGGGCGCCAGGTCGTCGCTTCCGTAAACT ---------CTGACGACAAGATAAGT 180 1198
Dl3BHSD2 GAATTAGCCCAAAACGTCATTTCCTCGATTAA ------------CTCCGATAAGGTCAGC 174 1199
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
45
AtSDR5_AT2G47140 GAGCTCGGTCAAAACGTTGCAGTTTCGATCGG ------------TGAAGACAAAGCGAGT 174 1200
Erche07g001535 GAGCTCGGTCAAAGCGTTGCCGTTTCGGTCGG ------------AGAAGACAAGGCGACT 174 1201
Ecre_5540 gagctcggtcaaaacgttgccgtttcggtcgg ------------agaagacaaggcgact 174 1202
AT2G47150 GAGCAAGGCA-AAACGTCGCCGTTTCAATCGG------------CAAAGACAGAGCAAGT 158 1203
AT2G47120 GAACTAGGCCAAAACGTCGCAGTTTTGATCGG ------------GAAAGACAAAGCTAGT 177 1204
Ecre_7213 gagcttggtcaaaacttagctgtttccatcgg ------------gctagagaaagcaacg 174 1205
AtSR3_AT2G471430 GAACTTGGTCAAAACGTTGCCGTTTCTGTCGG ------------GAAAGACAAAGCAAGT 174 1206
AtSDR4_AT3G29250 GAGCTTGGCCAAAACCTCGCCGTTTCGATAGG ------------GCTAGACAAAGCAAGT 288 1207
Ecre_9065 gagcttgctcaaaacgtcgccgtttcaatcgg ------------gctagacaaagctagt 177 1208
AT3G29260 GAGCTTGGTCAAAACGTCGCCGTTTCGATCGG ------------GCTAGACAAAGCAAGT 174 1209
* * * * * * 1210
1211
AT3G51680 TTCATTAGCTGCGATGTCTCCGTAGAAGCCGACGTGGAAAACCTTGTGAACGTAACCGTT 324 1212
Dl3BHSD1 TACTACCACTGCGACGTCAGAGATGAAAAACAAGTGGCGGCCACCGTCCGCTACGCGGTG 240 1213
Dl3BHSD2 TACTTTCACTGTGACGTGAGAGATGAGAAACAAGTGGCGGATACCGTCAACTACGCCACC 234 1214
AtSDR5_AT2G47140 TACTATCATTGCGATGTCACGAACGAGACGGAAGTTGAAAACGCCGTTAAGTTCACCGTC 234 1215
Erche07g001535 TACTATCATTGCGATGTTACCAACGAGACGGAAGTTGAAAACGCCGTTAAGTTCACCGTC 234 1216
Ecre_5540 tactatcattgcgatgttaccaacgagacggaagttgaaaacgccgttaagttcaccgtc 234 1217
AT2G47150 TTTTACCGTTGTGATGTTACAAACGAGACGGA ---------------------------- 190 1218
AT2G47120 TTTTACCGTTGCGATGTGACAAATGAGACGGAAGTCGAGGACGCAGTTAAGTTCACCGTC 237 1219
Ecre_7213 ttttaccgttgcgatataacaaaagaaacggaggtagagaacgccgttaagttcaccgtc 234 1220
AtSR3_AT2G471430 TTTTACCGTTGCGATGTTACAAACGAAAAGGAGGTAGAAAACGCCGTTAAGTTCACCGTC 234 1221
AtSDR4_AT3G29250 TTTTACCGTTGTAATGTAACCGACGAGACGGATGTCGAGAACGCCGTTAAGTTCACCGTT 348 1222
Ecre_9065 ttttaccgttgcgatataacggatcagatggaggtagagaatgccgttaaattcacagtt 237 1223
AT3G29260 TTTTACCGTTGCGATATAACGGATGAGACGGAAGTTGAGAACGCCGTTAAGTTCACCGTT 234 1224
* ** * * * * 1225
1226
AT3G51680 GCACGGTACGGTAGGCTTGACATTCTATTCAACAACGCGGGAGTTCTCGGAGATCAGAAG 384 1227
Dl3BHSD1 GAGAAATACGGGCGCCTCGACATCATGCTGAGCAACGCCGGAGTCTTCGGGGCCTTGATG 300 1228
Dl3BHSD2 GCAAAATACGGCACTCTCGACATAATGTTTAGCAACGCGGCAGTCCTCGGACCCGATATA 294 1229
AtSDR5_AT2G47140 GAAAAATATGGGAAGCTTGACGTTCTGTTTAGTAACGCCGGCGTAATAGAGCCGTTTGTG 294 1230
Erche07g001535 GAAAAACACGGGAAGCTTGACGTTCTGCTCAGTAACGCTGGCGTTATAGATCCATTTACG 294 1231
Ecre_5540 gaaaaacacgggaagcttgacgttctgttcagtaacgccggcgttatagaaacatttacg 294 1232
AT2G47150 -------------------------------ACCAACCCGGCGTCTTGGAAACACCGGGA 219 1233
AT2G47120 GAAAAACACGGAAAGCTAGACGTTCTGTTTAGCAACGCCGGAGTCTTGGAACCACTGGAA 297 1234
Ecre_7213 gaaaaatacggtaagcttgacgttctgtttagtaacgctggcgttatggaacagccagga 294 1235
AtSR3_AT2G471430 GAAAAGTACGGGAAGCTTGACGTTCTCTTTAGTAACGCCGGCGTTATGGAACAGCCGGGA 294 1236
AtSDR4_AT3G29250 GAAAAACACGGAAAGCTTGACGTTCTGTTTAGTAACGCCGGGGTCTTGGAAGCGTTTGGA 408 1237
Ecre_9065 gaaaaacatggtaagcttgacgttctgtttagtaacgccggcatcatggaacggccggga 297 1238
AT3G29260 GAAAAACACGGAAAGCTTGACGTTCTGTTTAGTAACGCCGGGGTCATGGAACCGCATGGA 294 1239
* * * * * * 1240
1241
AT3G51680 AAACACAAAAGCATATTAGACTTCGACGCGGACGAGTTTGACCACGTGATGCGTGTGAAC 444 1242
Dl3BHSD1 ------ACGAACGTAATCGATCTCGACATGGTTGACTTTGAAAATGTATTGGCGACTAAC 354 1243
Dl3BHSD2 ---------AGCGTATTGGAACTTGACATGGGAAAATTGGACGACACTTTCGCGACGAAT 345 1244
AtSDR5_AT2G47140 ---------AGCATCCTCGACTTAAACCTCAACGAGTTAGACCGAACGATCGCCATTAAC 345 1245
Erche07g001535 ---------AGCATCCTCGACTTAGATCTGGACGAATTCGACCGAGTGGTCGCCGCTAAC 345 1246
Ecre_5540 ---------agcatcctcgacttagatctggacgaattcgaccgagtggtcaccgttaac 345 1247
AT2G47150 ---------AGCATCCTTGATTTGAATCTTGAACGGTTTCACCGAACAATGGCTGTCAAC 270 1248
AT2G47120 ---------AGCTTCCTCGACTTTGACCTCGAACGGTTTGACCGCATAATGGCTGTTAAC 348 1249
Ecre_7213 ---------agcttcctcgacttggatcttgaacactttgaccgaaccatggcggtcaac 345 1250
AtSR3_AT2G471430 ---------AGCTTTCTCGACTTGAATCTGGAACAGTTTGACCGAACCATGGCGGTCAAC 345 1251
AtSDR4_AT3G29250 ---------AGCGTTCTTGATTTGGATCTTGAGGCGTTTGATCGAACGATGGCGGTTAAC 459 1252
Ecre_9065 ---------agcattcttgatttggatcttgagaagtttgaacgaaccatggcggtcaac 348 1253
AT3G29260 ---------AGCATTCTTGATTTGGATCTTGAGGCGTTTGATCGAACGATGGCCGTCAAC 345 1254
* * * * ** * * ** * * ** 1255
1256
AT3G51680 GTACGTGGCGTAGGACTCGGCATGAAACACGGGGCACGCGCTATGATCAAGAGAGGATTC 504 1257
Dl3BHSD1 GTGCGCGGAGTTGCCAACACTATAAAGCACGCGGCACGAGCCATGGTGGAGGGGAAGGTC 414 1258
Dl3BHSD2 GTACGTGGGGTCGCCGCCACGATTAAGCACGCAGGGCGGGCCATGGTGGAGAGGAAGGTA 405 1259
AtSDR5_AT2G47140 CTCCGCGGCACAGCCGCATTCATCAAGCATGCTGCACGTGCCATGGTGGAGAAAGGCATC 405 1260
Erche07g001535 CTCCGTGGCGCAGCCGCATTTATCAAACATGCTGCACGTGCCATGGTCGAGAAAGGCACG 405 1261
Ecre_5540 ctccgtggcgcagccgcatttatcaaatatgctgcacgtgccatggtcgagaaaggcacg 405 1262
AT2G47150 GTTCGTGGAGCGGCTGTGTCTATCAAACACGCCGCACGAGCCATGGTGGAGAAAGGCACA 330 1263
AT2G47120 GTTCGCGGTGCAGCTGCGTTTATCAAACACGCGGCACGAGCCATGGTGGAGAAAGGCACG 408 1264
Ecre_7213 gttcgcggggcggctgcctttatcaaacacgcggcacgtgccatggtggagaagggcacg 405 1265
AtSR3_AT2G471430 GTTCGTGGTGCGGCTGCGTTTATCAAACACGCTGCACGAGCCATGGTGGAGAAAGGCACG 405 1266
AtSDR4_AT3G29250 GTTCGCGGTGCGGCTGCGTTTATCAAACACGCGGCACGTTCGATGGTGGCTAGTGGTACT 519 1267
Ecre_9065 gttcgcggtgcggctgcgtttatcaaacatgtggcgcgtactatggttgctaatgggaca 408 1268
AT3G29260 GTTCGCGGTGCGGCTGCGTTTATAAAACATGCAGCGCGTTCGATGGTGGCTAGTGGAACT 405 1269
* ** ** * ** ** * * * ** * *** * 1270
1271
AT3G51680 AAAGGCTGCATAATCTCCACGGCGAGTGTAGCCGGTGTGATGGGTGGAATGGGACCACAC 564 1272
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
46
Dl3BHSD1 AAGGGGTCCATCATTTGCACCGCCAGCGTGTCGGCGAGCCTTGGAGGCATGGGCCCGCCC 474 1273
Dl3BHSD2 AAGGGGTCCATTATCTGCACTGCCAGCGTGGCGGCGTGCGTTGGGGGGGTGGCCCCGATT 465 1274
AtSDR5_AT2G47140 CGCGGCTCCATCGTTTGCACCACTAGCGTCGCGGCTGAGATCGCTGGCACGGCACCACAC 465 1275
Erche07g001535 CGCGGCTCCATCGTTTGCACGACCAGCGTCGCAGCTGAGGTCGCCGGCACCGGACCACAC 465 1276
Ecre_5540 cgcggctccatcgtttgcacgaccagcgtctcaggtgaggtcgccggcaccggaccacac 465 1277
AT2G47150 CGTGGCTCCATCGTTTGTACGACCAGTGTTACGTCGGAGATCGTGGTC -AGGGACCTCAT 389 1278
AT2G47120 CGTGGCTCCATCGTTTGTACGACGAGCGTCTCGGCGGAGATCGGTG---GGGGGCATCAT 465 1279
Ecre_7213 cgtgggtcaatcgtatgtaccacaagcgtcgcggcggagatcggtggtccgggacctcat 465 1280
AtSR3_AT2G471430 CGTGGGTCAATCGTATGTACGACCAGCGTCGCGTCGGAGATCGGTGGTCCAGGACCTCAC 465 1281
AtSDR4_AT3G29250 CGTGGCTCCATTGTATGTACGACGAGTATTGCGGCAGAGATAGGTGGTCCGGGACCTCAT 579 1282
Ecre_9065 cgtggttcgattgtatgtactactagtatcgcggccgagattggtggtcctgcacctcat 468 1283
AT3G29260 CGTGGCTCCATTGTTTGTACAACGAGTGTGACGGCTGAGATTGGTGGTCCGGGACCTCAC 465 1284
** * ** * * ** * ** * * * * * * * 1285
1286
AT3G51680 GCTTACACAGCCTCGAAACATGCGATCGTTGGTTTGACCAAGAACGCAGCGTGTGAGCTA 624 1287
Dl3BHSD1 GCTTACACGGCTTCCAAACACGCCGTCCTGGGCCTAGTCAAGGGCGCTTGCGCCGAATTG 534 1288
Dl3BHSD2 GCTTACACCGCTACTAAACATGCTGTGGTGGGGCTGGTGAAGTCGGCTTGCGGCGAGCTT 525 1289
AtSDR5_AT2G47140 GGGTACACGACGTCGAAGCATGGGCTGTTGGGTTTGATCAAATCGGCTTCTGGTGGATTA 525 1290
Erche07g001535 GGGTACACGGCGTCTAAGCATGGGCTATTGGGTTTGATCAAATCAGCTTCTGGTGGATTG 525 1291
Ecre_5540 gggtacacggcggctaagcatgggctagtgggtttgatcaaaacagcttctggtggattg 525 1292
AT2G47150 GAATACACGGCGTCGAAGCATGGGCTCT -------------------------------- 417 1293
AT2G47120 GGTTACACGGCGTCTAAACACGGGCTTGTCGGCCTGATTAGATCGGCCTGTGGTGATTTG 525 1294
Ecre_7213 gcgtacacggcgtcgaagcacgcgcttctcgggctgatgagatcggcatgtggcgggctg 525 1295
AtSR3_AT2G471430 GCGTACACGGCGTCTAAGCACGCTCTTCTCGGGCTGGTTAAATCGGCTTGTGGCGGGCTA 525 1296
AtSDR4_AT3G29250 AGTTACACGGCTTCTAAGCACGCGCTTCTCGGGCTGATCCGATCAGCGTGTGCTGGACTG 639 1297
Ecre_9065 agttacacagcgtctaagcacgcgctcctcgggctgattcgatcagcgtgtggtgggtta 528 1298
AT3G29260 AGTTACACAGCGTCGAAACACGCGCTTCTCGGGTTGGTTCGATCAGCGTGTGGCGGGTTG 525 1299
***** * * ** ** * * 1300
1301
AT3G51680 GGCAAGTATGGGATTAGGGTTAATTGTATATCACCGTTTGGAGTTGCCACGTCGATGCTG 684 1302
Dl3BHSD1 GGGGTGCACGGGATCCGAGTCAACTCGGTGGCGCCGTACGGTGTGGCGACCCCGATGCCG 594 1303
Dl3BHSD2 GGCGCGCATGGGATTAGGGTTAACTGTGTCTCGCCGTATTTGGTGGCGACGCCGCTCACT 585 1304
AtSDR5_AT2G47140 GGAAAATATGGTATAAGAGTAAACGGCGTTGCTCCATTTGGTGTCGCAACACCGTTAGTT 585 1305
Erche07g001535 GGGAAATACGGAATAAGAGTGAACGGCGTTGCTCCGTATGGGGTCGCCACACCGTTAGTT 585 1306
Ecre_5540 gggaaatacggaataagagtaaacggcgttgctccgtttggggtcgctacaccgttagtt 585 1307
AT2G47150 ------------------------------------------------------------ 417 1308
AT2G47120 GGGAAGTATGGGATTAGAGTCAATGGAGTCGCACCGTACGCGGTGGCAACGCCAATGACT 585 1309
Ecre_7213 gggaagtacgggattagagtcaacggtgttgcaccgtatgcggtggcgacggcaatcaat 585 1310
AtSR3_AT2G471430 GGGAAGTACGGGATTAGAGTCAACGGCGTTGCACCATACGCGGTGGCGACGGCGATAAAT 585 1311
AtSDR4_AT3G29250 GGGCAGTACGGTATTAGAGTCAACGGTGTTGCACCGTATGGGGTTGCCACGGGGATGACT 699 1312
Ecre_9065 gggaagtacgggattagagtcaatggcgttgcaccgtatggggttgcgacggggttgact 588 1313
AT3G29260 GGGAAGTACGGGATTAGAGTCAACGGTGTTGCACCGTATGGAGTAGCAACGGGGTTAACT 585 1314
1315
1316
AT3G51680 GTTAACGCGTGGCGAAAGACGAGTGGTGGTGACGTGGAAGATGATGACGTGGAGGAGATG 744 1317
Dl3BHSD1 TGCAGTGCTTACGGAATGACACCGAGTCAG ---------------------------ATG 627 1318
Dl3BHSD2 TGCAGCGCGTACGAGATGGAGCCGAGTGAA ---------------------------GTA 618 1319
AtSDR5_AT2G47140 TGTAATGGTTTCAAGATGGAACCAAACGTG ---------------------------GTG 618 1320
Erche07g001535 TGTAATGGTTTCAATATAGAGCCAAACGTG ---------------------------GTG 618 1321
Ecre_5540 tgtgataggtacaatatggagccaaacgcg ---------------------------gtg 618 1322
AT2G47150 ------CACGACGAGGAGACGGCGAAGCAG---------------------------ACG 444 1323
AT2G47120 AGCCA---CGACGAGGTAACGGGAAAGCAG---------------------------TTG 615 1324
Ecre_7213 agccg---tgacgaggaaacagtgaagatg---------------------------gtg 615 1325
AtSR3_AT2G471430 AGCCG---TGACGAGGAAACGGTGAGGATG---------------------------GTG 615 1326
AtSDR4_AT3G29250 AGCGCCTACAATGAGGAAGCGGTGAAGATG ---------------------------CTT 732 1327
Ecre_9065 agcca---caatgaggaaacggtgaagttt---------------------------gtt 618 1328
AT3G29260 AGCTA---CAACGAGGAAACTGTGAAGATG---------------------------GTT 615 1329
1330
1331
AT3G51680 GAGGAGTTTGTGAGGAGTTTGGCTAATTTGAAAGGAGAGACATTGAGAGCGAATGATATA 804 1332
Dl3BHSD1 GAGGAGGCCAATAACTCCAGGGCTAACTTGAAGGGGGTGGTTTTGAAGGCTAAGCATGTA 687 1333
Dl3BHSD2 GAAGCCACCATGTGCGCCAACGCTAACTTGAAGGGAGTGGTTTTGAAAGCTATGCATGTT 678 1334
AtSDR5_AT2G47140 GAGCAGAACACGTCAGCTTCGGCGAATCTAAAGGGCATTGTATTGAAAGCTCGTCACGTG 678 1335
Erche07g001535 GAGGCGAACACTTTAGCGAACGGAAATCTAAAGGGCATCATATTGAAAGCTCGCCACGTG 678 1336
Ecre_5540 gaggagagcactctagcgtccggaaatctaaagggcatcatgttgaaagctcgccacgtg 678 1337
AT2G47150 GAGGAGTATTGCGAAGCCAGAGGGATTTTTAAAGGTGTTGTGTTAAAGGCTCGACACGTG 504 1338
AT2G47120 GAGGATTATTTTGACGCCAAGGGAATTCTCAAGGGGATGGTGCTTAAAGCTAGCCACGTT 675 1339
Ecre_7213 gaggactattgcgccgccacggggattctcaagggtgtggtgcttaaggctcgccatgtg 675 1340
AtSR3_AT2G471430 GAGGAATATAGCGCAGCCACGGGGATTCTCAAAGGTGTGGTGCTTAAGGCTCGCCATGTG 675 1341
AtSDR4_AT3G29250 GAAGAATATGGTGAAGCCCTAGGGAATCTCAAAGGTGTGGTGCTTAAAGCTCGCCACATC 792 1342
Ecre_9065 gaagaatattgtgaagccacggggaatctcaaaggtgttgtgcttaaagctcgtcacgtg 678 1343
AT3G29260 GAGGATTACTGTTCAGCCACGGCGATTCTCAAAGGTGTTGTACTTAAAGCTCGACATGTG 675 1344
** * * * ** ** * * ** * * 1345
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
47
1346
AT3G51680 GCTGAAGCAGCGTTATATTTGGCGAGTGATGAGTCTAAGTATGTGAACGGACATAATCTT 864 1347
Dl3BHSD1 GCTGAGGCGGCTCTCTTCTTGGCTTCCGATGAGTCGGCTTATGTCAGTGGACAAAACTTG 747 1348
Dl3BHSD2 GCTGAGGTGGCTCTGTTCTTGGCTTCCGATGAGTCCGCTTATGTTAGTGGACAAAATGTG 738 1349
AtSDR5_AT2G47140 GCAGAAGCTGCTCTGTTTTTAGCGTCCGATGAGTCGGCTTACGTTAGCGGACAGAACCTG 738 1350
Erche07g001535 GCAGAAGCTGCTTTGTTTTTAGCATCCGATGCGTCGGCTTACGTTAGCGGACAGAACCTG 738 1351
Ecre_5540 gcagaaactgctttgtttttagcatccgatgcgtcggcttacgttagcggacagaacctg 738 1352
AT2G47150 GCAGAAGCTGCTCTGTTTCTCGCTTCGGATGATTCGGTTTATATCAGTGGTCAGAATTTA 564 1353
AT2G47120 GCACAAGTGGCTCTGTTCTTGGCTTCTGATGATTCGGCTTATATAAGTGGTCAGAATTTG 735 1354
Ecre_7213 gcagaggctgctttgttcctggcttcggatgattcagcttacgttagcggccagaatctg 735 1355
AtSR3_AT2G471430 GCAGAGGCGGCTTTGTTTCTGGCTTCGGATGATTCGGCTTACGTTAGCGGTCAGAATCTG 735 1356
AtSDR4_AT3G29250 GCAGAAGCAGCTTTGTTTTTGGCTTCTGATGATTCGGTTTATATTAGCGGTCAGAATCTG 852 1357
Ecre_9065 gcagaagttgctttgtttctggcttctgatgagtcggtttatattagcggtcagaatcta 738 1358
AT3G29260 GCAGATGCAGCTTTGTTTTTGGCTTCTGATGATTCGGTTTATATTAGTGGTCAAAACTTG 735 1359
** * ** * * * ** **** ** ** * * ** ** ** * 1360
1361
AT3G51680 GTCGTTGACGGTGGTGTTACGACTGCAAGAAACTGTGTTGGTTTGTGA 912 1362
Dl3BHSD1 GCTGTCGACGGCGGCTTCACCGTCGTGCGTTAG --------------- 780 1363
Dl3BHSD2 GCGGTTGACGGCGGGTTCACGGTCGTTAAGGCTCTCGGAGTTTAA --- 783 1364
AtSDR5_AT2G47140 GCTGTTGACGGTGGTTACTCGGTGGTGAAGCCGTAG ------------ 774 1365
Erche07g001535 GCCGTTGACGGGGGTTACTCGGTGGTTAAGCAGTAG ------------ 774 1366
Ecre_5540 gccgttgacgggggttactcggtggttaagcagtag ------------ 774 1367
AT2G47150 GCAGTGGACGGTGGTTTTTGCGTCGTTAAGCCTATTTGA --------- 603 1368
AT2G47120 GCGGTGGATGGTGGTTATACTGTCGTTAAGCCAAGCCGTGATTAA --- 780 1369
Ecre_7213 gctgttgacggtggttttagcatcgttaagcccatgtga --------- 774 1370
AtSR3_AT2G471430 GCTGTTGACGGGGGTTATAGCGTCGTTAAGCCCATTTGA --------- 774 1371
AtSDR4_AT3G29250 GTGGTTGATGGTGGTTTTAGCGTCGTTAAGCTCATGACCACGTGA --- 897 1372
Ecre_9065 gcggtggacggtggttttagcgtcgtgaagctgtcatga --------- 777 1373
AT3G29260 GGGGTTGACGGCGGTTATAGCGTCGTTAAGCTGACATCGAATTAA --- 780 1374
* ** ** ** ** * 1375
1376
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
48
Figure S16. Multiple sequence alignment of 3-ketosteroid isomerases (3KSI). Coding 1377
sequences were aligned using Clustal Omega. Species included: Arabidopsis thaliana (At/AT), 1378
Calotropis gigantea (Cg), Erysimum cheiranthoides (Ec/Erche), and Digitalis lanata (Dl). 1379
Sequences correspond to gene phylogeny in Figure 6b. 1380
1381
CLUSTAL O(1.2.4) multiple sequence alignment 1382
1383
1384
AT1G47290 ATGGTGATGGAAGTTACAGAGACTGA------------GCGATGGTGCGTTGTAACTGGT 1385
Erche04g028310 ATGGAGATGATAGAAGAGAAGAACAGAGGAATAGAAGGCAAAGTAGTAGTCGTGACGGGT 1386
Erche07g017170 ------ATGCATTTGAGTGAGAACGAAGGTGTCGAAGGTAAGACCTTCTTGGTCACTGGA 1387
AT2G33630 ------ATGCATTTGAGTGAGAATGAAGGTGTCGAAGGTAACACCTTCGTGGTCACTGGA 1388
Dl_DN10245 ------atgcatttgagcgagaacgagggaatagagaagaaaaccttcgtggtgactggc 1389
Cg010433 ------atgcatctaagcgaaaacgaagggattgaaaataacagctttgtggtgacgggt 1390
*** * * * ** ** ** 1391
1392
AT1G47290 GGTAGAGGATTCGCTGCAAGACATCTTGTAGAAATGCTCGTACGTTACCAAATGTTCCAC 1393
Erche04g028310 GGGTTGGGTTTAGTAGGCTCCACCGTGTGCCTTGAGCTGCTCC --------------GCC 1394
Erche07g017170 GGTCTTGGCTTCGTCGGTGCTGCCCTCTGCTTTGAGCTCGTTC --------------GTC 1395
AT2G33630 GGTCTTGGCTTCGTCGGTGCAGCTCTCTGCTTAGAGCTCGTTC --------------GTC 1396
Dl_DN10245 gggctgggcttcgtgggctcggccctctgctcggagctctcca --------------gac 1397
Cg010433 ggccatggatttgtaggcgccgccctctgccttgagctagtta--------------gaa 1398
** ** ** * * * *** 1399
1400
AT1G47290 GTTCGTATCGCCGATTTAGCTCCTGCGATAGTGCTCAATCCTCACGAGGAAACTGGAATT 1401
Erche04g028310 GTGGCGCTCTCCAGGTTCGCTCCTTAGACTGCCGCACCACTTCT -------------TCT 1402
Erche07g017170 GTGGAGCTCGCCATGTCCGCTCTTTCGACCTCCGCCACTCTTCT -------------CCT 1403
AT2G33630 GTGGTGCTCGCCAAGTTCGCTCTTTTGACCTCCGTCACTCTTCT -------------CCT 1404
Dl_DN10245 gaggggcttatcaagttcgggcctttgaccttcgctttgaatct -------------cct 1405
Cg010433 gaggagctcgtgtagtcaaggcttttgatcttcgtacaaattct -------------ccc 1406
* * * * * ** ** 1407
1408
AT1G47290 CTCGGTGAAGCAATTAGATCCGGTAGAGTTCAATACGTCTCCGCTGATCTTCGGAACAAA 1409
Erche04g028310 TGGTCCGACCGTCTCAAAGAATCCGGCGTCCACTGCATAAATGGAGATGTTGTGAGCAGA 1410
Erche07g017170 TGGTCCGATGACCTCAAAAACAGTGGCGTTCGCTGCATCCAAGGTGATGTGACCAAGAAA 1411
AT2G33630 TGGTCCGATGATCTCAAAAACAGTGGCGTTCGCTGCATTCAAGGTGATGTGACTAAGAAA 1412
Dl_DN10245 tggtccgaggatctccggcatcgtggtgttcgttgcatccaaggggatgttgcaaagaaa 1413
Cg010433 tggtcccaagatctcagtacaaaaggcgtccaatttgtccatggagatgtttcacggaag 1414
* * * ** * * * * *** * * 1415
1416
AT1G47290 ACTCAAGTTGTCAAAGGTTTTCAAGGAGCAGAAGTGGTGTTTCATATGGCAGCTCCAGAT 1417
Erche04g028310 GAGGACGTAGAAGAGGCTGTTGAAGGAGTGGACATTGTTATTCATCTTGCTTCGTACGGT 1418
Erche07g017170 GAAGATGTGGATAAGGCTCTAGATGGTGCGGACTGTGTCTTTCATCTTGCTTCCTATGGC 1419
AT2G33630 CAAGATGTGGATAACGCTTTAGATGGAGCAGACTGTGTTTTGCATCTTGCTTCTTATGGT 1420
Dl_DN10245 gaagatgttgaaaaagctttacgaggcgcagattgtgttttccacctcgcttcatatggc 1421
Cg010433 caagatgtggaaaaggcattatggggagcagattgtgtcttccaccttgcctcttatggc 1422
* ** * * * * ** * ** ** * ** * ** * * 1423
1424
AT1G47290 TCATCGATTAACAATC---------ACCAGCTTCAGTACTCAGTTAATGTTCAAGGGACA 1425
Erche04g028310 GGTTCGGGTAAGGAAATGGTTCGGGCTCATCAGATTGAGGAAGTCAACGTAGAAGGGACG 1426
Erche07g017170 ATGTCTGGTAAAGAGATGCTTCAGTTTGGTCGTTGTGACGAGGTTAACATTAACGGCACT 1427
AT2G33630 ATGTCTGGGAAGGAGATGCTTCGGTTTGGTCGTTGTGATGAGGTTAACATCAACGGGACT 1428
Dl_DN10245 atgtctggcaaagaaatgctccagtatggccgcattgatcagataaatataaatggaact 1429
Cg010433 atgtccggaaaagaaatgctccaatttggtcgtgttgatgaggttaatattactggaacc 1430
** ** * * * * ** * ** ** 1431
1432
AT1G47290 ACAAATGTAATTGATGCTTGTATTGAGGTTGGAGTAAAGAGGCTAATCTATACAAGTTCT 1433
Erche04g028310 CGTAACGTTTTGGAAACATGTGTGAAGAAAGGGATCACCAGGGTAGTGTATTTAAGCACG 1434
Erche07g017170 TGTAACGTCTTGGAGGCTGTGTTCAAACACGAGATCACAAGACTTGTCTATGTCAGCACT 1435
AT2G33630 TGTAATGTCTTGGAAGCTGCGTTTAAACATGAGATTACAAGAATTGTGTATGTTAGCACT 1436
Dl_DN10245 tgccacattctggatgcttgtctggaccatggaatcagcaggcttgtgtatgtgagcaca 1437
Cg010433 tgtcttgttttggacgcttgcgtggatcttggaatcaagagacttgtttatgtaagcaca 1438
* * ** * * * * * * ** * * *** ** * 1439
1440
AT1G47290 CCGAGTGTTGTGTTTGACGGGGTCCATGGTACTTTGAATGCTGATGAATCACTGCCGTAT 1441
Erche04g028310 AAAGATGTCGTTTTCAGTGGGAA---AGAGATTGAGAATGGAGATGAAACTCTACCTTAT 1442
Erche07g017170 TACAATGTTGTCTTTGGTGGTAA---GGAGATTCAAAATGGCAATGAAGGTTTGCCGTAT 1443
AT2G33630 TACAATGTTGTGTTTGGTGGTAA---AGAGATTCTCAATGGTAATGAAGGTTTGCCTTAT 1444
Dl_DN10245 tacaatgttgtatttggtggaaa---ggaaattgtaaatggtaacgagagtttaccttac 1445
Cg010433 tacaacgttgtttttggtggaaa---ggaaatactgaatggcaatgaaagtctgccttat 1446
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
49
** ** ** ** * * **** * ** * ** ** 1447
1448
AT1G47290 CCACCTAAGCATAATGA------TTCATATTCAGCTACTAAAGCTGAAGGGGAAGCTTTG 1449
Erche04g028310 GTAGCTTCCAATGAATACGTCAGTTCATATGATCGGACAAAATCTATAGCCGAACAGTTG 1450
Erche07g017170 TTCCCTCTTGATGATCATGTCGACGCCTATGGTCGAACTAAATCCATTGCAGAACAGTTA 1451
AT2G33630 TTCCCTCTTGATGATCATGTTGATGCATATAGTCGAACTAAATCGATTGCAGAACAGTTG 1452
Dl_DN10245 tttccgctggatgaccatgtagatccctatggcagcagtaaatctatagctgaacaattg 1453
Cg010433 ttccctatggatgaccatgtcgatgcatatggccgaagtaaagccattgctgaacagtta 1454
* ** * * * *** * *** * * *** ** 1455
1456
AT1G47290 ATTTTGAAAGCGAATGGAA---------------------GAAGTGGACTACTCACTTGT 1457
Erche04g028310 GTTCTAGAGAACAACGGTCGTACGGTTGAGAACGGACATGGAAGTTTTTTATCGACATGT 1458
Erche07g017170 GTCCTCAAGAGTAATGGTCGACCATTTAAGAATGGGGG ---CAAACGGGTGTACACATGT 1459
AT2G33630 GTTCTCAAGAGTAATGGTCGACCTTTTAAGAATGGAGG ---CAAACGGATGTATACATGT 1460
Dl_DN10245 gttctgaagagcaatagcaaacccttcagaaagaaaca ---aggaaaactctacacatgt 1461
Cg010433 gtattgaagagcaatggccgccccctgaagaacaagaatggaaaacgcctctatacatgt 1462
* * * ** * * ** *** 1463
1464
AT1G47290 TGCATACGTCCTAGCAGCATATTTGGTCCTGGTGATAAATTAATGGTTCCATCGCTTGTT 1465
Erche04g028310 GTGATTCGATGCCCGATTGTTTATGGACCTGGTGAAGAGAAGTATCTTAATAGGATAATC 1466
Erche07g017170 GCAATTCGTCCAGCGGCTATATATGGACCCGGCGAAGACAGGCATCTTCCTAGGATCGTT 1467
AT2G33630 GCGATTCGTCCAGCGGCTATATATGGACCTGGCGAAGATAGGCATCTTCCTAGGATTGTT 1468
Dl_DN10245 gcaatccgccccggtgctatatacgggccaggtgaagaaagacacttgcccagaattata 1469
Cg010433 gcagtgcgtcctgctgctatttatggacctggtgaagaaaggcatcttccgagaatatta 1470
* ** * * ** ** ** ** * * * * 1471
1472
AT1G47290 ACTGCTGCCAGGGCTGGGAAATCCAAGTTCATTATAGGTGATGGGAGTAACTTCTATGAT 1473
Erche04g028310 TCTGATGCAAGATTGGGTTTATTTCTCTTCAAAATTGGCGATACAAGCTCAAAAACCGAC 1474
Erche07g017170 AATCTAGCAAAGTTAGGTTTGATGCTCTTCAAGATCGGTGAACCGAGTGTCAAAACAGAC 1475
AT2G33630 ACTCTAACAAAGTTGGGTTTGGCTCTCTTCAAGATCGGTGAACCGAGTGTCAAATCAGAC 1476
Dl_DN10245 aagcttgccaaattaggtcttctgcccttcaagattggcacaaagaatgtgaaagcagac 1477
Cg010433 aaattgatcaaattaggtcttgtgccatttaagattggtgatgccactgcgaaaactgac 1478
* ** ** * ** ** * ** 1479
1480
AT1G47290 TTCACTTATGTTGAAAATGTTGTGCACGCCCATGTCTGTGCTGAGCG ---------AGCT 1481
Erche04g028310 TGGATTTATGTGGATAACATTGTATTCGCACTCATGTTGGCAACTACTGATTTACTCAAT 1482
Erche07g017170 TGGATTTATGTTGAAAACCTTGTCCTCGCAATCATCCTTGCAAGCATGGGACTCTTGGAC 1483
AT2G33630 TGGATTTATGTCGAAAACCTTGTCCTAGCAATCATCTTGGCAAGTATGGGACTCTTGGAT 1484
Dl_DN10245 tgggtttatgtcgataaccttgtgttggccctgatcttagctagcatgggtcttttagac 1485
Cg010433 tgggtctacgtggataaccttgtattagccatattattggccagtatgggccttttagat 1486
* ** ** ** ** **** ** * ** 1487
1488
AT1G47290 CTAGCATCAGGAGGAGAAGTATGTGCAAAAGCTGCTGGCCAGGCTTACTTCATTACCAAC 1489
Erche04g028310 GAACGCT------------------CGAAAGCCTCAGGGAAGGCCTACTTTGTTTCTGAT 1490
Erche07g017170 GACATTCCGGGCAGAGAAGGGCAGCCCGTCGCTGCTGGTCAACCATACTTTGTTTCTGAT 1491
AT2G33630 GACATTCCTGGCAGAGAAGGACAACCTGTTGCTGCTGGTCAACCATATTTTGTCTCTGAC 1492
Dl_DN10245 gacattcctgggagagttggagaaccagttgctgctggtcaaccttatttcatatcagat 1493
Cg010433 gacattcctggacgagaaggacagccagtcgctgctgggcaaccttacttcatatcagat 1494
* ** * ** * * ** ** * * * 1495
1496
AT1G47290 ATGGAGCCAATTAAATTTTGGGAGTTTATGTCACAGCTTCTTGAAGGACTTGGCTATGAG 1497
Erche04g028310 GGTAATCCAATAAATTTCTTCGAATTTCTTCAGCCACTTTTAAAGAATCTTGATTATGAT 1498
Erche07g017170 GGTTCACCGGTGAATACCTTTGAGTTTCTACGTCCCTTACTAAGAAGTTTAGACTATGAC 1499
AT2G33630 GGTTACCCGGTGAATACCTTTGAGTTTCTGCGTCCTTTACTAAAAAGTTTAGACTATGAC 1500
Dl_DN10245 gggtctccagtcaatagttttgagttcctccagcccttactcaagagtctggagtatgat 1501
Cg010433 ggctcgccagttaatagttttgagttcatccgtccactggttaatagcctggattatgac 1502
** * ** * ** ** * * * * * * ***** 1503
1504
AT1G47290 AGGCCAAGTATAAAGATACCTGCAAGTCTCATGATGCCAATAGCATATCTTGTGGAACTA 1505
Erche04g028310 CTTCCCAAGTTATCCCTATCTATTTCGCTTGCGGTTTTCCAGGGAAAAATATGTGAAACA 1506
Erche07g017170 CTGCCCAAGTTTACAATATCTGTACCTTTTGGGCTGACCTTGGGTAAGATCTTCCAAGGT 1507
AT2G33630 CTGCCCAAGTGTACAATCTCTGTACCTTTTGCGCTGTCCTTGGGTAAGATCTTCCAAGGT 1508
Dl_DN10245 atgccgaatttgtcactggaagtaccacatgctctatttctcggaaaactcttttggggt 1509
Cg010433 ctgccacaaatgtcattagcagttccccatgcacttcttttgggaaaattttgtactgct 1510
** * * * * * 1511
1512
AT1G47290 GCAT------------ATAAATTACTCGGACCGTATGGGATGAAAGTACCAGTGCTAACA 1513
Erche04g028310 ATATACGCAATGCTATCACCGCTACTAAACCAATGGTGGATTCCACAACCATTGATTCTT 1514
Erche07g017170 TTCTACACTGTGTTATATCCATGGCTATCACAGAGCTGGTTACCACAGCCCCTTATTCTT 1515
AT2G33630 TTCTACACTGTGCTATATCCATGGCTATCAAAGAGCTGGTTACCACAGCCCCTTGTTCTT 1516
Dl_DN10245 ttctactcgcttttgcatccatggctacaccagtggtggattcctccgcccttgatcctt 1517
Cg010433 ctctactctattttgtatccttggttgtgtaaaaagtggcttcctcagccctttatactt 1518
* * ** * ** * * 1519
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
50
1520
AT1G47290 CCTTCTAGGGTTAGGCTACTCTCTTG-CAACAGAACATTTGATTCTTCAAAAGCAAAGGA 1521
Erche04g028310 CCACCTGAAGTTTATAAGGTTGGGGTGACTCATTACTACTCGA -TCGGCAAAATCAAGGA 1522
Erche07g017170 CCTGCTGAAGTCTACAAGGTCGGTGTTACCCATTACTTCTCAT -ATCTCAAAGCCAAGGA 1523
AT2G33630 CCTGCTGAAGTCTACAAGGTCGGTGTTACCCATTATTTCTCAT -ATCTTAAAGCCAAGGA 1524
Dl_DN10245 cctgctgaagtatataaggtgggagttacccattacttctcat -tcttaaaagcaaggaa 1525
Cg010433 cctgctgaagtctacaaggttggtgtaacacattacttttcgt -atatgaaagcaagaga 1526
** ** ** * ** * * *** * * 1527
1528
AT1G47290 TCGTTTAGGCTATTCTCCTGTTGTCCCACTTCAGGAAGGTATAAAGAGGACAATAGATTC 1529
Erche04g028310 AGAACTTGGGTACGAGCCCAAGACACAACCTGAAGAAGGCATGACCGAAACCATTTCAT - 1530
Erche07g017170 AGAGCTTGGATATGTTCCATTCAAGAGCTCCCAGGAAGGTATGGCTGCAACTATCTCAT - 1531
AT2G33630 GGAGCTTGGATATGTTCCATTCAAGAGCTCCAAGGAAGGTATGGCTGCAACTATCTCAT - 1532
Dl_DN10245 cgaactgggatataccccaatggtcagtcctcaagagggcatgaacgcaacaattgaat - 1533
Cg010433 agagcttgggtacatcccaatagtgagccctcgagagggtatggctgccactatctcgt - 1534
* ** ** ** ** ** ** ** ** * 1535
1536
AT1G47290 ATTCTCACACTTGAAAGCTCAAAATCAACCCAAAACAGAAGTTACTGAAACAATTCAATG 1537
Erche04g028310 --------ATTTTAAAGAAAAGAAGAGGAGAGAGGTTGATGGTCCAAGCATTTACGCATG 1538
Erche07g017170 --------ACTGGCAGGAAAGGAAACGGAGATCTTTAGTCGGTCCAACCATATTCACTTG 1539
AT2G33630 --------ACTGGCAGGAAAGGAAGCGGAGATCTTTAGACGGTCCAACCATGTTCACTTG 1540
Dl_DN10245 --------actggaaggatagaaaaaggagaacaatagatggcccaaaaatatatgaatg 1541
Cg010433 --------attggaaagagaagaagaagagaagtctggacggaccaacaatattcgcatg 1542
* * * * ** * * * * ** 1543
1544
AT1G47290 GAAAA--------AGCAGACTCTCATTGCCATAGTCATTCTGATTACTCTCTATC----- 1545
Erche04g028310 GATTTTCTGTGTGATCGGTTTGCCTAGCATTATATCAGTCGCGTGGCTACCTGACATTGG 1546
Erche07g017170 GATAGCTGTTATACTATCAATGTCAGCTCTTTTTGCTTCTGGATGGTTACCCGACATAGG 1547
AT2G33630 GATAGCTGTTACAATAGGAATGTCTGCTCTTTTTGCTGCCGGATGGTTACCCGACATAGG 1548
Dl_DN10245 gctatttgtgttgactggaatgacgacgctattttgttctgtatacatgcctgatgttgg 1549
Cg010433 gctgttctgtgtgattggaatgttggttgtatttgcagcagcatatctgccagattttgg 1550
* * * * * 1551
1552
AT1G47290 ----ATAACTTTGTTGC-----AACCACCGGATCATCTTCCGTCA--------TAATAAC 1553
Erche04g028310 ACCCATACCATTCTTTCGAGTCATTGCAATGTTTATCTTTAGGTCGATGTTGGTGTTACG 1554
Erche07g017170 ACCTGTGCCTTACTTTAGAGCCATACACCTCTTCTTCTTCCGGAAAATCATGATTGTAAG 1555
AT2G33630 ACCTGTGCCTTTCTTAAGAGCCATACACCTCTTCTTTTTCCGGACAATCACGATTGTAAA 1556
Dl_DN10245 tccctttcccctatttagagcagtgcacctcttctttttccgctctatgtggctgctaca 1557
Cg010433 tcctattcccataatcagggcttttgctcttttcttcctacgctctatgacagcattaag 1558
* * * * * * * ** 1559
1560
AT1G47290 TGCTGTTTCCAAGGTTTTGTTGGTATCATCAATTTTTAT --------------------- 1561
Erche04g028310 GATAGCATCCGGGATTGTGGTGACAACTCACGTGGGTGAAGCGGTGTATGCGTTATGGCT 1562
Erche07g017170 GGCTGTCTTCATCATATCAGTGGGACTACATGTTGGAGAAGCAATCTATGCGTGGTTTCT 1563
AT2G33630 GGCTGTCTTCATTGTAGCAGTGGTACTACATGTTGCAGAAGGAATCTATGCGTGGTTTCT 1564
Dl_DN10245 tatagtctggcttttatctgcagcagcacatattggtgaggctgtttatgcatggaaact 1565
Cg010433 ggtgcttttccttgcgtctgcagcagctcatattggcgaagccttatacgcatggcaact 1566
* * * 1567
1568
AT1G47290 ------------------------------------------------------------ 1569
Erche04g028310 GGCTCGGAGAGTGGACCCAAAGAATGCAAAAGCTTGGTTTTGGCGGACGCTACTTCTTGC 1570
Erche07g017170 GGCTAAACGAGTCGACCCAGGAAATGCAGTGGGGTGGTTTTGGCAAACCGTCGCTCTCGG 1571
AT2G33630 GGCTAAACGAGTCGACCCAGGAAATGCAATGGGGTGGTTCTTGCAAACCAGCGCTCTCGG 1572
Dl_DN10245 tgcaagaaaggtcgatcctgcaaatgcgaaagcctggttttggcaaacgttcgctttggg 1573
Cg010433 tgcaaaaagagtggatcctgcaaatgcaaagggctggttttggcaaactttagcattggg 1574
1575
1576
AT1G47290 --GTTCATCAATGGCATT-----TTACCAGAGAAAATG------AAAGTGTTCGGGAGCA 1577
Erche04g028310 TACTTTCTCGCTTCGATTACTTTTGAAAAGAGCCAAGGAAGTAAAACAATCAACACTAAG 1578
Erche07g017170 GATATTCGGTATGCGGTTTTTGTTAAAGAGAGCCAAAGACCACCAAGTTTAA -------- 1579
AT2G33630 GTTTTTCTCAATGCGGTTTTTATTGAAGAGAGCGAAAGAGCACCAGATTTAA -------- 1580
Dl_DN10245 attcttttcattgcgttttctgttgaagagagccaaaacctag ----------------- 1581
Cg010433 gttcttttccctgcgttttctgttaaagagggctaaagaaaatacttag ----------- 1582
* * ** * * ** * ** 1583
1584
AT1G47290 AGAAGATCGACTAA-------------------------- 1585
Erche04g028310 AGAAGGTCTACTAACCAATTCGGGGTCGTCAATTGCTTGA 1586
Erche07g017170 ---------------------------------------- 1587
AT2G33630 ---------------------------------------- 1588
Dl_DN10245 ---------------------------------------- 1589
Cg010433 ---------------------------------------- 1590
1591
1592
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
51
Figure S17. Multiple sequence alignment of Progesterone 5β-reductases (P5βR). Coding 1593
sequences were aligned using Clustal Omega. Species included: Arabidopsis thaliana (At/AT), 1594
Erysimum cheiranthoides (Ec/Erche), Erysimum crepidifolium (Ecre), Digitalis lanata (Dl), and 1595
Marchantia polymorpha (Mp). Sequences correspond to gene phylogeny in Figure 6c. 1596
1597
CLUSTAL O(1.2.4) multiple sequence alignment 1598
1599
1600
Dl_DN67489 ------------------------------------------------------------ 1601
AT5G58750 AT---------------------------------------GGGGTC----------TGA 1602
Erche06g007150 AT---------------------------------------GGAGTC----------TGA 1603
Erche06g011020 AT---------------------------------------GGGGTC----------TGA 1604
Ecre_P5BR2 AT---------------------------------------GGGGTC----------TGA 1605
Mp0191s0002 ------------------------------------------------------------ 1606
Dl_DN4564 atgtatactgacacaacgacttggtggtacaaaagatc ---cattggcgatattaaacag 1607
DlP5BR2 ATGTATACCGACACAACGACTTGGTGGTACAAAAGATC ---CATTGGCGATATTAAACAG 1608
AT4G24220_VEP1 ---------------ATGAGTTGGTGGTGGGCTGGCGCCATCGGAGC------TGCCAAG 1609
Erche02g027660 ---------------ATGAGTTGGTGGTGGGCTGGCGCCATCGGAGC------TGCCAAG 1610
Ecre_P5BR1 ---------------ATGAGTTGGTGGGGGGCTGGCGCCATCGGAGC------TGCCAAG 1611
Dl_DN477 ------------atgagcagctggtgggcggctggagctaccggcgccgcgaaggagaaa 1612
DlP5BR1 ---------------atgagctggtggtgggctggagcgataggcgc------tgcaaag 1613
1614
1615
Dl_DN67489 ---------atggctgtgaatgaccaaaatcatggatctcttgttgcagccgtctttgga 1616
AT5G58750 AAATGGCAGCTTGATGAGAAGAAACGA--AGTAGACGAGAATGTAGCGTTAATCTTTGGC 1617
Erche06g007150 AAGTGGCATCTTGATGAGACGAAACGA--AGTAGACGAGAACGTCGCGTTGATCTTCGGC 1618
Erche06g011020 AAATGGCATCTTGATGAGAAGAAACGA--AGTAGACGAGAACGTCGCGTTGATCTTCGGC 1619
Ecre_P5BR2 AAATGGCAGCTCGATGAGAAGAAACGA--AGTAGACGAGAACGTCGCGTTGATCTTCGGC 1620
Mp0191s0002 ---------------------------------ATGGGTAGAGCGGCCCTGATCTGCGGT 1621
Dl_DN4564 aaaaatgtcgaaacaaatggtgttgctttaaactacaagagtgtcgccctcatagttggg 1622
DlP5BR2 AAAAATGTCGAAACAAATGGTGTTGCTTTAAACTACAAGAGTGTCGCCCTCATAGTTGGG 1623
AT4G24220_VEP1 AAGAAACTCGACGAAGATGAACCATCACAAAGCTTCGAGAGCGTCGCTCTCATCATCGGC 1624
Erche02g027660 AAGAAACTCGACGACGATGAGCCGACGCAAAGCTACGAGAGCGTCGCTCTCATCATTGGC 1625
Ecre_P5BR1 AAGAAACTCGACGACGATGAGCCGTCGCAAAGCTACGAGAGCGTCGCTCTCATCATCGGC 1626
Dl_DN477 aaaactggagaagataatgaggcaccgtcaaagcaccagagcgtgggcttgatagtcgga 1627
DlP5BR1 aaaaggttggaagaagatgacgcacagccaaagcattcgagcgtggcgttgatagttggg 1628
* * * ** 1629
1630
Dl_DN67489 gttactggccttgtgggaaaggagctcgccggaaaactt ---ctttccaccggt------ 1631
AT5G58750 GTCACCGGGCTTGTGGGTCGAGAGATTGTTAAGACGCTATTAATGTCTAAACCA ------ 1632
Erche06g007150 GTCACGGGACTCGTTGGTCGAGCGATTGTAAAAACGCTACTAACGTCTGAACCC ------ 1633
Erche06g011020 GTCACGGGACTCGTTGGTCGAGAAATTGTAAAAACGCTACTCACGTCGAAACCC ------ 1634
Ecre_P5BR2 GTCACGGGACTCGTTGGTCGAGAGATTGTAAAAACGCTACTAACGTCAAAACCC ------ 1635
Mp0191s0002 GCGACCGGAATTGTGGGCAAATATTTGGTGGACATGCTTTCCAGCCCCGACTGCCCGTCC 1636
Dl_DN4564 gtcaccggcatcgccggaagcggtctggctgaaactctatccatgtccgacacgccaggt 1637
DlP5BR2 GTCACCGGCATCGCCGGAAGCGGTCTGGCTGAAACTCTATCCATGTCCGACACGCCAGGT 1638
AT4G24220_VEP1 GTTACTGGAATCGTCGGAAACAGCTTGGCGGAGATTCTCCCTCTTTCCGACACACCCGGT 1639
Erche02g027660 GTTACAGGAATCGTCGGAAACAGCCTTGCAGAGATTCTCCCTCTTTCCGACACACCCGGA 1640
Ecre_P5BR1 GTTACAGGAATCGTCGGAAACAGCCTGGCGGAGATTCTCCCTCTTTCCGACACACCCGGT 1641
Dl_DN477 gttaccggaattgttgggaatagtctggcggagatcctgccgcgctccgacacccccggc 1642
DlP5BR1 gtaaccggaatcatcggcaacagcctggcggagatcctgccactggccgacacccccggc 1643
* ** ** * ** * * * ** * 1644
1645
Dl_DN67489 ---aaatggaagatctatggaatagcaagaagccggaaggaaagttcgagttctcaatat 1646
AT5G58750 ---GGATGGAGAATCTACGGCGTAGCGCGTAACCCGGAGAT------------------- 1647
Erche06g007150 ---AGATGGAAAATTTACGGCGTGGCGCGTAAGCCGGAGAT------------------- 1648
Erche06g011020 ---AGATGGAAAATCTACGGCGTAGCGCGTAACCCGGAGAT------------------- 1649
Ecre_P5BR2 ---AGATGGAAAATTTACGGCGTAGCGCGTAACCCGGAGAT------------------- 1650
Mp0191s0002 GGACCATGGAAGGTGTACGCGCTAGCTCGAAGATCCCACACTGGTGCCAAAGT ------- 1651
Dl_DN4564 ggaccgtggaaagtctacggggtcgcgcgccgcccttgtccagagtggctagc ------- 1652
DlP5BR2 GGACCGTGGAAAGTCTACGGGGTCGCGCGCCGCCCTTGTCCAGAGTGGCTAGC ------- 1653
AT4G24220_VEP1 GGTCCATGGAAAGTCTACGGCGTCGCTCGTCGTCCTCGTCCTACCTGGAACGC ------- 1654
Erche02g027660 GGTCCCTGGAAAGTCTACGGCGTCGCTCGCCGTCCCCGTCCCAGCTGGAACGC ------- 1655
Ecre_P5BR1 GGTCCCTGGAAAGTCTACGGCGTCGCTCGCCGTCCCCGTCCCAGCTGGAACGC ------- 1656
Dl_DN477 ggcccatggaaggtctacggcgtcgcccgccgcccgcgccccagttggaacga ------- 1657
DlP5BR1 ggtccgtggaaggtatacggcgtcgcccgccgcaccagacccgcctggcatga ------- 1658
**** * ** * * ** * 1659
1660
Dl_DN67489 tttgcccgaactgaaagcgatccaaattaccatttcatttcgtgtgatcttcttaatcca 1661
AT5G58750 --------CAATTCCATGACGAAGATGTACAACTTCATCTCCTGCGATCTGCTTAACGCA 1662
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
52
Erche06g007150 --------CAATTCCAT---------GTGCAATTTCATCTCCTGCGATCTGCTTAACGCA 1663
Erche06g011020 --------CAATTCCATGGCGAAGATGTACAATTTCATCTCCTGCGATCTGCTTAACGCA 1664
Ecre_P5BR2 --------CAATACCATGGCGAAGATGTACAGTTTCATCTCCTGCGATCTGCTTAACGCA 1665
Mp0191s0002 --------TTGCTTCAAGTCCGAGAACTATACGTACATTCAAGCGAATCTGCTGGATAAG 1666
Dl_DN4564 -----------------caaactccacgtcagctacatccaatgtgacatcgggtcaact 1667
DlP5BR2 -----------------CAAACTCCACGTCAGCTACATCCAATGTGACATCGGGTCAACT 1668
AT4G24220_VEP1 -----------------CGATCATCCGATCGATTACATCCAGTGCGATGTCTCCGACGCC 1669
Erche02g027660 -----------------CGATCATCCGATCGATTACATCCAGTGCGATGTCTCCAACGCT 1670
Ecre_P5BR1 -----------------CGATCATCCGATCGATTACATCCAGTGCGATGTCTCCAACGCC 1671
Dl_DN477 -----------------agaaaaccctattaactacatccggtgtgacatatccgacccg 1672
DlP5BR1 -----------------ggataatccgatcaattacgtccagtgcgacatatccgatcca 1673
* * * * * 1674
1675
Dl_DN67489 tgggaaacacaagcaaagctctccccga---tgaatgacataactcatgtattttgggtc 1676
AT5G58750 TCTGAGACTAAACAGAGGTTGTCTCCATTACAAGACATCGTGAGTCACGTGTTTTGGGTC 1677
Erche06g007150 TCTGAGACTAAACAGAAGCTGACTCCATTACAGGACATCGTGAGTCACGTGTTTTGGGTC 1678
Erche06g011020 TCTGAGACTAAACAAAAGCTGTCTCCATTACAGGACATCGTGAGTCACGTGTTTTGGGTC 1679
Ecre_P5BR2 TCTGAGACTAAACAGAAGCTGTCTCCATTACAGGACATCGTGAGTCACGTGTTTTGGGTC 1680
Mp0191s0002 GACGACACCTACGAGAAGCTATCGCCTC---TGAAAGACGTGAGCCATATCTTCTGGGTG 1681
Dl_DN4564 gatgacacgtcagccaaattgtctccac---tttccgacatcactcacattttctacgtg 1682
DlP5BR2 GATGACACGTCAGCCAAATTGTCTCCAC---TTTCCGACATCACTCACATTTTCTACGTG 1683
AT4G24220_VEP1 GAAGACACAAGATCCAAGCTTTCCCCTT---TAACCGATGTCACACATGTCTTCTACGTC 1684
Erche02g027660 GAAGATGCAAGATCCAAGCTTTCCCCTT---TAACCGATGTCACTCACGTCTTCTACGTC 1685
Ecre_P5BR1 GAAGATGCAAGATCCAAGCTTTCCCCTT---TAACCGATGTCACTCACGTCTTCTACGTC 1686
Dl_DN477 gatgatacccgggtcaagctgtcacctc---tcacagatatcactcacgtgttttacgta 1687
DlP5BR1 gatgactcccaagccaagctgtcacctc---tgactgatgttacccacgtgttctacgtt 1688
** * * * * ** * * ** * ** * ** 1689
1690
Dl_DN67489 acttggtccagccagtttcctctggataacctcgagtgctctgagcagaacagggcaatg 1691
AT5G58750 ACGTGGTCTGGTGAGTTTCCATTGGATACCGACGAATGTTGCGTACAGAACAAGACGATG 1692
Erche06g007150 ACGTGGTCTGGCGAGTATCCATTGGATAGCGACGAGTGCTGTGTCCAGAACAAGACGATG 1693
Erche06g011020 ACGTGGTCTGGCGAGTATCCATTAGATAGCGACGAGTGCTGTGTCCAGAACAAGACGATG 1694
Ecre_P5BR2 ACGTGGTCTGGCGAGTATCCATTGGATACCGACGAGTGCTGTGTCCAGAACAAGACGATG 1695
Mp0191s0002 ACTTGGGTACAGGGCA------AGGACGAGGAAGAGAGCTGTGCGAAGAATGGTCAGATG 1696
Dl_DN4564 tcctggaccggatccg------a------------agattgtgataagaacgcaatcatg 1697
DlP5BR2 TCCTGGACCGGATCCG------A------------AGATTGTGATAAGAACGCAATCATG 1698
AT4G24220_VEP1 ACCTGGACCAATCGTG------AATCGGAAAGTGAAAACTGTGAAGCAAATGGCTCAATG 1699
Erche02g027660 ACCTGGACCAACCGCG------AATCGGAGAGCGAAAACTGCGAGGCTAACGGCTCAATG 1700
Ecre_P5BR1 ACCTGGACCAAGCGCG------AATCGGAGAGCGAAAACTGCGAGGCTAACGGCTCAATG 1701
Dl_DN477 acatgggcaaaacggt------ccaccgaggctgaaaattgcgaagccaatggcaaaatg 1702
DlP5BR1 acctgggctaatcgat------ccaccgaacaagaaaactgtgaagccaatagcaaaatg 1703
* *** * * ** *** 1704
1705
Dl_DN67489 atgtccaacgccctgaacgccatactccccacgtccaaggcgttaaagcatttctccctc 1706
AT5G58750 CTGATGAACGCTTTGGACGCGATTCTCCCAAACGCTAAGAGGTTAAAGCATTTCTCGCTT 1707
Erche06g007150 CTGTCAAACGCTTTGGACGCGATTCTCCCAAACGCTAAGAGGTTAAAGCATTTCTCGCTT 1708
Erche06g011020 CTGACAAACGCTTTGGACGCGATTCTCCCAAACGCTAAGAGGTTAAAGCATTTCTCGCTT 1709
Ecre_P5BR2 CTGACAAACGCTTTGGACGCGATTCTCCCAAACGCTAAGAGGTTAAAGCATTTCTCGCTT 1710
Mp0191s0002 CTCATCAATACTCTGGATGCCGTCGTGGCGAATTCCAGTGCTTTGGAGCACATCGTTCTT 1711
Dl_DN4564 ttcaaaaacatcctcgattcagtcatcccaaatgctccaaatctcaaacacatttccctc 1712
DlP5BR2 TTCAAAAACATCCTCGATTCAGTCATCCCCAATGCTCCAAATCTCAAACACATTTCCCTC 1713
AT4G24220_VEP1 CTCCGTAACGTTCTCCAAGCGATTATCCCATACGCGCCAAATCTCCGACATGTTTGTCTC 1714
Erche02g027660 ATCCGTAACGTTCTCCAAGCGATTGTCCCACACGCGCCTAATCTCCGGCACATTTGTCTC 1715
Ecre_P5BR1 CTCCGTAACGTTCTCCAAGCGATTGTCCCACACGCGCCTAATCTCCGGCACATTTGTCTC 1716
Dl_DN477 atgaagaatgttctcgactctgtaatccctaattgccctaatttgaagcacatttgtttg 1717
DlP5BR1 ttcaggaacgtgcttgatgcagttatccctaattgccccaatttgaagcacatctcattg 1718
* ** * * * * * * * ** * * 1719
1720
Dl_DN67489 cagacgggcaccaagcattacgtctctcttcaacaaggaaatacagatcattcaacgatg 1721
AT5G58750 CAAACGGGGATGAAGCATTATGTGTCTTTGGTGGAAGAGACAATGGCTCGTGGAGAAGGT 1722
Erche06g007150 CAAACGGGGATGCACCATTACAG------------------CGAATCCCATGGAGAAGGT 1723
Erche06g011020 CAAACGGGGATGAAGCATTACGTTTCTCTGGTCGAAGAGACTCTGTCCCGCGGAGAAGGT 1724
Ecre_P5BR2 CAAACGGGGATGAAGCATTACGTGTCTCTGGTCGAAGAGACTCTGTCACACGGAGAAGGT 1725
Mp0191s0002 CAGACGGGATGTAAGCATTATCTTGGACCCTTCGACCAGTTCGGTGG ---AGACGTGAAG 1726
Dl_DN4564 caaacaggaatcaagcactattggggcaacatggttgatgaaatggacaccactaatgta 1727
DlP5BR2 CAAACAGGAATCAAGCACTATTGGGGCAACATGGTTGATGAAATGGACATCACTAATGTA 1728
AT4G24220_VEP1 CAGACAGGGACAAAGCACTACCTTGGCCCTTTCACCAACGTTGA ---------CGGACCT 1729
Erche02g027660 CAGACGGGGACGAAGCACTACGTCGGCCCTTTCAGCAACCTCGG ------CGGCGGACCT 1730
Ecre_P5BR1 CAGACGGGGACGAAGCACTACCTCGGCCCTTTCAGCAACCTCGA ---------CGGACCT 1731
Dl_DN477 cagactgggaggagacattacatgggcttttttgaatcagggat ------g------aga 1732
DlP5BR1 cagactgggaggaagcattacatgggaccatttgaatcctacgg ------gaaaatagaa 1733
** ** ** ** ** 1734
1735
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
53
Dl_DN67489 aaacatgaaattatcttatttgacgagcattcgccgagggttctaaatgcagagcctaac 1736
AT5G58750 TCG----AGTTTGTATTATTACAG--CGAGGAGTGTCCAAGAAAGAGCTCTGGGAAGAAT 1737
Erche06g007150 TCG----AGTTTGTGTTATTACAG--CGAGGAGTGTCCGAGAAAGAGCTCTGGGAAGAAT 1738
Erche06g011020 TCG----AGTTTGTGTTATTACAG--CGAGGAGTGTCCGAGAAAGGGCTCTGGGAAGAAT 1739
Ecre_P5BR2 TCG----AGTTTGTGTTATTACAG--CGAGGAGTGTCCGAGAAAGGGCTCTGGGAAGAAT 1740
Mp0191s0002 CCTCACGACACCCCATTCCGAGA---GGATGTGCC------CAGACTTCCAGGCCAGAAT 1741
Dl_DN4564 tcacatgattgtccctttaatga---atacatgcc------tagacttagacaacccaat 1742
DlP5BR2 TCACATGATTGTCCCTTTAATGA---ATACATGCC------TAGACTTAGACAACCCAAT 1743
AT4G24220_VEP1 CGTCACGATCCACCGTTCACTGA---GGATATGCC------GAGATTGCAGATCCAGAAT 1744
Erche02g027660 CGCCACGATCCGCCTTTTACTGA---GGATATGCC------GAGATTGCAGATCCAGAAT 1745
Ecre_P5BR1 CGCCACGATCCGCCTTTTACTGA---GGATATGCC------GAGATTGCAGATCCAGAAT 1746
Dl_DN477 tgccacgatgctccgcataccga---ggatttgcc------ccgattggattgtttgaat 1747
DlP5BR1 tcccatgatccaccctacactga---ggatttgcc------caggttgaagtacatgaac 1748
* * * * ** 1749
1750
Dl_DN67489 ttttactacgccctcgaagacttgttacagg ------ataaattgccacttcatcgggtg 1751
AT5G58750 TTCTACTATGTTTTGGAGGACTTGCTGAAGG ------AGAAGATCACTCGTAGTTCCGTT 1752
Erche06g007150 TTCTATTACGTTTTGGAGGATTTGCTGGAGG ------AGAAGATCTCTGGTAATTCGGTT 1753
Erche06g011020 TTTTATTACGTTTTGGAGGATTTGCTGAAGG ------AGAAGATCTCTGGTAATTCGGTT 1754
Ecre_P5BR2 TTCTATTACGTTTTGGAGGATTTGCTGAAGG ------AGAAGATCTCTGGTAGTTCGGTT 1755
Mp0191s0002 TTCTACTACACCTTGGAGGATATTGTGTTCAACCACCTCAAGCAGCACCAAGGTCATCTG 1756
Dl_DN4564 ttctattacaatcttgaagacctactttatgaagcctgcaggacacaaaacggtgctcta 1757
DlP5BR2 TTCTATTCCAATCTTGAAGACCTACTTTATGAAGCCTGCAGGACACAAAACGGTGCTCTA 1758
AT4G24220_VEP1 TTCTATTATACCCAAGAGGATATTCTGTTTGAAGAGATCAAGAAGATAGA ---AACCGTG 1759
Erche02g027660 TTCTATTACACTCAGGAGGATATTCTGTTTGAAGAGATCAAGAAGAAAGA ---AAGTGTG 1760
Ecre_P5BR1 TTCTATTACACTCAGGAGGATATTCTGTTTGAAGAGATCAAGAAGAAAGAAATTAGTGTG 1761
Dl_DN477 ttttactacactttagaggatattctctttgaggaggtggggaagaagga ---aggtttg 1762
DlP5BR1 ttttactatgatttagaggatattatgcttgaggaggtggagaagaagga ---gggtttg 1763
** ** * ** ** * * * 1764
1765
Dl_DN67489 ggatggtccatccaccgccccggattgataatcggttgttcccatagaacaacttacaat 1766
AT5G58750 GTTTGGTCGGTTCAAAGACCTGGTTTGCTAATGGGAAGCTCTTCAAGAACTCTGTACAAC 1767
Erche06g007150 GTTTGGTCGGTTCAAAGACCTGGTTTGCTATTGGGAAGCTCTACAAGAACTCTGAAAAAT 1768
Erche06g011020 GTTTGGTCGGTCCAAAGACCTGGTTTGCTAATGGGAAGCTCTTCAAGAACTCTGTACAAT 1769
Ecre_P5BR2 GTTTGGTCGGTTCAAAGACCTGGTTTGCTAATGGGAAGCTCTTCAAGAACTCTGTATAAT 1770
Mp0191s0002 ACTTACTCCATTCACAGACCGACCAATATCTTTGGGTTCTCAGCTGGGAATTTGATGAAC 1771
Dl_DN4564 acatggaccgtccatcgccccgcgctaattttcgggttctcgccatgtagtttgatgaac 1772
DlP5BR2 ACATGGACAGTCCATCGCCCCGCACTAATTTTCGGGTTCTCACCATGTAGTTTGATGAAC 1773
AT4G24220_VEP1 ACGTGGTCTATCCACAGACCAAACATGATCTTTGGGTTCTCTCCTTATAGTTTGATGAAC 1774
Erche02g027660 ACGTGGTCTATTCATAGACCAAACACGATCTTTGGATTCTCTCCTTACAGTTTGATGAAC 1775
Ecre_P5BR1 ACGTGGTCTATACATAGGCCAAACACGATCTTTGGATTCTCTCCTTACAGTTTGATGAAC 1776
Dl_DN477 agctggtcagtgcacaggcctggtttaattttcgggttctctccgtatagtattatgaac 1777
DlP5BR1 acttggtcggttcatcgcccagggaatatattcgggttttctccatatagtatgatgaat 1778
* * * ** * ** * * ** ** * ** 1779
1780
Dl_DN67489 tttataggtagtttatgcgtgtatggaactatttgcaagtatctgaatctcccttttgtg 1781
AT5G58750 TTCATGGGAAGTCTTTGTGTTTATGGAGCGATGTGTAAGTATTTGAATCTTCCTTTTGTG 1782
Erche06g007150 TTCATGGGAATTCTGTGTGTTTATGGAGCAATGTGTAAGTATTTGAATCTTCCTTTTGTG 1783
Erche06g011020 TTCATGGGAAGTCTTTGCGTTTATGGAGCAATGTGTAAGTATTTGAATCTCCCCTTTGTG 1784
Ecre_P5BR2 TTCATGGGAAGTCTTTGCGTTTATGGAGCAATGTGTAAGTATTTGAATCTCCCTTTTGTG 1785
Mp0191s0002 TTGTTGGGAACGCTTTCAGTGTATGCAGCCATCTGCAAACACGAGGGACTTCCATTTGTG 1786
Dl_DN4564 atagtcgcgacgctaagtgtttacgctgcaatttgcaagtatgagaacaagccattggtg 1787
DlP5BR2 ATAGTCGCAACGCTAAGTGTTTATGCCGCGATTTGCAAATATGAGAACAAGCCGTTGGTG 1788
AT4G24220_VEP1 ATTGTTGGGACTCTCTGTGTCTATGCAGCGATATGTAAGCATGAAGGGTCTCCGTTGTTG 1789
Erche02g027660 ATTGTTGGGACTCTTTGTGTCTACGCAGCGATCTGCAAGCATGAAGGGTCTCCGTTGTTG 1790
Ecre_P5BR1 ATTGTTGGGACTCTCTGTGTGTACGCAGCGATCTGCAAGCATGAAGGGTCGCCGTTGTTG 1791
Dl_DN477 gtgatggttagcttttgtgtttacgcggctatatgtaagcatgagggtgtgaagttgaaa 1792
DlP5BR1 ttggtgggtaccctttgtgtttatgcagctatttgcaaacacgagggaaaggttttgagg 1793
* * * * * ** ** * * ** ** ** * ** 1794
1795
Dl_DN67489 tttgggggcacaaagcaatgctgggaagaaatgtttgtagatgcttcagatgctcgactg 1796
AT5G58750 TTTGGAGGAACAAGAGAATGTTGGGAAGAGAGTTACATAGATGGCTCTGATTCGAATTTA 1797
Erche06g007150 TTTGGAGGGACAAGAGAGTGTTGGGAAGAGAGTTACATTGATGGCTCTGATGCGAATTTA 1798
Erche06g011020 TTTGGAGGGACACGAGAATGTTGGGAAGAGAGTTACATTGATGGCTCTGATTCGAATTTA 1799
Ecre_P5BR2 TTTGGAGGGACAAGAGAGTGTTGGGAAGAGATTTACATTGATGGGTCTGATGCCAATTTA 1800
Mp0191s0002 TTTCCAGGAAACAAAATCTCTTGGGAGCAGC ---TGTCCGATGCCTCCTCCGCAGATCTG 1801
Dl_DN4564 tataccgggacagaaacgtcgtggaattgtt ---tagtggatgccgtggattcggattta 1802
DlP5BR2 TATACCGGGACACAAACGTCGTGGAATTGTT ---TAGTGGATGCTGTGGATTCGGATTTG 1803
AT4G24220_VEP1 TTTCCTGGGAGCAAGAAAGCTTGGGAAGGGT ---TCATGACGGCTTCTGACGCGGATTTG 1804
Erche02g027660 TTTCCTGGGAGCAAGAAGGCTTGGGAAGGCT ---TCACGACGGCTTCGGACGCGGACCTG 1805
Ecre_P5BR1 TTTCCTGGGAGCAAGAAGGCTTGGGAAGGGT---TCACGACGGCTTCGGACGCGGACCTG 1806
Dl_DN477 tttccgggttgtaaaaccacgtgggatgggt ---attcagattgctcggattcggatctg 1807
DlP5BR1 tttactggttgtaaggctgcgtgggatgggt ---actcggattgctctgatgcggatttg 1808
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
54
* * ** *** * * * 1809
1810
Dl_DN67489 gtggccgaacagcacatttgggctgcaactacatttgaagctgatgcgcaaggagaagca 1811
AT5G58750 GTCGCGGAGCAGCATATATTCGCTGCAACAAGTGGGAAAGTACGCGAGAAAGGGGAAGCT 1812
Erche06g007150 GTCGCGGAACAGCATATATTCGCTGCAACAAGTGGGAAAGTACGCAACCGAGGTGAAGCA 1813
Erche06g011020 GTCGCGGAACAGCATATATTCGCTGCAACAAGTGGGAAAGTACGCAACAGAGGTGAAGCA 1814
Ecre_P5BR2 GTCGCGGAACAGCATATATTCGCTGCAACAAGTGGGAAAGTACGCAACAGAGGTGAAGCA 1815
Mp0191s0002 ATTGCAGAGCAGGAGATATGGGCCGCCACCACTATCGAT ------GCCAAGAACCAAGCT 1816
Dl_DN4564 ttagcggaccacttggtgtggggtgggacaaaccctaat ------gcgaagaatcaagct 1817
DlP5BR2 TTATCAGAGCACTTGGTATGGGGTGCGATCAGCCCAAAT ------GCGAAGAACCAAGCT 1818
AT4G24220_VEP1 ATTGCGGAGCAGCAGATTTGGGCGGCGGTTGATCCGTAT ------GCGAAGAACGAGGCG 1819
Erche02g027660 ATCGCTGAGCAGCAGATTTGGGCTGCGGTTGATCCGTAT ------GCGAAGAACGAGGCG 1820
Ecre_P5BR1 ATCGCTGAGCAGCAGATTTGGGCTGCGGTTGATCCGTAT ------GCTAAGAACGAGGCG 1821
Dl_DN477 attgcggagcaccagatctgggcggcggtggatcctaaa ------gcgaagaacgaggcg 1822
DlP5BR1 atagcggagcatcatatttgggctgcagtggatccttat ------gcaaaaaacgaggcc 1823
* * ** ** * * * * * * ** 1824
1825
Dl_DN67489 tttaatgccattaatggtgattgttatgcgtggaaggacatgtggcgggatattggattt 1826
AT5G58750 TTTAACGCCATTAATGGAGTAGGGTTTACTTGGAAGGAGATTTGGCCGGAAATAGGGAAG 1827
Erche06g007150 TTTAACTCCATTAATGGGGTAGGATTTACTTGGAAGGAGATTTGGCCGGATATCGGGAGG 1828
Erche06g011020 TTTAACGCCATTAATGGGGTAGGGTTTACTTGGAAGGAGATTTGGCCGGATATCGGGAGG 1829
Ecre_P5BR2 TTTAACGCCATTAATGGGGTAGGGTTTACTTGGAAGGAGATTTGGCCGGAGATTGGGAGG 1830
Mp0191s0002 TACAACATCTCCAATGGAGATGTTTTCAAGTGGAAGAAATTGTGGCCATTGCTTGCCGCT 1831
Dl_DN4564 ttcaatatcaacaatggcgacgtttttaaatggaaacacatatggaaagtgttggcggag 1832
DlP5BR2 TTCAATATCAACAATGGCGACGTTTTTAAATGGAAACATATATGGAAAGTGTTGGCGGAG 1833
AT4G24220_VEP1 TTTAACTGCAACAATGCTGATATCTTCAAGTGGAAGCATCTGTGGAAGATTCTAGCTGAG 1834
Erche02g027660 TTTAACTGCAACAACGCGGATATCTTCAAGTGGAAACATCTGTGGAAGATTTTGGCAGAG 1835
Ecre_P5BR1 TTTAACTGCAACAACGCGGATATCTTCAAGTGGAAACATCTGTGGAAGATTCTGGCTGAG 1836
Dl_DN477 tttaatatcagcaatggggatgtgttcaaatggaagcatttctggaaagtgttggctgag 1837
DlP5BR1 tttaatgtgagtaatggagatgtgtttaaatggaagcatttttggaaggtgttggcggag 1838
* ** ** * * * ***** * * *** * * 1839
1840
Dl_DN67489 aagcttggggcggatgtgccaaaagag---gacatgttatgtgaggatttcgtgttttcg 1841
AT5G58750 AAACTTGGTGTACAAGTTAACGAAACA---ACCATGTTTGATGAAGGTTTCTGGTTTGGG 1842
Erche06g007150 AAACTTGGTGTGCAAGTTAATGAAACG---ACGATGTTTGATGAAAATTTCTGGTATGGG 1843
Erche06g011020 AAGCTTGGGGTGCAAGTTACCGAAACG---ACGATGTTTGATGAAGGTTTCTGGTATGGG 1844
Ecre_P5BR2 AAACTTGGGGTGCAAGTTAACGAAACA---ACGATGTTTGATGAAGGTTTCTGGTATGGG 1845
Mp0191s0002 GAGCTTGGAATTGACGCCGCCC------CATAT---CACGGAGAGCCTCTGAACTTGACT 1846
Dl_DN4564 caatttg------aaatcgagtttgtgggttatgaaggcaaggagtttgtgagcttagag 1847
DlP5BR2 CAGCTTCAGCTTGAGATTGAGTTTGTGGGTTATGAAGGTAAGGAGCCGGTGTCTTTGGAG 1848
AT4G24220_VEP1 CAGTTTGGGATTGAGGAG------TATGGATTTGAGGAAGGGAAGAATTTGGGGTTGGTG 1849
Erche02g027660 CAGTTTGGAATTGAGCAG------TATGGATTTGAGGAAGGAAAGAATTTGGGGTTAGTG 1850
Ecre_P5BR1 CAGTTTGGGATTGAGGAG------TATGGATTTGAGGAAGGGAAGAATTTGGGGTTAGTG 1851
Dl_DN477 caatttgaggttgagtat------gcagagtacgaggaaggggagaatctgagcttccaa 1852
DlP5BR1 cagtttggagtagggtgt------ggagagtatgaagaaggggtggatttgaaattgcag 1853
* ** * * 1854
1855
Dl_DN67489 ttggcgatgggggataagggtggtgtttggagggacattgttgagaaagaggggttggtg 1856
AT5G58750 AGAGAGATGGTTGAGAGAAAACATGTGTGGGATGAGATTGTTGTGAAGGAGAAGCTTGTT 1857
Erche06g007150 AGAGAGATGGGAGAGAGAAAACATGTGTGGGACGAGATTGTGGTGAAGGAGGGGCTTGTT 1858
Erche06g011020 AGAGAGATGGGCGAGAGAAAAAATGTATGGGACGAGATTGTGGTGAAGGAGAGGCTTGTT 1859
Ecre_P5BR2 AGAGAGATGGGAGAAAGAAAACATGTGTGGGACGAGATTGTGGTGAAGGAGAGGCTTGTT 1860
Mp0191s0002 CAGAACTTCAGCGGGAAGGATCAAGCATGGGATACGATTGTGAAGGAAAAGGGCTTGGTT 1861
Dl_DN4564 aatctcatgaaggataaggactcggtgtgggacgagatagtgaagaagtacgatcttgtc 1862
DlP5BR2 GGTCTCATGAAGGATAAGGACTCGGTATGGGACGAGATGGTGGAGAAATACGACCTTGTC 1863
AT4G24220_VEP1 GAGATGATGAAAGGGAAAGAGAGAGTGTGGGAGGAGATGGTTAAGGAGAATCAATTGCAA 1864
Erche02g027660 GAGATGATGAAGGGGAAAGAGAGAGTGTGGGAGGAGATGGTGAAGGAGAATCAGTTGCAG 1865
Ecre_P5BR1 GAGATGATGAAGGGGAAAGAGAGAGTGTGGGAGGAAATGGTGAAGGAGAATCAGCTGCAG 1866
Dl_DN477 gatttgatgaaggataaaggtccgatttgggatgaaattgtgggggagaacggattggag 1867
DlP5BR1 gatttaatgaaggggaaggagccggtttgggaggaaatcgtgagggagaatggattgaca 1868
* * * *** ** ** * * * * 1869
1870
Dl_DN67489 gagactgagatggaggatttggctaactgggagtttctggatattcttttccgatgcccc 1871
AT5G58750 AGGACAGAGATTGAGGATTTGGCGAATTGGTATTTCTTGGATGCTCTGTTTAGATGTCCG 1872
Erche06g007150 CGGACAGAGATTGAGGATTTGGCGAATTGGGTTTTCTTGGATGGGCTGTTTAGATGTCCG 1873
Erche06g011020 CGGACAGAGATTGAGGATTTGGCGAATTGGGTTTTCTTGGATGTGCTGTTTAGATGTCCG 1874
Ecre_P5BR2 CGGACAGAGATTGAGGATTTGGCGAATTGGTTTTTCATGGATGTGCTGTTTAGATGTCCG 1875
Mp0191s0002 CCGACCAAATTGAAAGATGTTGGCAATTTTTGGTTCGCGGACCTCGTCCTCAACGTGCCG 1876
Dl_DN4564 ccgacgaaacttagggacatcgcggcgttttggtttgcagatgtggcgtttagcatcgag 1877
DlP5BR2 CCCACGAAACTTAGGGACATAGCGGCATTTTGGTTTGCGGATGTGGCGTTTAGCATCGAG 1878
AT4G24220_VEP1 GAGAAGAAGCTTGAGGAAGTTGGTGTGTGGTGGTTTGCTGATGTTATACTTGGAGTTGAA 1879
Erche02g027660 GAGAAGAAGCTTGATGAAGTTGGTGTGTGGTGGTTTGCGGATGTTATACTTGGAGTTGAA 1880
Ecre_P5BR1 GAGAAGAAGCTTGAGGAAGTTGGTGTGTGGTGGTTTGCGGATGTTATACTTGGAGTTGAA 1881
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
55
Dl_DN477 actaataaattggaagacattgcgaattgggggttcgcggatcttgtacttggctttgaa 1882
DlP5BR1 cctacgaaactgaaggatgtcggaatttggtggtttggtgatgttatacttgggaatgag 1883
* * * ** * * * ** ** * 1884
1885
Dl_DN67489 gcgaagatgttagcaacccgtgacaagattgatcgaatgggattcgagataaggtatcgt 1886
AT5G58750 TTTAAGCTTCTTGGGAAAAGAGAAAAAGTAGATAGGTTTGGGTTTAAGAGGAAATATAGA 1887
Erche06g007150 TTTAAGCTTCTTGGGAAGAGAGATAAAGTAGATAGGTTTGGGTTTAAGAGGAAATGTAGA 1888
Erche06g011020 TTTAAGCTTCTTGGGAAGAGAGATAAAGTGGATAGGTTTGGGTTTAAGAGGAAATATAGA 1889
Ecre_P5BR2 TTTAAGCTTCTTGGGAAGAGAGATAAAGTGGATAAGTTTGGGTTTAAGAGGAAATATAGA 1890
Mp0191s0002 TTCGAGAATGTGAGCTGCATGAACAAGGCCAAGGAGTTCGGATTCCATGGCTTCCGTGAC 1891
Dl_DN4564 ggagcggt---ttcgagcatgaacaagaacaaggagtttgggttcatggggttcagggat 1892
DlP5BR2 GGAGCGGT---TTCGAGCATGAACAAGAACAAGGAGTTTGGGTTCATGGGGTTCAGGGAT 1893
AT4G24220_VEP1 GGAATGAT---TGATAGTATGAACAAGAGTAAGGAATATGGCTTCCTTGGTTTCAGGAAC 1894
Erche02g027660 GGAATGAT---TGATAGTATGAACAAGAGTAAGGAACATGGCTTCCTTGGTTTTAGGAAC 1895
Ecre_P5BR1 GGAATGAT---TGATAGTATGAACAAGAGTAAGGAACATGGCTTCCTTGGTTTTAGGAAC 1896
Dl_DN477 tgtctcct---tgatacgatgaacaagagcaaggagcatggatttaagggatttaggaac 1897
DlP5BR1 tgtttcct---ggatagtatgaacaagagcaaggagcatggctttttgggatttaggaac 1898
* ** * ** ** 1899
1900
Dl_DN67489 gctttggattcgatatcgtattgcattaatttgatgcgagtcgagagatttatcccgtaa 1901
AT5G58750 ACCCTAGATTCGGTTTTGTATTGGATTGATGTGATGAGAGATGAAAAACTCATTCCTTTG 1902
Erche06g007150 ACCCTAGATTCGATTTTGTATTGGATCGATGTGATGAGAGATGAAAAACTCATTCCTTTG 1903
Erche06g011020 ACCCTAGATTCGATTTTGTATTGGATTGATGTGATGAGAGATGAAAAACTCATTCCTTTC 1904
Ecre_P5BR2 ACCCTAGATTCGATTTTATATTGGATTGATGTGATGAGAGATGAAAAACTCATTCCTTTG 1905
Mp0191s0002 ACGGAAAACTCAGTGAAGTCTATCATTCATGAAATGGTCGAAGCTAAAATCATACCGTCA 1906
Dl_DN4564 agcaccaagtcttttatatcttctgttaacaaagtgagatcttacagatttgtcccttga 1907
DlP5BR2 AGCACCAAGTCTTTTATATCTTCTGTTAACAAAGTGAGATCTTATAGATTTGTCCCTTGA 1908
AT4G24220_VEP1 TCCAACAACTCTTTTATCTCTTGGATTGACAAGTACAAGGCGTTCAAGATCGTACCTTGA 1909
Erche02g027660 TCCAACAACTCTTTTATCTCTTGGATTGACAAGTACAAGGCTTTCAAGATCGTGCCTTGA 1910
Ecre_P5BR1 TCCAACAACTCTTTTATCTCTTGGATTGACAAGTACAAGGCTTTCAAGATCGTGCCTTGA 1911
Dl_DN477 tccaagaactcgttcatttattggattgataagatgagatcttacaagattgtgccctaa 1912
DlP5BR1 tccaagaatgcgttcatttcttggattgacaaggcaaaagcttacaagattgttccttga 1913
* * * * * * * * * * ** * 1914
1915
Dl_DN67489 --------------------------------------- 1916
AT5G58750 TAA------------------------------------ 1917
Erche06g007150 TAA------------------------------------ 1918
Erche06g011020 TAA------------------------------------ 1919
Ecre_P5BR2 TAA------------------------------------ 1920
Mp0191s0002 TTCCACGAAAGATATCAGTTGAGACACACAGCTGAATGA 1921
Dl_DN4564 --------------------------------------- 1922
DlP5BR2 --------------------------------------- 1923
AT4G24220_VEP1 --------------------------------------- 1924
Erche02g027660 --------------------------------------- 1925
Ecre_P5BR1 --------------------------------------- 1926
Dl_DN477 --------------------------------------- 1927
DlP5BR1 --------------------------------------- 1928
1929
1930
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
56
Figure S18. Multiple sequence alignment of steroid 5α-reductases (5αR/DET2). Coding 1931
sequences were aligned using Clustal Omega. Species included: Arabidopsis thaliana (At/AT), 1932
Calotropis gigantea (Cg), Erysimum cheiranthoides (Ec/Erche), Digitalis lanata (Dl), and 1933
Marchantia polymorpha (Mp). Sequences correspond to gene phylogeny in Figure 6d. 1934
1935
CLUSTAL O(1.2.4) multiple sequence alignment 1936
1937
1938
M_polymorpha_0170s0018 -----------------ATGCCAACGTTTGAAA----TTCACGACGAGGCGTGGTATCCT 1939
Cg_12956 ATGGTGGATCTGCCTTTTACCAATTCTGCAACAATGGCTGCAGATGAAGCATTCTTCAAG 1940
Erche07g010950 ---------------------------ATGGAAGAGATCGCCGATCAGAGCTTCTTCCGC 1941
AtDET2_AT2G38050 ---------------------------ATGGAAGAAATCGCCGATAAAACCTTCTTCCGA 1942
Cg_5349 ---ATGACACTATCACAGTTTCCTTCCTGGAAAATGATTACAGATCAAGAACTCTTCCAT 1943
Dl2934 ---------------------------------atgaactccgaccaagatttatacaac 1944
** * * 1945
1946
M_polymorpha_0170s0018 TGGATACTGGGGGGACTCTTTGCACTCTCTCTAGTAACTTACTGGGCTTGTGACCGTATA 1947
Cg_12956 TACTGTCTCATCATTTTCTCACTATTCTCACCAATTTCAAGCCTCT ---------CCTCA 1948
Erche07g010950 TATTGCGTCCTCACCCTAATTTTCTCCGGCCCACCAACCGCCGTCGCTTTAAAATTCCTC 1949
AtDET2_AT2G38050 TACTGTCTCCTCACTCTTATTTTCGCCGGCCCACCAACCGCCGTCCTTCTGAAATTCCTC 1950
Cg_5349 TACAGCCTCATCGTTTTCTTTCTAATCTCACCACCAACTGCAGTCGCCCTTCGCTATATC 1951
Dl2934 tactgtctcctctcaatcctcttcctcacacctcccaccatcatcgctctcctcttcctc 1952
* * * * * * 1953
1954
M_polymorpha_0170s0018 ACGGCTCCCTATGGC---CGTCATGTAAAGCGTGGGTGGGGTCCTGCCTGGGGAGTACGT 1955
Cg_12956 ACCGCTTCCTACGGCAGACATCGTCGTCCAACGACCACCGGAAAAACCATCCCGGCACCA 1956
Erche07g010950 GAAGCTCCTTACGGC---AAACACTTCCGTTCCGGATGGGGTCCCACCGTATCTCCGCCG 1957
AtDET2_AT2G38050 CAAGCTCCTTACGGT---AAACACAACCGTACCGGATGGGGTCCCACCGTATCTCCACCG 1958
Cg_5349 ACAGCTCCTTACGGC---AAGCACAGGCGTTCAGGCTGGGGACCCACCATCCCCGCACCT 1959
Dl2934 accgccccgtacggc---aagcacaaccgccccggatggggccccaccatcccgccgcca 1960
** * ** ** * ** ** * 1961
1962
M_polymorpha_0170s0018 GAGTGCTGGATTGTGATGGAGAGTCCTGCTCTATGGGCAATGGTTTTGTTCTATTCTATG 1963
Cg_12956 ATAGCATGGTTCCTCTTCGAAAGTCCTACGCTCTGGCTTACAATCCTCCTATTTCCATTA 1964
Erche07g010950 ATTGCTTGGTTCGTCATGGAGAGTCCGACCTTGTGGCTCACGCTCCTTCTCTTCCCCTTT 1965
AtDET2_AT2G38050 ATTGCTTGGTTCGTCATGGAGAGCCCAACCTTGTGGCTCACTCTCCTCCTCTTCCCCTTT 1966
Cg_5349 GTGGCTTGGTTCCTGATGGAGAGTCCAACACTCTGGCTCACCACCCTCCTCTTCCCTTTT 1967
Dl2934 ctcgcctggtttctaatggagagccccacattgtggctcacactcctcctcttcccccac 1968
*** * * * ** ** ** * * *** * * * * * 1969
1970
M_polymorpha_0170s0018 GGTGAGCAAAAGTTGGGTCGTGTACCATTGATTCTACTCAGATTACACCAGGTCCATTAC 1971
Cg_12956 GGCAAAAATCACTCAAATCCAAAATCCATAATCCACATATCGTTCTACCTAATCCACTAT 1972
Erche07g010950 GGTCGTCACTCTCATAATCCTAAATCTCTCCTCCTCTTCTCTCCTTTTCTCCTCCATTAC 1973
AtDET2_AT2G38050 GGTCGTCACGCTCTCAACCCTAAATCTCTACTTCTATTCTCTCCTTATCTCATTCATTAC 1974
Cg_5349 GGTCAAAACAGGACCAATCCAAAAGCTCTTGTCTTGGGATCACTCTACCTCATCCACTAT 1975
Dl2934 ggcagaaacagccacaatccacgcgccttcatcctcatgtcccccttcctcctccactac 1976
** * * * * * * * ** ** 1977
1978
M_polymorpha_0170s0018 TTCAACAGGGTACTCATCTATCCCATGCG ------------------------------- 1979
Cg_12956 TTCCACCGCGTTCTAATCTATCCGCTCGTTATGTTCCTAATAGTTAACCGCAAAAACCCT 1980
Erche07g010950 TTCCACCGCACCATCATTTACCCTCTTCGCCTCTTCCGCAGCTCCACCTC ---------- 1981
AtDET2_AT2G38050 TTCCACCGCACCATCATTTACCCTCTTCGCCTCTTCCGCAGCTCCTTCCC ---------- 1982
Cg_5349 TTCCACCGCACTATCCTCTACCCAATTAGACTATATTTAAGGAGCTCACC ---------- 1983
Dl2934 ctccaccgtacgttcatttacccactcagactcttcctcaagatccggaa ---------- 1984
** ** * * * ** ** * 1985
1986
M_polymorpha_0170s0018 -----------CATGAAAGTACGAGGCAAGGGTATGCCAATCATAGTGGCAGCTTGCGCT 1987
Cg_12956 AAAACTAAAACCCCCAAATCCGGCGGACACGATTACCCGATCAAAGAAACAGTTCTCGGA 1988
Erche07g010950 -----------CTCT------GGCAAAAGTGGTTTCCCGATCACTGTCGCCGCCATGAGT 1989
AtDET2_AT2G38050 -----------CGCC------GGTAAAAACGGATTTCCGATCACCATCGCCGCCTTGGCT 1990
Cg_5349 -----------CCGGAAAA---CGCCTAGCGAGTTTCCTGTAAGTATGGCATCGATGGCT 1991
Dl2934 -----------acagaaaatccggaaacccggtttcccggtcagcatggccctgctggct 1992
* ** * * * 1993
1994
M_polymorpha_0170s0018 TTCGCTTTCAACATTCTCAACAGCTATGTCCAAGCTCGGTGGCTGTCCAACTATGGATCA 1995
Cg_12956 ACAATTTACAATCTCATCAACGCTTATCTCCAAGCGAGATCGGCTTCGGAATACACCGAT 1996
Erche07g010950 TTCACCTTTAATCTCATCAACGGTTATATCCAGGCGAGGTGTGTTTCGCACTACAAGAAC 1997
AtDET2_AT2G38050 TTCACCTTTAATCTCCTCAATGGTTATATCCAGGCGAGGTGGGTTTCGCATTACAAGGAT 1998
Cg_5349 TTTGTTTTCAATATCTTGAATGCTTATTTGCAGATAAGGTGGGTCACACACTATGCT --- 1999
Dl2934 tttgggtttaatttgttgaatggttacttgcaagccagatgggtttctgaatacgcc --- 2000
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint
57
* ** * * ** ** * ** * * * * ** 2001
2002
M_polymorpha_0170s0018 TACCCCGAC------TCATGGCTTACCAGTCCGAAGTTTATTCTCGGAGCAACTCTGTTT 2003
Cg_12956 TTCGGTAATGATAATGATAAATTATTCCGTTTACGATTTATGTTCGGAATGGCTATTTTC 2004
Erche07g010950 GACTACGAA---GACACACATTGGTTCTGGTGGCGGTTTATTATTGGTACGGTGGTGTTT 2005
AtDET2_AT2G38050 GACTACGAA---GACGGAAACTGGTTCTGGTGGCGGTTTGTTATCGGTATGGTGGTTTTC 2006
Cg_5349 GTGTACGAA---GATAGTAAGTGGTTCTGGTGGCGGTTCTTTACTGGACTTGCCATTTTC 2007
Dl2934 gatctagac---ggagatcagtggttctggatgcggtttacaagcggcgcggtggttttc 2008
* * * ** ** * ** 2009
2010
M_polymorpha_0170s0018 GGGCTGGGATTTTTGGGCAATTTTTGGAGCGACTCA ------------------------ 2011
Cg_12956 GTTACAGGAATGACGATAAATGTGAGTTCGGATTACGCTTTACTGAGACTGAAGAGCGAT 2012
Erche07g010950 GTAGCCGGTATGTGGATAAATATCACGTCGGACCGGACTCTGGTACGAC ----------- 2013
AtDET2_AT2G38050 ATAACCGGCATGTATATAAATATCACGTCGGACCGGACTTTGGTACGAT ----------- 2014
Cg_5349 GTGGTGGGCATGGCAGTAAACGTAATGTCAGACTATGCCTTGTTGGAGC ----------- 2015
Dl2934 gtcggcggcatgatggcgaatatatggtcggataatttgttgatggggt ----------- 2016
** * ** * ** 2017
2018
M_polymorpha_0170s0018 ---------------TACCTCTTCTCACTGCGGGCAGACGAAGATGATAGGAGCTACAAG 2019
Cg_12956 CAAACGACGTCGGGAGCGGGAGCAGGAGAAGGAGAAAAGGGAATAAAAAATAGATACAAA 2020
Erche07g010950 -------------------------------TGAAGAAAGAGAATCGGGGAGGTTATGTG 2021
AtDET2_AT2G38050 -------------------------------TGAAGAAAGAGAACCGGGGAGGTTATGTG 2022
Cg_5349 -------------------------------TGAAGAGTAAGGGTGGTGGGGGATACAAA 2023
Dl2934 -------------------------------tgaagaaagagagtggaggagggtatagg 2024
* ** 2025
2026
M_polymorpha_0170s0018 ATTCCGAAGGCCGGTTTGTTTAAGTTCATTACATGTCCGAATTATTTTTCGGAGATGGTA 2027
Cg_12956 ATACCAAAAGGGGGAATGTTCGAATTGGTGAGCTGTCCAAATTATTTTGGGGAAATAATG 2028
Erche07g010950 ATACCGAGAGGAGGCTGGTTCGAGCTTGTAAGCTGTCCGAATTACTTGGGAGAGGCGATA 2029
AtDET2_AT2G38050 ATACCGAGAGGAGGCTGGTTCGAGTTGGTAAGCTGTCCGAATTATTTTGGAGAGGCGATT 2030
Cg_5349 ATTCCCAGAGGTGGGTTGTTTGAGTTGGTTAGTTGCCCAAATTATTTTGGAGAAGTATTG 2031
Dl2934 gtaccaaagggtgggctgttcgagtgggttagcagcccaaattattttggggagatagtg 2032
* ** * * ** *** * * * * ** ***** ** ** * 2033
2034
M_polymorpha_0170s0018 GAATGGTTGGGATGGGCCATCATGACCTGGTCTCCAGCTGGGCTTGCTTTCTTCATTTAC 2035
Cg_12956 GAATTTTTTGGTTGGGCATTGGTGACGTGTCGTTGGGCACCTTTTATATTCTTCTTAAAC 2036
Erche07g010950 GAGTGGTTGGGCTGGGCTGTAATGACTTGGTCTTGGGCCGGGTTTGGTTTTTTTCTGTAC 2037
AtDET2_AT2G38050 GAGTGGTTGGGCTGGGCTGTTATGACTTGGTCTTGGGCCGGTATTGGATTTTTTCTGTAC 2038
Cg_5349 GAGTGGTTCGGATGGTGTTTGGTGAACTGGTCCTGGTCCAGTTTGGGGTTTTTCTTGTTC 2039
Dl2934 gagtggttcgggtgggccgtgatgacttggtcttggtccgggtttgggttcttcatgtgg 2040
** * ** ** *** * *** ** * * ** ** * 2041
2042
M_polymorpha_0170s0018 ACCATAGCTAATCTGGCCCCTAGAGCTGTAAGCAACCATCAGTGGTACCTGAGCAAGTTC 2043
Cg_12956 ACTTGTAGTATTTTGATCCCTAGGGCTTTTGCACATCACAAATGGTATTTGGATAAGTTT 2044
Erche07g010950 ACGTGTTCCAATTTGTTCCCGCGTGCACGTGCGAGCCACAAGTGGTACATGGACAAGTTC 2045
AtDET2_AT2G38050 ACGTGTTCCAATTTGTTTCCGCGTGCACGTGCGAGTCACAAGTGGTACATTGCCAAGTTC 2046
Cg_5349 ACTTGTGCTAATTTGATCCCTAGGGGTGTCTCAAATCACAAATGGTACCTTGACAAGTTT 2047
Dl2934 acttgtggtaatttagttcccagagcagcggcaactcacaagtggtatttggagaaattt 2048
** * * * ** * * ** * ***** * ** ** 2049
2050
M_polymorpha_0170s0018 AATGACTAT---CCCAAAGAGCGAAGAATTCTTATACCCTTTGTGTATTGA 2051
Cg_12956 GGAGAAGAATATCCTAAAAATAGAAAAGCTGTTATTCCTTTCGTATGTTAA 2052
Erche07g010950 AAGGATGAGTATCCCAAGACTCGAAAAGCTGTTATTCCTTTTGTGTACTGA 2053
AtDET2_AT2G38050 AAGGAAGAGTATCCCAAGACTCGTAAAGCTGTTATTCCTTTTGTGTACTGA 2054
Cg_5349 GCAGAGGACTACCCTAAGAACAGAAAAGCTGTTATTCCATTTATTTACTGA 2055
Dl2934 ggagaggattatcccaagaacaggaaagctgttattccatttgtatactaa 2056
** * ** ** * * * * **** ** ** * * * * 2057
2058
.CC-BY-ND 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprint (whichthis version posted April 11, 2024. ; https://doi.org/10.1101/2024.04.10.588904doi: bioRxiv preprint